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1. Introduction 
Steroids are an unique class of chemical compounds that are found throughout 
the animal and plant kingdom and this class includes sterols such as cholesterol, 
ergosterol, bile acids, steroid hormones (Petrow et al., 1996). The modern era of 
steroid research began with steroid chemistry in the early 1900s. Dr. Adolf Windaus, 
a Gottingen chemist, worked for over 20 years on the isolation of steroids, 
development of assays for detecting steroids, and the use of classical chemistry to 
elucidate steroid structures (Adolf et al., 1909). Hundreds of distinct steroids are 
found in plants, animals, and fungi. All steroids are made in cells either from the 
sterol lanosterol (animals and fungi) or the sterol cycloartenol (plants). Both sterols 
are derived from the cyclization of the triterpene squalene Steroid molecules possess a 
common chemical skeleton of four fused rings, consisting of three six-membered 
rings and a five-membered ring. Chemically, this hydrocarbon scaffold is a 
cyclopentano perhydrophenanthrene, describing the three rings of phenanthrene and 
the cyclopentane ring (Gareth et al., 2003). 
Pregnenolone serves as the common precursor in the formation of the 
adrenocorticoids and other steroid hormones. This steroid is converted through 
enzymatic oxidations and isomerization of the double bond to a number of 
physiologically active steroids, including the adrenocorticoids cortisol 
(hydrocortisone), corticosterone, and aldosterone (Auchus et al., 2003) 
Since the introduction of cortisone and hydrocortisone anti-inflammatory steroids 
have remained an important and un-replaced drug class. Although not without adverse 
effects, these compounds have continued to be the "drug of choice "in the treatment of 
afflictions ranging from the moderate skin rash to severe acute inflammatory 
disorders (Baxter et al., 1979). The generation of corticosteroids is intricately 
balanced when the production and regulatory process malfunctions, the result is either 
an excess (Cushing’s syndrome) or deficiency (Addison's disease) in glucocorticoid 
levels.  
Glucocorticoids and their metabolites were recognized early as possessing 
powerful anti-inflammatory and immunomodulatory properties. Even before 1950, 
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reports of the anti-arthritic properties of cortisone by Hench and coworkers indicated 
the potential for these compounds to reduce the suffering of patients with 
inflammatory diseases (Wepierre et al., 1979) 
Prednisone is an inactive form of Prednisolone which is drug of choice in 
systemic anti-inflammatory, anti-asthmatic and for immunosuppressive effect. 
Dexamethasone and Betamethasone are long acting steroids used as anti-
inflammatory and for immunosuppressive effect where water retention is undesirable. 
Beclometasone and budesonide are locally used anti-inflammatory and for 
immunosuppressive agents. Flucortisone is a drug of choice for mineralocorticoids 
effect. triamcinolone having only glucocorticoid activity and mineralocorticoids 
activity is absent while Dexamethasone and Betamethasone are having minimum 
mineralocorticoids activity compare to other steroids (Rang and Dale et al., 2003). 
Adrenocorticosteroids are also used in  treatment of non-adrenal disorders like 
angioneurotic edema, asthma, contact dermatitis, allergic rhinitis, urticaria, lupus 
erythematosus, polymyositis, allergic conjunctivitis, optic neuritis, autoimmune 
hemolytic anemia, idiopathic thrombocytopenic purpura, multiple myeloma, cerebral 
edema, multiple sclerosis, organ transplantation, prevention of infant respiratory 
distress, sarcoidosis, aspiration pneumonia, atopic dermatitis, seborrheic dermatitis 
and seborrheic dermatitis (Goldfien et al., 1998). 
Adverse effects of adrenocorticoids are always a big question mainly, for long 
term administration. Adrenocortical insufficiency results due to suppression of the 
pituitary-adrenal axis and inhibition of ACTH production. Musculoskeletal effects 
like muscle wasting, muscle pain and weakness, delayed wound healing, atrophy of 
protein matrix of bone are observed  with use of steroid. Immune system also affected 
with increased susceptibility to infection, especially with high dose and systemic 
glucocorticoids. Fluid and electrolyte disturbances occur due to mineralocorticoid-like 
action by glucocorticoids results in sodium retention. Ocular effects include mainly 
increases in intraocular pressure (IOP) and the development of posterior subcapsular 
cataracts. Endocrine effects include varying effects including hypercorticism, 
amenoriea, hyperglycemia. GI disturbances are also observed like varying effects 
including nausea, anorexia, increased appetite, and the development and increased 
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severity of ulcers. Nervous system and psychological effects like headache, vertigo, 
insomnia, increased motor activity, euphoria, mood swings, depression, anxiety etc. 
also observed. Dermatologic effects include skin atrophy and skin thinning from a 
decrease in collagen synthesis, impaired wound healing, acne, increased perspiration. 
(Olin et al., 1996) 
Production of steroid drugs is a large scale industry, total world consumption 
of steroids precursors was one thousand tones, two third of which came from 
diosgenin and the remaining one third from the variety of miscellaneous sources. Till 
today, more than four thousand plant species have been investigated which has 
resulted in the identification of some thirty naturally occurring steroids sapogenins 
many of which could provide valuable source materials for steroids compounds 
(Applezweig et al., 1962). 
Major herbal steroids include diosgenin, solasodine, tigogenin, yoccagenin, 
ticogenin, barbourgenin, sarsepogenin, smilagenin, yamogenin, hecogenin.  Diosgenin 
is mainly obtained from Allium fuscoviolacenum, Allium narcissifolium, Aspidistra 
elatior, Balanites roxburghii, Convallaria keisukei, Costus speciosus, Dioscorea 
composita, Dioscorea floribunda, Dioscorea deltoidea, Dioscorea gracillima, 
Dioscorea polystachya, Dioscorea prazeri, Dioscorea sativa, Dioscorea septembola, 
Funkia ovata, Kallstroemia pubescens, Ophiopogon japonicus, Paris polyphyalla, 
Polygonatum latifolium, Polygonatum multiflorum, Smilax exfelsa, Solanum introsum, 
Solanum indicum, Tamas communis and Tribulus terrestris, Trigonella foenum and 
Trigonella tschonoskii.  
Plant material that used as source of Solasodine are Solanum eleagnifolium, 
Solanum jubatum, Solanum incanum, Solanum khasianum, Solanum laciniatum, 
Solanum mammosum, Solanum marginatum, Solanum platanifolium, Solanum 
sodomaeum, Solanum tomentosum, Solanum trachysyphyum, Solanum trilobatum, 
Solanum verbascifolium and Solanum xanthocarpum (Amrit et al., 1999). 
Yamogenin can be derived from plants like Aspargus officinalis, Smilex 
officinalis and Trigonella foenum graceum.  Hecogenin is mainly found from agave 
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genus. In various species like A. americana, A. cantala, A. sisalana, A. angustifolia, 
leaves yield a valuable fiber (Marston et al., 1985). 
Herbal medicines are safer than allopathic medicine. There would be no 
serious side effects associated with longer use of herbal material. Herbal extract 
contains many chemical constitutes which eliminate the unwanted effects of active 
principle. In many cases it has been shown that potential harm is minimized through a 
selected method of preparation. Herbal material is being used in specific way 
particularly by addition of other material which may decrease the toxicity by 
countering unwanted pharmacological effects (Evans et al., 2004). 
Today 80 % of the world's populations are dependent on herbs for their health. 
Some herbal treatments are well established, and have undergone clinical testing. This 
approach is best called phytotherapy and uses one remedy for one condition based on 
proper scientific testing (Eric et al., 1963) 
A large number of academic, industrial and government institutes are 
conducting research on the steroid in India but there is few evidence of systemic study 
of steroids.  Herbal steroids are mainly used for production of synthetic steroids. 
Herbal steroid are also used in phytotherapy.  A few studies showed it to be anti-
arthritic, anti-inflammatory, and Immunosuppressant. Benefits were also claimed in 
cases of antibacterial and anti-allergic. The collective scientific evidence, scarce as it 
is, shows that herbal steroid is more likely to build profit margins compare to 
available synthetic steroids (Swami et al., 2005). 
Steroid possesses glucocorticoid as well as mineralocorticoid activity. There is 
no credible research on the evaluation of herbal steroids.  Apart from precursor for 
allopathic steroids, many activities have been reported for important herbal steroids.  
Dioscorea Species can be used in preparation of medicaments for preventing 
mucositis caused by radiotherapy and chemotherapy (Faming et al., 2005). The 
ethanolic extract of Dioscorea membranacea exhibited potent inhibitory activity 
against β hexosaminidase release as a marker of degranulation in RBL-2H3 cells, 
which shows their anti-allergic activities (Tewtrakul et al., 2006). Diosgenin obtained 
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from Dioscorea composita shows antiphlogistic activity with dose of 1-500 mg daily 
(Roux et al., 1964). Diosgenin modulates certain aspects of acquired immunity, 
including the enhancement of antigen-specific IgG2a and IFN-γ expression, which 
may be mediated through the up-regulation of Th1 differentiation (Jan et al., 2007). 
Dioscorea membranacea contain Nitric oxide inhibitory substances and it is used for 
treatment of the inflammatory diseases (Tewtrakul et al., 2007). Diosgenin, induces 
apoptosis, cell cycle arrest and COX activity in osteosarcoma cells and Diosgenin 
treatment caused an inhibition of 1547 cell growth with a cycle arrest in G1 phase and 
apoptosis induction (Moalic et al., 2001) Plant steroid, diosgenin, causes an inhibition 
of the growth of fibroblast-like synoviocytes (FLS) from human rheumatoid arthritis 
(RA), with apoptosis induction associated with cyclooxygenase-2 (COX-2) up-
regulation (Liagre et al., 2004). Tribulus terrestris extracts for antibacterial, antiviral, 
anti-herpes cream. This product was also found to be very successful in suppository 
form for the treatment of vulvo-vaginal, vulvo-hemorrhoidal and colonic conditions 
(Alexis et al., 2002).  
Many experiments have been reported on evaluation of therapeutic activity of 
Solanum Species. The anti-inflammatory effect of solasodine and of methanol extract 
of Solanum trilobatum was evaluated and it showed significant anti-inflammatory 
activity (Emmanuel et al., 2006). Solasodine and preparation of solasodine organic 
acid salts useful as antitumor, anti-asthmatic or anti-inflammatory agent (Liu et al., 
2004). Solasodine hydrochloride from the fruit juice of Solanum nigrum or Solanum 
aviculare can be prepared and it can be used for treatment of neoplasm, asthma, and 
inflammation as oral or injection medication (Liu et al., 2002). 
Yamogenin is mainly found along with diosgenin containing plant. The 
nomenclature of yamogenin its self suggest its origin from wild yam and other varity 
of yam. Fenugreek seeds have been widely studied for their reputed antidiabetic, 
hypocholesterolemic and antifertility effects. The consumption of defatted fenugreek 
can help in the management of diabetes, hypercholesterolemia, prevention of 
atherosclerosis and coronary heart disease (Al-Habori et al., 2002). A formulation of 
Smilax china which considered as good source for Yamogenin has been reported for 
treatment of gynecological inflammation (Han et al., 2007). 
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Agave genus is the only reported source for hecogenin and many agave plants 
have been identified as source for hecogenin (Marston et al., 1985). The methanolic 
extract of Agave intermixta may be mediated by its constituent hecogenin and might 
contribute to the anti-inflammatory activity shown by this species (Quilez et al., 2004).  
Anti-inflammatory activity also reported for Lyophilized aqueous extract obtained 
from Agave americana (Peana et al., 1997) Hecogenin is shown to inhibit 5α-
reductase type 1 activity in I-C cells and its preparations suitable for treating acne, 
seborrhea. These preparations may contain anti-inflammatory or anti-irritant agents 
such as ursolic acid (L'oreal et al., 2002).  
The roots of Hemidesmus indicus are woody and have a sweet taste, with 
cooling effect, and used in various ailment of diseases, a well-known drug in the 
Ayurveda system of medicine (Kirtikar and Basu et al., 1991). Inflammation induced 
by Viper venom and Propiono bacterium acne are reported to be treated by root 
extract (Jain et al., 2003). A lep of root powder applied topically is used to treat 
swellings, inflammation and chronic rheumatism (Alam et al., 1994, 1998). Many 
other reports suggest the activity against inflammation induced due to pathogenesis 
for example, asthma, leprosy, swelling of joints, inflamed eyes and in chronic cough, 
etc. 
Many pharmacologic activities of steroid containing plants and herbal steroids 
viz. diosgenine, solasodine, yamogenin, sarsepogenin and hecogenin have been 
reported (Applezweig et al., 1962).  
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2. Review of Literature 
2.1 Steroids 
2.1.1 Introduction to steroids 
Corticosteroids are a class of steroid hormones that are produced in the adrenal 
cortex. Corticosteroids are involved in a wide range of physiologic systems such as 
stress response, immune response and regulation of inflammation, carbohydrate 
metabolism, protein catabolism, blood electrolyte levels, and behavior. 
Glucocorticoids such as cortisol control carbohydrate, fat and protein metabolism 
and are anti-inflammatory by preventing phospholipid release, decreasing eosinophil 
action and a number of other mechanisms. Mineralocorticoids such as aldosterone 
control electrolyte and water levels, mainly by promoting sodium retention in the 
kidney. 
2.1.2 Classification 
Some of the common categories of steroids (Facts about gonane, 2010): 
1) Animal steroids  
a) Insect steroids  
i) Ecdysterone 
b) Vertebrate steroids  
i) Steroid hormones  
(1) Androgens, estrogens, and progestagens. 
(2) Corticosteroids include glucocorticoids and mineralocorticoids.  
(3) Anabolic steroids  
ii) Cholesterol 
2) Plant steroids  
a) Phytosterols 
b) Brassinosteroids 
3) Fungus steroids  
a) Ergosterols 
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In general, corticosteroids are grouped into four classes, based on chemical 
structure. Allergic reactions to one member of a class typically indicate an intolerance 
of all members of the class. This is known as the "Coopman classification” after S. 
Coopman, who defined this classification in 1989. (Coopman . et al. 1989) 
 
The highlighted steroids are often used in the screening of allergies to topical 
steroids (Wolverton et al. 2001) 
Group A 
(Short- to medium-acting glucocorticoids) 
Hydrocortisone, Hydrocortisone acetate, Cortisone acetate, Tixocortol pivalate, 
Prednisolone, Methylprednisolone, and Prednisone. 
Group B 
Triamcinolone acetonide, Triamcinolone alcohol, Mometasone, Amcinonide, 
Budesonide, Desonide, Fluocinonide, Fluocinolone acetonide, and Halcinonide. 
Group C 
Betamethasone, Betamethasone sodium phosphate, Dexamethasone, Dexamethasone 
sodium phosphate, and Fluocortolone. 
 
Group D 
Hydrocortisone-17-butyrate, Hydrocortisone-17-valerate, Aclometasone dipropionate, 
Betamethasone valerate, Betamethasone dipropionate, Prednicarbate, Clobetasone-17-
butyrate, Clobetasol-17-propionate, Fluocortolone caproate, Fluocortolone pivalate, 
and Fluprednidene acetate. 
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2.1.3  Chemistry 
Steroids are a unique class of chemical compounds that are found throughout 
the animal and plant kingdom, and this class includes sterols such as cholesterol and 
ergosterol, bile acids, and steroid hormones. Modern scientific research on steroid 
chemistry and biochemistry began in the early twentieth century, and several major 
treatises on the subject have been published (Nes et al. 1977). 
The biological and medical significances of steroids have been observed since 
ancient times, even though the exact chemical nature and properties of steroids began 
to be understood only in the late 1920s and early 1930s  
Egyptians and Romans used extracts of plants such as purple foxglove to treat 
dropsy. The physical effects of castration were well recognized in eunuchs and in 
medieval castrati choirs.  
Scientific observations in more modern times began examining the biological 
consequences of hormones without the realization of nature of the chemicals 
involved. Berthold, a Gottingen physiologist, reported the effects of implanted testis 
in studies with cocks in 1849 (Berthold et al. 1849). In 1855, Addison discovered the 
relationship of the adrenal glands with a particular disease characterized by bronze 
skin color (ll), and this disease of chronic adrenal insufficiency is now referred to as 
Addison's disease. 
The modern era of steroid research began with steroid chemistry in the early 
1900s. Dr. Adolf  Windaus, a Gottingen chemist, worked for over 20 years on the 
isolation of steroids, development of assays for detecting steroids, and the use of 
classical chemistry to elucidate steroid structures. Munich was engaged in natural 
products chemistry, including bile acids (Wieland et al.,1916), and was awarded the 
Nobel prize in 1928 for his research on this subject. The original chemical structures 
of cholesterol and other steroids proposed in 1928 were subsequently found to be 
incorrect, and correct structures were identified in 1932 (Rosenheim  et al., 1932).  
Chemical studies on compounds involved in reproduction began in the 1920s, 
and in 1929 Adolf F. Butenandt and Edward A. Doisy independently reported the 
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isolation of an active steroid sex hormone estrone, from the urine of pregnant women 
(Doisy et al. 1930). Throughout the 1930s, many steroid hormones were isolated and 
structures determined, including progesterone by Butenandt and corticosteroids by 
Reichstein. 
The synthesis of steroids followed shortly thereafter by research groups led by 
Bachmann, Woodward, Robinson, and Cornforth (Woodward et al. 1951) 
Studies on the biochemical mechanism of action of steroids began in the late 
1950s with the use of tritiated estrogens of high specific activity. Jensen and Jacobson 
reported the accumulation of physiological levels of estrogen in target organs and 
postulated the presence of a receptor. Research on the biochemistry and molecular 
biology of steroid hormone action has exploded in the past few decades and 
constitutes a major effort in the field today. 
Two important discoveries in the late 1940s and early 1950s had a dramatic 
effect not only on steroid research but also on the pharmacological applications of 
steroids. The first was the clinical report by Hench from the Mayo Clinic on the 
significant improvement in patients with rheumatoid arthritis following cortisone 
treatment. The second was the application of estrogen and progestin preparations for 
contraception, demonstrated by Pincus and colleagues. These two series of studies 
showed for the first time that steroids could be considered as drugs. As a result, 
extensive research on the medicinal chemistry, pharmacology, and clinical studies of 
steroid agonists and antagonists has evolved and continues to provide new insights 
and new medicinal agents for therapies in many different diseases and 
chemoprevention strategies. 
 
2.1.4 Structure and Physical Properties of Steroids 
Steroid molecules possess a common chemical skeleton of four fused rings, 
consisting of three six-membered rings and a five-membered ring (Figure 2.1). 
Chemically, this hydrocarbon scaffold is a cyclopentanoperhydro- phenanthrene, 
describing the three rings of phenanthrene (rings A, B, and C) and the cyclopentane 
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ring (ring D). In steroids, the phenanthrene ring system is completely saturated 
(hydrogenated) and is thus referred to as a perhydrophenanthrene. This steroid 
scaffold contains 17 carbon atoms, and the numbering of the carbon atoms begins 
with the carbons of the phenanthrene and is then followed by numbering the 
remaining carbons of the cyclopentane ring (Figure 2.1). Additional carbon atoms on 
steroids include angular methyl groups attached to C13 and C10 and alkyl substituents 
on C17 (Figure 2.2). When the steroid nucleus is drawn in a two dimensional 
representation, the steroid scaffold appears planar and substituents on carbons of the 
steroid scaffold may be located either above or below the "plane" of the steroid. 
 
 
 
 
Figure 2.1 Basic steroid structure 
 
Figure 2.2 Side chain on steroid scaffold 
 
Substituents located above the plane are drawn with solid lines or with solid 
wedges, and these moieties are referred to as being in the p-configuration. 
Substituents located below the plane are drawn with dashed lines and are referred to 
as having the a-configuration. The angular methyl groups numbered 18 and 19 are 
attached in the p-configuration (above the steroid plane) to C13 and C10, respectively.  
The systematic names for steroids are based on the steroid hydrocarbon 
system, and the particular systematic name begins by selection of the stem name 
based on the hydrocarbon system (Figure 2.3). Cholestane is the term used for 
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steroids with 27 carbon atoms (i.e., the C27 steroid structure). Pregnanes are steroids 
with 21 carbon atoms, androstanes have 19 carbon atoms, estranes have 18 carbon 
atoms, and gonanes have 17 carbon atoms. 
 
 
 
Figure 2.3 Structure of steroid stem names. 
 
Examples of the trivial names, systematic names, and chemical structures for 
common steroids are illustrated in Figure 2.4. Cholesterol is the central steroid of the 
animal kingdom and functions as an essential component of cell membranes and as a 
biosynthetic precursor to other steroids in the body. Cholesterol has 27 carbon atoms, 
a hydroxyl group in the P-configuration at carbon 3, and contains a carbon-carbon 
double bond between carbons 5 and 6. 
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Figure 2.4 Structure of common steroids 
2.1.5 Pharmacology of adrenal corticoids 
The adrenal cortex synthesizes two classes of steroids: the corticosteroids 
(glucocorticoids and mineralocorticoids), which have 21 carbon atoms, and the 
androgens, which have 19 (Figure 2.5).  
The actions of corticosteroids historically were described as glucocorticoid 
(carbohydrate metabolism-regulating) and mineralocorticoid (electrolyte balance-
regulating), reflecting their preferential activities. In humans, cortisol 
(hydrocortisone) is the main glucocorticoid and aldosterone is the main 
mineralocorticoid (Figure 2.6). Although the adrenal cortex is an important source of 
androgen precursors in women, patients with adrenal insufficiency can be restored to 
normal life expectancy by replacement therapy with glucocorticoids and 
mineralocorticoids (Allolio et al., 2002). 
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Figure 2.5 Pathways of corticosteroid biosynthesis 
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2.1.5.1  Physiological actions.  
The effects of corticosteroids are numerous and widespread, and include 
alterations in carbohydrate, protein, and lipid metabolism; maintenance of fluid and 
electrolyte balance; and preservation of normal function of the cardiovascular system, 
the immune system, the kidney, skeletal muscle, the endocrine system, and the 
nervous system. In addition, corticosteroids endow the organism with the capacity to 
resist such stressful circumstances as noxious stimuli and environmental changes.  
Until recently, corticosteroid effects were viewed as physiological (reflecting 
actions of corticosteroids at doses corresponding to normal daily production levels) or 
pharmacological (representing effects seen only at doses exceeding the normal daily 
production of corticosteroids). More recent concepts suggest that the anti-
inflammatory and immunosuppressive actions of corticosteroid of the major 
"pharmacological" uses of this class of drugs also provide a protective mechanism in 
the physiological setting. 
Many of the immune mediators associated with the inflammatory response 
decrease vascular tone and could lead to cardiovascular collapse if unopposed by the 
adrenal corticosteroids. This hypothesis is supported by the fact that the daily 
production rate of cortisol can rise at least tenfold in the setting of severe stress. In 
addition, as discussed below, the pharmacological actions of corticosteroids in 
different tissues and their physiological effects are mediated by the same receptor. 
Thus, the various glucocorticoid derivatives used as pharmacological agents generally 
have side effects on physiological processes that parallel their therapeutic 
effectiveness. 
Corticosteroids are grouped according to their relative potencies in Na
+
 
retention, effects on carbohydrate metabolism (i.e., hepatic deposition of glycogen 
and gluconeogenesis), and antiinflammatory effects. In general, potencies of steroids 
as judged by their ability to sustain life in adrenalectomized animals closely parallel 
those determined for Na
+
 retention, while potencies based on effects on glucose 
metabolism closely parallel those for antiinflammatory effects. The effects on Na
+
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retention and the carbohydrate/antiinflammatory actions are not closely related and 
reflect selective actions at distinct receptors, as noted above.  
Some steroids that are classified predominantly as glucocorticoids (e.g., 
cortisol) also possess modest but significant mineralocorticoid activity and thus may 
affect fluid and electrolyte handling in the clinical setting. In contrast, aldosterone is 
exceedingly potent with respect to Na
+
 retention, but has only modest potency for 
effects on carbohydrate metabolism.  
  
2.1.5.2  General Mechanisms for Corticosteroid Effects.  
Corticosteroids interact with specific receptor proteins in target tissues to 
regulate the expression of corticosteroid-responsive genes, thereby changing the 
levels and array of proteins synthesized by the various target tissues (Figure 2.7). 
Although corticosteroids predominantly act to increase expression of target genes, 
there are well-documented examples in which glucocorticoids decrease transcription 
of target genes (De Bosscher et al., 2003), as discussed below. In addition to these 
genomic effects, some immediate actions of corticosteroids may be mediated by 
membrane-bound receptors (Norman et al., 2004). 
The receptors for corticosteroids are members of the nuclear receptor family 
of transcription factors that transduce the effects of a diverse array of small, 
hydrophobic ligands, including the steroid hormones, thyroid hormone, vitamin D, 
and retinoids.  
These receptors share two highly conserved domains: a region of 
approximately 70 amino acids forming two zinc-binding domains, called zinc fingers, 
that are essential for the interaction of the receptor with specific DNA sequences, and 
a region at the carboxyl terminus that interacts with ligand (the ligand-binding 
domain). 
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Figure 2.6 Structure and nomenclature of corticosteroid products and selected 
synthetic derivatives 
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Figure 2.7 Intracellular mechanism of action of the glucocorticoid receptor 
Although complete loss of glucocorticoid receptor (GR) function apparently is 
lethal, mutations leading to partial loss of GR function have been identified in rare 
patients with generalized glucocorticoid resistance (Bray et al.,  2003).  
 
2.1.5.3  Glucocorticoid Receptor 
 The GR resides predominantly in the cytoplasm in an inactive form until it 
binds glucocorticoids (Figure 2.6). Steroid binding results in receptor activation and 
translocation to the nucleus.  
 
The recognition that the metabolic effects of glucocorticoids generally are 
mediated by transcriptional activation, while the antiinflammatory effects largely are 
mediated by transrepression, suggests that selective GR ligands may maintain the 
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antiinflammatory actions while lessening the metabolic side effects (Coghlan et al., 
2003). 
2.1.5.4  Carbohydrate and Protein Metabolism 
Corticosteroids profoundly affect carbohydrate and protein metabolism. 
Teleologically, these effects of glucocorticoids on intermediary metabolism can be 
viewed as protecting glucose-dependent tissues (e.g., the brain and heart) from 
starvation. They stimulate the liver to form glucose from amino acids and glycerol 
and to store glucose as liver glycogen.  
The mechanisms by which glucocorticoids inhibit glucose utilization in 
peripheral tissues are not fully understood. Glucocorticoids decrease glucose uptake 
in adipose tissue, skin, fibroblasts, thymocytes, and polymorphonuclear leukocytes.  
Similarly, the mechanisms by which the glucocorticoids promote 
gluconeogenesis are not fully defined. Amino acids mobilized from a number of 
tissues in response to glucocorticoids reach the liver and provide substrate for the 
production of glucose and glycogen. In the liver, glucocorticoids induce the 
transcription of a number of enzymes. 
2.1.5..6 Lipid Metabolism 
Two effects of corticosteroids on lipid metabolism are firmly established. The 
first is the dramatic redistribution of body fat that occurs in settings of endogenous or 
pharmacologically induced hypercorticism, such as Cushing's syndrome. The other is 
the permissive facilitation of the lipolytic effect of other agents, such as growth 
hormone and adrenergic receptor agonists, resulting in an increase in free fatty acids 
after glucocorticoid administration. With respect to fat distribution, there is increased 
fat in the back of the neck ("buffalo hump"), face ("moon facies"), and supraclavicular 
area, coupled with a loss of fat in the extremities.  
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2.1.5..7 Electrolyte and Water Balance 
Aldosterone is by far the most potent endogenous corticosteroid with respect 
to fluid and electrolyte balance. Thus, electrolyte balance is relatively normal in 
patients with adrenal insufficiency due to pituitary disease, despite the loss of 
glucocorticoid production by the inner cortical zones. Mineralocorticoids act on the 
distal tubules and collecting ducts of the kidney to enhance reabsorption of Na
+
 from 
the tubular fluid; they also increase the urinary excretion of K
+
 and H
+
. Conceptually, 
it is useful to think of aldosterone as stimulating a renal exchange between Na
+
 and 
K
+
 or H
+
, although this does not involve a simple 1:1 exchange of cations in the renal 
tubule.  
Glucocorticoids also exert effects on fluid and electrolyte balance, largely due 
to permissive effects on tubular function and actions that maintain glomerular 
filtration rate. Glucocorticoids play a permissive role in the renal excretion of free 
water.  
In addition to their effects on monovalent cations and water, glucocorticoids 
also exert multiple effects on Ca
2+
 metabolism. Steroids interfere with Ca
2+
 uptake in 
the gut and increase Ca
2+
 excretion by the kidney. These effects collectively lead to 
decreased total body Ca
2+
 stores.  
2.1.5.7  Cardiovascular System 
The most striking effects of corticosteroids on the cardiovascular system result 
from mineralocorticoid-induced changes in renal Na
+
 excretion, as is evident in 
primary aldosteronism. The resultant hypertension can lead to a diverse group of 
adverse effects on the cardiovascular system, including increased atherosclerosis, 
cerebral hemorrhage, stroke, and hypertensive cardiomyopathy.  
 
2.1.5.8  Skeletal Muscle  
Permissive concentrations of corticosteroids are required for the normal 
function of skeletal muscle, and diminished work capacity is a prominent sign of 
 Review of literature…  
 
 
 
 
    33 
 
adrenocortical insufficiency. In patients with Addison's disease, weakness and fatigue 
are frequent symptoms that may reflect an inadequacy of the circulatory system. 
Excessive amounts of either glucocorticoids or mineralocorticoids also impair muscle 
function. In primary aldosteronism, muscle weakness results primarily from 
hypokalemia rather than from direct effects of mineralocorticoids on skeletal muscle.  
 
2.1.5.9  Central Nervous System 
Corticosteroids exert a number of indirect effects on the CNS, through 
maintenance of blood pressure, plasma glucose concentrations, and electrolyte 
concentrations. Increasingly, direct effects of corticosteroids on the CNS have been 
recognized, including effects on mood, behavior, and brain excitability.  
 
2.1.5.10  Formed Elements of Blood   
Glucocorticoids exert minor effects on hemoglobin and erythrocyte content of 
blood, as evidenced by the frequent occurrence of polycythemia in Cushing's 
syndrome and of normochromic, normocytic anemia in adrenal insufficiency. More 
profound effects are seen in the setting of autoimmune hemolytic anemia, in which 
the immunosuppressive effects of glucocorticoids can diminish the self-destruction of 
erythrocytes.  
 2.1.5.11 Anti-inflammatory and Immunosuppressive Actions   
In addition to their effects on lymphocyte number, corticosteroids profoundly 
alter the immune responses of lymphocytes. These effects are an important facet of 
the antiinflammatory and immunosuppressive actions of the glucocorticoids. 
Glucocorticoids can prevent or suppress inflammation in response to multiple inciting 
events, including radiant, mechanical, chemical, infectious, and immunological 
stimuli. Although the use of glucocorticoids as antiinflammatory agents does not 
address the underlying cause of the disease, the suppression of inflammation is of 
enormous clinical utility and has made these drugs among the most frequently 
prescribed agents. Similarly, glucocorticoids are of immense value in treating diseases 
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that result from undesirable immune reactions. These diseases range from conditions 
that predominantly result from humoral immunity, such as urticaria, to those that are 
mediated by cellular immune mechanisms, such as transplantation rejection. The 
immunosuppressive and antiinflammatory actions of glucocorticoids are inextricably 
linked, perhaps because they both involve inhibition of leukocyte functions. 
Multiple mechanisms are involved in the suppression of inflammation by 
glucocorticoids. It is now clear that glucocorticoids inhibit the production by multiple 
cells of factors that are critical in generating the inflammatory response. As a result, 
there is decreased release of vasoactive and chemoattractive factors, diminished 
secretion of lipolytic and proteolytic enzymes, decreased extravasation of leukocytes 
to areas of injury, and ultimately, decreased fibrosis. Glucocorticoids can also reduce 
expression of proinflammatory cytokines, such as COX-2 and NOS2. Some of the cell 
types and mediators that are inhibited by glucocorticoids are summarized in Table 2.1 
The net effect of these actions on various cell types is to diminish markedly the 
inflammatory response. 
Table 2.1     Effects of Glucocorticoids on Components of Inflammatory / Immune 
Responses 
CELL TYPE FACTOR COMMENTS 
Macrophages 
and monocytes 
  
  
Arachidonic acid and its 
metabolites 
(prostaglandins and 
leukotrienes) 
Mediated by glucocorticoid inhibition 
of cyclooxygenase-2 and phospholipase 
A2. 
Cytokines, including: 
interleukin (IL)-1, IL-6, 
and tumor necrosis factor-
α (TNF-α) 
Production and release are blocked. The 
cytokines exert multiple effects on 
inflammation (e.g., activation of T cells, 
stimulation of fibroblast proliferation). 
Acute phase reactants These include the third component of 
complement. 
Endothelial 
cells 
Endothelial leukocyte 
adhesion molecule-1 
(ELAM-1) and 
ELAM-1 and ICAM-1 are intracellular 
adhesion molecules that are critical for 
leukocyte localization. 
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intracellular adhesion 
molecule-1 (ICAM-1) 
Acute phase reactants Same as above, for macrophages and 
monocytes. 
Cytokines (e.g., IL-1) Same as above, for macrophages and 
monocytes. 
Arachidonic acid 
derivatives 
Same as above, for macrophages and 
monocytes. 
Basophils Histamine, leukotriene C4 IgE-dependent release inhibited by 
glucocorticoids. 
Fibroblasts Arachidonic acid 
metabolites 
Same as above for macrophages and 
monocytes. Glucocorticoids also 
suppress growth factor-induced DNA 
synthesis and fibroblast proliferation. 
Lymphocytes Cytokines (IL-1, IL-2, IL-
3, IL-6, TNF-α, GM-CSF, 
interferon-γ) 
Same as above for macrophages and 
monocytes. 
The influence of stressful conditions on immune defense mechanisms is well 
documented, as is the contribution of the HPA axis to the stress response (Sapolsky et 
al., 2000). This has led to a growing appreciation of the importance of glucocorticoids 
as physiological modulators of the immune system, where glucocorticoids appear to 
protect the organism against life-threatening consequences of a full-blown 
inflammatory response (Chrousos, 1995).   
2.1.6 Pharmacokinetics of corticoids 
2.1.6.1 Absorption  
Hydrocortisone and numerous congeners, including the synthetic analogs, are 
orally effective. Certain water-soluble esters of hydrocortisone and its synthetic 
congeners are administered intravenously to achieve high concentrations of drug 
rapidly in body fluids. More prolonged effects are obtained by intramuscular injection 
of suspensions of hydrocortisone, its esters, and congeners. Minor changes in 
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chemical structure may markedly alter the rate of absorption, time of onset of effect, 
and duration of action.  
Glucocorticoids also are absorbed systemically from sites of local 
administration, such as synovial spaces, the conjunctival sac, skin, and respiratory 
tract. When administration is prolonged, when the site of application is covered with 
an occlusive dressing, or when large areas of skin are involved, the absorption may be 
sufficient to cause systemic effects, including suppression of the HPA axis. 
 
2.1.6.2  Transport, Metabolism, and Excretion.  
After absorption, 90% or more of cortisol in plasma is reversibly bound to 
protein under normal circumstances. Only the fraction of corticosteroid that is 
unbound can enter cells to mediate corticosteroid effects. Two plasma proteins 
account for almost all of the steroid-binding capacity: corticosteroid-binding globulin 
(CBG; also called transcortin), and albumin. At normal or low concentrations of 
corticosteroids, most of the hormone is protein-bound. At higher steroid 
concentrations, the capacity of protein binding is exceeded, and a greater fraction of 
the steroid exists in the free state. Corticosteroids compete with each other for binding 
sites on CBG. CBG has relatively high affinity for cortisol and most of its synthetic 
congeners and low affinity for aldosterone and glucuronide-conjugated steroid 
metabolites; thus, greater percentages of these latter steroids are found in the free 
form. 
All of the biologically active adrenocortical steroids and their synthetic 
congeners have a double bond in the 4,5 position and a ketone group at C 3 (Figure 
2.6). As a general rule, the metabolism of steroid hormones involves sequential 
additions of oxygen or hydrogen atoms, followed by conjugation to form water-
soluble derivatives. Reduction of the 4,5 double bond occurs at both hepatic and 
extrahepatic sites, yielding inactive compounds. Subsequent reduction of the 3-ketone 
substituent to the 3-hydroxyl derivative, forming tetrahydrocortisol, occurs only in the 
liver. Most of these A ring-reduced steroids are conjugated through the 3-hydroxyl 
group with sulfate or glucuronide by enzymatic reactions that take place in the liver, 
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and to a lesser extent in the kidney. The resultant sulfate esters and glucuronides are 
water-soluble and are the predominant forms excreted in urine. Neither biliary nor 
fecal excretion is of quantitative importance in humans. 
Synthetic steroids with an 11-keto substituent, such as cortisone and 
prednisone, must be enzymatically reduced to the corresponding 11-hydroxy 
derivative before they are biologically active. The type 1 isozyme of 11-
hydroxysteroid dehydrogenase catalyzes this reduction, predominantly in the liver, 
but also in specialized sites such as adipocytes, bone, eye, and skin. In settings in 
which this enzymatic activity is impaired, it is prudent to use steroids that do not 
require enzymatic activation (e.g., hydrocortisone and prednisolone rather than 
cortisone or prednisone).  
Such settings include severe hepatic failure and patients with the rare 
condition of cortisone reductase deficiency, who are unable to activate the 11-keto 
steroids because of a partial loss of 11 HSD1 activity and a relative deficiency in the 
enzyme hexose-6-phosphate dehydrogenase, which supplies reducing equivalents to 
the 11-hydroxysteroid dehydrogenase. 
2.1.7 Structure-Activity Relationships  
Chemical modifications to the cortisol molecule have generated derivatives 
with greater separations of glucocorticoid and mineralocorticoid activity; for a 
number of synthetic glucocorticoids, the effects on electrolytes are minimal even at 
the highest doses used (Table 2.2).  
Table 2.2 Relative Potencies and Equivalent Doses of Representative Corticosteroids 
Compound 
Anti 
inflammatory 
potency 
Na
+
-retaining 
potency 
Duration of 
action* 
Equivalent 
dose,
 a
 (mg) 
Cortisol 1 1 S 20 
Cortisone 0.8 0.8 S 25 
Fludrocortisone 10 125 I 
b
 
Prednisone 4 0.8 I 5 
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Prednisolone 4 0.8 I 5 
6α-Methyl 
prednisolone 
5 0.5 I 4 
Triamcinolone 5 0 I 4 
Betamethasone 25 0 L 0.75 
Dexamethasone 25 0 L 0.75 
*
S, short (i.e., 8-12 hour biological half-life); I, intermediate (i.e., 12-36 hour 
biological half-life); L, long (i.e., 36-72 hour biological half-life).  
a
 These dose relationships apply only to oral or intravenous administration, as 
glucocorticoid potencies may differ greatly following intramuscular or intraarticular 
administration.  
b
This agent is not used for glucocorticoid effects. 
Based on these differential potencies, the corticosteroids traditionally are 
divided into mineralocorticoids and glucocorticoids. Estimates of potencies of 
representative steroids in these actions are listed in Table 2.2. 
 In addition, these modifications have led to derivatives with greater potencies 
and with longer durations of action. A vast array of steroid preparations is available 
for oral, parenteral, and topical use. Some of these agents are summarized in Table 2.3.  
Table 2.3. Available Preparations of Adrenocortical Steroids and Their Synthetic 
Analogs 
 
Nonproprietary name 
(trade name) 
Types of 
preparations 
Nonproprietary name 
(trade name) 
Types of 
preparati
ons 
Alclometasone 
dipropionate 
(ACLOVATE) 
Topical Cortisol (hydrocortisone) 
valerate (WESTCORT) 
Topical 
Amcinonide Topical Cortisone acetate Oral, 
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(CYCLOCORT) (CORTONE ACETATE) injectable 
Beclomethasone 
dipropionate 
(BECLOVENT, 
VANCERIL, others) 
Inhalation Desonide (DESOWEN, 
TRIDESILON) 
Topical 
Betamethasone 
(CELESTONE) 
Oral Desoximetasone 
(TOPICORT) 
Topical 
Betamethasone 
dipropionate 
(DIPROSONE, others) 
Topical Dexamethasone 
(DECADRON, others) 
Oral, 
topical 
Betamethasonesodium 
phosphate (CELESTONE 
PHOSPHATE, others) 
Injectable Dexamethasone acetate 
(DECADRON-LA, others) 
Injectable 
Betamethasonesodium 
phosphate and acetate 
(CELESTONE 
SOLUSPAN) 
Injectable Dexamethasonesodium 
phosphate (DECADRON 
PHOSPHATE, 
HEXADROL 
PHOSPHATE, others) 
Topical, 
ophthalmic
, otic, 
injectable 
Betamethasone valerate 
(BETA-VAL, 
VALISONE, others) 
Topical Diflorasone diacetate 
(FLORONE, MAXIFLOR) 
Topical 
Budesonide 
(PULMICORT, 
RHINOCORT) 
Inhalation Fludrocortisone acetate* 
(FLORINEF) 
Oral 
Clobetasol propionate 
(TEMOVATE) 
Topical Flunisolide (AEROBID, 
NASALIDE) 
Inhalation 
Clocortolone pivalate 
(CLODERM) 
Topical Fluocinolone acetonide 
(FLUONID, SYNALAR, 
others) 
Topical 
Cortisol (hydrocortisone) 
(CORTEF, 
HYDROCORTONE, 
Topical, enema, 
otic solutions, 
oral, injectable 
Fluocinonide (LIDEX) Topical 
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others) 
Cortisol (hydrocortisone) 
acetate (HYDRO 
CORTONE ACETATE 
others) 
Topical, 
suppositories, 
rectal foam,  
Fluorometholone acetate 
(FLAREX) 
Ophthalmi
c 
Cortisol (hydrocortisone) 
butyrate (LOCOID) 
Topical Flurandrenolide 
(CORDRAN) 
Topical 
Cortisol (hydrocortisone) 
cypionate (CORTEF) 
Oral Medrysone (HMS 
LIQUIFILM) 
Ophthalmi
c 
Cortisol (hydrocortisone) 
sodium phosphate  
Injectable Methylprednisolone acetate 
(DEPO-MEDROL, 
MEDROL ACETATE) 
Topical, 
injectable 
Cortisol (hydrocortisone) 
sodium succinate (A-
HYDROCORT, SOLU-
CORTEF) 
Injectable Methylprednisolone sodium 
succinate (A-
METHAPRED, SOLU-
MEDROL) 
Injectable 
Mometasone furoate 
(ELOCON) 
Topical Prednisone (DELTASONE, 
others) 
Oral 
Prednisolone (DELTA-
CORTEF) 
Oral Triamcinolone 
(ARISTOCORT, 
KENACORT) 
Oral 
Prednisolone acetate 
(ECONOPRED, others) 
Ophthalmic, 
injectable 
Triamcinolone acetonide 
(KENALOG, others) 
Topical, 
inhalation,
injectable 
Prednisolone sodium 
phosphate (PEDIAPRED, 
others) 
Oral, 
ophthalmic, 
injectable 
Triamcinolone diacetate 
(ARISTOCORT, 
KENACORT 
DIACETATE) 
Oral, 
injectable 
Prednisolone tebutate 
(HYDELTRA-T.B.A., 
others) 
Injectable Triamcinolone hexacetonide 
(ARISTOSPAN) 
Injectable 
*
 Fludrocortisone acetate is intended for use as a mineralocorticoid.  
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Note: Topical preparations include agents for application to skin or mucous membranes 
in creams, solutions, ointments, gels, pastes (for oral lesions), and aerosols; ophthalmic 
preparations include solutions, suspensions, and ointments; inhalation preparations 
include agents for nasal or oral inhalation. (Bernard et al., 2006 ) 
2.2   Allopathic steroids and their therapeutic uses 
2.2.1  Replacement Therapy  
Adrenal insufficiency can result from structural or functional lesions of the 
adrenal cortex (primary adrenal insufficiency or Addison's disease) or from structural 
or functional lesions of the anterior pituitary or hypothalamus (secondary adrenal 
insufficiency). In developed countries, primary adrenal insufficiency most frequently 
is secondary to autoimmune adrenal disease, whereas tuberculous adrenalitis is the 
most frequent etiology in underdeveloped countries. Other causes include 
adrenalectomy, bilateral adrenal hemorrhage, neoplastic infiltration of the adrenal 
glands, acquired immunodeficiency syndrome, inherited disorders of the 
steroidogenic enzymes, and X-linked adrenoleukodystrophy (Carey et al., 1997). 
Secondary adrenal insufficiency resulting from pituitary or hypothalamic dysfunction 
generally presents in a more insidious manner than does the primary disorder, 
probably because mineralocorticoid biosynthesis is preserved.  
 
2.2.2  Acute Adrenal Insufficiency  
This life-threatening disease is characterized by gastrointestinal symptoms 
(nausea, vomiting, and abdominal pain), dehydration, hyponatremia, hyperkalemia, 
weakness, lethargy, and hypotension. It usually is associated with disorders of the 
adrenal rather than the pituitary or hypothalamus, and sometimes follows abrupt 
withdrawal of glucocorticoids used at high doses or for prolonged periods.  
2.2.3  Chronic Adrenal Insufficiency 
Patients with chronic adrenal insufficiency present with many of the same 
manifestations seen in adrenal crisis, but with lesser severity. These patients require 
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daily treatment with corticosteroids (Coursin et al., 2002). Traditional replacement 
regimens have used hydrocortisone in doses of 20 to 30 mg/day. Cortisone acetate, 
which is inactive until converted to cortisol by 11 HSD, also has been used in doses 
ranging from 25 to 37.5 mg/day.  
 
2.2.4  Congenital Adrenal Hyperplasia  
This term denotes a group of genetic disorders in which the activity of one of 
the several enzymes required for the biosynthesis of glucocorticoids is deficient. The 
impaired production of cortisol and the consequent lack of negative feedback 
inhibition lead to increased release of ACTH. As a result, other hormonally active 
steroids that are proximal to the enzymatic block in the steroidogenic pathway are 
produced in excess. Congenital adrenal hyperplasia (CAH) includes a spectrum of 
disorders whose precise clinical presentation, laboratory findings, and treatment 
depend on which of the steroidogenic enzymes is deficient. 
 
2.2.5  Therapeutic Uses in Nonendocrine Diseases  
Outlined below are important uses of glucocorticoids in diseases that do not 
directly involve the HPA axis. The disorders discussed are not inclusive; rather, they 
illustrate the principles governing glucocorticoid use in selected diseases for which 
glucocorticoids are more frequently employed. The dosage of glucocorticoids varies 
considerably depending on the nature and severity of the underlying disorder. For 
convenience, approximate doses of a representative glucocorticoid (generally 
prednisone) are provided.  
 
2.2.6  Rheumatic Disorders  
Glucocorticoids are used widely in the treatment of a variety of rheumatic 
disorders and are a mainstay in the treatment of the more serious inflammatory 
rheumatic diseases, such as systemic lupus erythematosus, and a variety of vasculitic 
disorders, such as polyarteritis nodosa, Wegener's granulomatosis, Churg-Strauss 
 Review of literature…  
 
 
 
 
    43 
 
syndrome, and giant cell arteritis. For these more serious disorders, the starting dose 
of glucocorticoids should be sufficient to suppress the disease rapidly and minimize 
resultant tissue damage. Initially, prednisone (1 mg/kg per day in divided doses) often 
is used, generally followed by consolidation to a single daily dose, with subsequent 
tapering to a minimal effective dose as determined by clinical variables.  
While they are an important component of treatment of rheumatic diseases, 
glucocorticoids are often used in conjunction with other immunosuppressive agents 
such as cyclophosphamide and methotrexate, which offer better long-term control 
than steroids alone. The exception is giant cell arteritis, for which glucocorticoids 
remain superior to other agents. Caution should be exercised in the use of 
glucocorticoids in some forms of vasculitis (e.g., polyarteritis nodosa), for which 
underlying infections with hepatitis viruses may play a pathogenetic role. Although 
glucocorticoids are indicated in these cases, there is at least a theoretical concern that 
glucocorticoids may complicate the course of the viral infection by suppressing the 
immune system. To facilitate drug tapering and/or conversion to alternate-day 
treatment regimens, the intermediate-acting glucocorticoids such as prednisone and 
methylprednisolone are generally preferred over longer-acting steroids such as 
dexamethasone. 
 
2.2.7  Renal Diseases  
Patients with nephrotic syndrome secondary to minimal change disease 
generally respond well to steroid therapy, and glucocorticoids clearly are the first-line 
treatment in both adults and children. Initial daily doses of prednisone are 1 to 2 
mg/kg for 6 weeks, followed by a gradual tapering of the dose over 6 to 8 weeks, 
although some nephrologists advocate alternate-day therapy. Objective evidence of 
response, such as diminished proteinuria, is seen within 2 to 3 weeks in 85% of 
patients, and more than 95% of patients will have remission within 3 months. 
Cessation of steroid therapy frequently is complicated by disease relapse, as 
manifested by recurrent proteinuria. Patients who relapse repeatedly are termed 
steroid-resistant and often are treated with other immunosuppressive drugs such as 
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azathioprine or cyclophosphamide. Patients with renal disease secondary to systemic 
lupus erythematosus also are generally given a therapeutic trial of glucocorticoids.  
 
2.2.8  Allergic Disease 
The onset of action of glucocorticoids in allergic diseases is delayed, and 
patients with severe allergic reactions such as anaphylaxis require immediate therapy 
with epinephrine: for adults, 0.3 to 0.5 ml of a 1:1000 solution intramuscularly or 
subcutaneously (repeated as often as every 15 minutes for up to three additional doses 
if necessary). The manifestations of allergic diseases of limited duration such as hay 
fever, serum sickness, urticaria, contact dermatitis, drug reactions, bee stings, and 
angioneurotic edema can be suppressed by adequate doses of glucocorticoids given as 
supplements to the primary therapy  
 
2.2.9  Bronchial Asthma and Other Pulmonary Conditions  
Corticosteroids frequently are used in bronchial asthma. They sometimes are 
employed in chronic obstructive pulmonary disease (COPD), particularly when there 
is some evidence of reversible obstructive disease. Data supporting the efficacy of 
corticosteroids are much more convincing for bronchial asthma than for COPD. The 
increased use of corticosteroids in asthma reflects an increased appreciation of the 
role of inflammation in the immunopathogenesis of this disorder. In severe asthma 
attacks requiring hospitalization, aggressive treatment with parenteral glucocorticoids 
is considered essential, even though their onset of action is delayed for 6 to 12 hours. 
Intravenous administration of 60 to 120 mg of methylprednisolone (or equivalent) 
every 6 hours is used initially, followed by daily oral doses of prednisone (30 to 60 
mg) as the acute attack resolves. The dose then is tapered gradually, with withdrawal 
planned for 10 days to 2 weeks after initiation of steroid therapy. In general, patients 
subsequently can be managed on their prior medical regimen.  
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2.2.10  Infectious Diseases 
Although the use of immunosuppressive glucocorticoids in infectious diseases 
may seem paradoxical, there are a limited number of settings in which they are 
indicated in the therapy of specific infectious pathogens. One dramatic example of 
such beneficial effects is seen in AIDS patients with Pneumocystis carinii pneumonia 
and moderate to severe hypoxia; addition of glucocorticoids to the antibiotic regimen 
increases oxygenation and lowers the incidence of respiratory failure and mortality. 
Similarly, glucocorticoids clearly decrease the incidence of long-term neurological 
impairment associated with Haemophilus influenzae type b meningitis in infants and 
children 2 months of age or older. 
A long-standing controversy in medicine is the use of glucocorticoids in septic 
shock (Annane and Cavaillon, 2003). Although studies initially suggested a benefit 
from the routine administration of glucocorticoids to subjects with septic shock 
associated with gram-negative bacteremia, subsequent studies showed that 
glucocorticoid therapy in supraphysiologic doses was actually associated with 
increased mortality.  
2.2.11  Ocular Diseases 
Ocular pharmacology, including some consideration of the use of 
glucocorticoids, is discussed in. Glucocorticoids frequently are used to suppress 
inflammation in the eye and can preserve sight when used properly. They are 
administered topically for diseases of the outer eye and anterior segment and attain 
therapeutic concentrations in the aqueous humor after instillation into the conjunctival 
cul-de-sac. For diseases of the posterior segment, systemic administration is required. 
Generally, ocular use of glucocorticoids should be supervised by an ophthalmologist.  
 
2.2.12  Skin Diseases  
Glucocorticoids are remarkably efficacious in the treatment of a wide variety 
of inflammatory dermatoses. As a result, a large number of different preparations and 
concentrations of topical glucocorticoids of varying potencies are available. A typical 
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regimen for an eczematous eruption is 1% hydrocortisone ointment applied locally 
twice daily. Effectiveness is enhanced by application of the topical steroid under an 
occlusive film, such as plastic wrap; unfortunately, the risk of systemic absorption 
also is increased by occlusive dressings, and this can be a significant problem when 
the more potent glucocorticoids are applied to inflamed skin.  
 
2.2.13  Gastrointestinal Diseases 
Glucocorticoid therapy is indicated in selected patients with inflammatory 
bowel disease (chronic ulcerative colitis and Crohn's disease; Patients who fail to 
respond to more conservative management (i.e., rest, diet, and sulfasalazine) may 
benefit from glucocorticoids; steroids are most useful for acute exacerbations. In mild 
ulcerative colitis, hydrocortisone (100 mg) can be administered as a retention enema 
with beneficial effects. In more severe acute exacerbations, oral prednisone (10 to 30 
mg/day) frequently is employed.  
 
2.2.14  Hepatic Diseases 
The use of corticosteroids in hepatic disease has been highly controversial. 
Glucocorticoids clearly are of benefit in autoimmune hepatitis, where as many as 80% 
of patients show histological remission when treated with prednisone (40 to 60 mg 
daily initially, with tapering to a maintenance dose of 7.5 to 10 mg daily after serum 
transaminase levels fall).  
 
2.2.15  Cerebral Edema 
Corticosteroids are of value in the reduction or prevention of cerebral edema 
associated with parasites and neoplasms, especially those that are metastatic. 
Although corticosteroids are frequently used for the treatment of cerebral edema 
caused by trauma or cerebrovascular accidents, controlled clinical trials do not 
support their use in these settings.  
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2.2.16  Diagnostic Applications of Adrenocortical Steroids 
In addition to their therapeutic uses, glucocorticoids also are used for 
diagnostic purposes. To determine if patients with clinical manifestations suggestive 
of hypercortisolism have biochemical evidence of increased cortisol biosynthesis, an 
overnight dexamethasone test has been devised. Patients are given 1 mg of 
dexamethasone orally at 11 P.M., and cortisol is measured at 8 A.M. the following 
morning. Suppression of plasma cortisol to less than 1.8 µg/dl suggests strongly that 
the patient does not have Cushing's syndrome (Arnaldi et al., 2003).  
The formal dexamethasone suppression test is used in the differential 
diagnosis of biochemically documented Cushing's syndrome. Following 
determination of baseline cortisol levels for 48 hours, dexamethasone (0.5 mg every 6 
hours) is administered orally for 48 hours. This dose markedly suppresses cortisol 
levels in normal subjects, including those who have nonspecific elevations of cortisol 
due to obesity or stress, but does not suppress levels in patients with Cushing's 
syndrome. In the high-dose phase of the test, dexamethasone is administered orally at 
2 mg every 6 hours for 48 hours. Patients with pituitary-dependent Cushing's 
syndrome (i.e., Cushing's disease) generally respond with decreased cortisol levels. In 
contrast, patients with ectopic production of ACTH or with adrenocortical tumors 
generally do not exhibit decreased cortisol levels. Despite these generalities, 
dexamethasone may suppress cortisol levels in some patients with ectopic ACTH 
production, particularly with tumors such as bronchial carcinoids, and many experts 
prefer to use inferior petrosal sinus sampling after CRH administration to make this 
distinction. 
 
2.3 Toxicity of Adrenocortical Steroids  
Two categories of toxic effects result from the therapeutic use of 
corticosteroids: those resulting from withdrawal of steroid therapy and those resulting 
from continued use at supraphysiological doses. The side effects from both categories 
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are potentially life-threatening and mandate a careful assessment of the risks and 
benefits in each patient.  Following are list of issue related to toxicities of corticoids. 
 Withdrawal of Therapy  
 Fluid and Electrolyte Management  
 Immune Responses  
 Myopathy  
 Cataracts  
 Osteoporosis 
 Osteonecrosis  
 Regulation of Growth and Development 
 
2.4 Herbal steroids 
India has a rich heritage of plant based drugs both for use in preventive and 
curative medicines. Steroids and their related active metabolites are of great value in 
drug and pharmaceutical industry. They have numerous and diversified physiological 
functions and pharmacological effects such as influence on carbohydrate, protein, fat 
and purine metabolism; on electrolyte and water balance; on the functional capacities 
of the cardiovascular system viz., kidney, skeletal, muscle, nervous system and some 
organs and tissues.  The term steroid (= sterol like) is derived from sterol (In Greek, 
Stereos= solid and ol=alcohol) as most of these compounds contain alcoholic group. 
All the steroids are structurally related and mostly saturated, colourless compounds 
found in plants and animals. Steroid includes a variety of compounds, among which 
sapogenins hold a very important position. Sapogenins when linked with sugar 
constitutes the saponins. Saponins are natural products, which have the property of 
forming soapy leather when shaken with water. Many plant contains sapogenins as 
principle chemical constituents (Table 2.4) 
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 Table 2.4  Steroidal Sapogenin Yielding major Plants 
S. No. Name of Plant Part used 
1 Agave species Leaves 
2 Allium fuscoviolacenum Bulbs 
3 Allium narcissifolium Bulbs 
4 Asparagus officinalis Roots 
5 Aspidistra elatior Underground parts 
6 Balanites roxburghii Fruits and leaves 
7 Convallaria keisukei Underground parts 
8 Costus speciosus Rhizome 
9 Dioscorea composita Rhizome 
10 Dioscorea deltoidea Rhizome 
11 Dioscorea floribunda Rhizome 
12 Dioscorea gracillima Rhizome 
13 Funkia ovata Leaves 
14 Kallstroemia pubescens Whole plant 
15 Polygonatum latifolium Leaves 
16 Polygonatum multiflorum Leaves 
17 Smilax aspera Leaves 
18 Smilax exfelsa Leaves 
19 Solanum indicum Fruits 
20 Solanum introsum Fruits 
21 Solanum khasianum Fruit 
22 Solanum laciniatum Fruit, Leaves and stem 
23 Solanum sodomaeum Fruit, leaves and bud 
24 Solanum trilobatum Fruit 
25 Solanum verbascifolium Fruit 
26 Solanum xanthocarpum Fruit 
27 Tribulus terrestris Over ground parts 
28 Trigonella foenum Leaves and seeds 
29 Trigonella foenum graceum Roots and Leaves 
30 Trigonella tschonoskii Under ground parts 
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Production of steroid drugs is a large scale industry (Applezweig et al., 1962). 
In 1967, total world consumption of steroids precursors was one thousand tones, two 
third of which came from diosgenin and the remaining one third from the variety of 
miscellaneous sources. Other steroidal alkaloids that could become available in large 
quantities are tomatidine, Solasodine and Neotigogenin. Till today, more than four 
thousand plant species have been investigated which has resulted in the identification 
of some thirty naturally occurring steroids sapogenins many of which could provide 
valuable source materials for steroids compounds (Figure 2.8). 
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Figure 2.8 Common herbal Saponin molecules 
 
2.5 Lesser side effects of herbal drugs  
Steroids can cause liver disorders, stunted growth in children and teenagers, 
personality changes, ulcerous acne and high cholesterol levels. Because steroids are 
made from synthetically-produced testosterone, which imitates human sex hormones, 
they can also cause wasting of the testicles, impotence and negative changes in 
sexuality. Sometimes, when steroids are used illegally, they are injected with needles. 
Sharing these needles can also pass on the Human Immunodeficiency Virus, HIV, that 
causes the deadly disease AIDS. (Brancazsio et al., 1986) 
 
2.6 Traditional uses of herbal steroids 
Commercially source material for steroids is only few species belonging 
mainly to the genus Dioscorea and Solanum. Although diosgenin has been identified 
in other species such as Costus speciosus, Trigonella foenum graceum and 
Kallstromia pubescens but there is no evidence at present that they would be 
interesting commercially, and therefore, they have not been described in detail. 
Efforts have been directed towards the cultivation of several Solanum species as the 
source material for the production of steroids. Genus Dioscorea, with over 600 
species is widely distributed in tropical world, except few species in temperate. Some 
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of the species like Dioscorea alata and Dioscorea esculenta have been cultivated for 
a long for their edible tubers. There are about 15 species of this genus, which are 
known to contain steroidal sapogenins chiefly diosgenin. In the world, Mexico, 
Guatemala, Costa Rico, India and China are the major diosgenin producing countries. 
Most of the world production of diosgenin today is met from Central American 
species mainly Dioscorea floribunda and D. composita. The total turnover of bulk 
steroids in the world is estimated to be about 500 million US dollars and estimated 
world usage to be somewhere between 550-650 tones of diosgenin. In India, 
Dioscorea deltoidea and D. prazeri occurring in North-West and North-East 
Himalayas respectively are the natural sources of diosgenin.  
 
2.7 Current status and plant profile of selected herbal steroids 
2.7.1 Trigonella foenum-graecum 
2.7.1.1  Definition 
Fenugreek consists of the dried ripe seeds of Trigonella foenum-graecum L. 
(Fabaceae) 
2.7.1.2  Vernacular Name 
Sanskrit : Methika 
Bengali : Methi 
English : Fenugreek 
Gujrati  : Methi 
Hindi   : Methi 
Kannada  : Menthya Soppu 
Malayalam  : Ulluva 
Marathi  : Methis 
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Figure 2.9 Plant of Trigonella foenum Figure 2.10 Seeds of Trigonella foenum 
 
 
Figure 2.11 Morphological Character of  Trigonella foenum 
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2.7.1.3  Description
 
Indigenous to the Mediterranean region, China, India and Indonesia and 
cultivated in these countries (British Ph, 1996). Annual aromatic herb, up to 60 cm 
high with a well developed taproot and much branched roots. Stem solitary or basally 
branched, terete, slightly pubescent, green to purple (Figure 2.9). Leaves petiolate, 
alternate, trifoliolate; stipules triangular, small, adnate to the petiole. Rachis short. 
Leaflets obviate or oblong, 1.5–4.0 cm long, 0.5–2.0 cm wide, upper part of margin 
denticulate. (The Ayurvedic Ph. India, 1999) 
Flowers whitish, solitary, axillary, subsessile, 12–15 mm long. Calyx 
campanulate, finely pubescent, tube 4.5 mm long, with five lobes. Pistil with sessile 
ovary, glabrous style and capitate stigma. Fruits straight to occasionally sickle-shaped, 
linear pods, glabrous, with fine longitudinal veins, terminating in a beak 2–3 cm long. 
Seeds oblong-rhomboidal, 3– 5 mm long and 2–3 mm wide, with a deep furrow 
dividing each into two unequal lobes (Figure 2.10), with rounded corners, rather 
smooth, brownish (De Guzman et al., 1999). 
a) Macroscopic Characters 
Odor: characteristic, aromatic; taste: slightly bitter (European ph. 2000). 
Seeds oblong-rhomboidal, 3.0–5.0 mm long, 2.0–3.0 mm wide, 1.5–2.0 mm thick, 
with rounded corners, rather smooth. (African ph. 1985) Yellowish-brown to reddish 
brown, with a deep furrow dividing each seed into two unequal lobes, and a deep 
hilum at the intersection of the two furrows. Texture hard, not easily broken (Figure 
2.11). Testa thin, endosperm translucent and viscous; cotyledons two, pale yellow, 
radical curved, plump and long (European ph. 2000). 
b) Microscopic Characters 
Transverse section shows an epidermis of palisade cells, one layer, with thick 
cuticle and thick lamellated walls, and a relatively large lumen at the lower part. 
Longitudinal pit-canals fine and close. Sub-epidermal layer of basket-like cells, with 
bar-like thickening on the radial walls, followed by a parenchymatous layer. 
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Endosperm of several layers of polyhedral cells with stratified mucilaginous contents 
and thickened walls. Cotyledons of parenchymatous cells containing fixed oil and 
aleurone grains up to 15 μm in diameter (African ph. 1985). 
C) Powdered plant material 
Yellowish-brown showing fragments of the testa in sectional view with thick cuticle 
covering epidermal cells, with an underlying hypodermis of large cells, narrower at 
the upper end and constricted in the middle, with bar-like thickenings of the radial 
walls. Yellowish-brown fragments of the epidermis in surface view, composed of 
small polygonal cells with thickened and pitted walls, frequently associated with the 
hypodermal cells, circular in outline with thickened walls. Fragments of the 
hypodermis viewed from below, composed of polygonal cells with bar-like 
thickenings extending to the upper and lower walls. Parenchyma of the testa with 
elongated, rectangular cells with slightly thickened walls. Fragments of endosperm 
with irregularly thickened, sometimes elongated cells, containing mucilage (African 
ph. 1985). 
2.7.14  Identity, purity and strength (African ph. 1985, British Ph, 1996)
 
Foreign matter :  Not more than 2%  
Total Ash   :  Not more than 5%  
Acid-insoluble ash  :  Not more than 2% 
Alcohol-soluble extractive :  Not less than 5%  
Water-soluble extractive : Not less than 20%  
Microbiological Purity tests 
Tests for specific microorganisms and microbial contamination limits are as 
described in the WHO guidelines on quality control methods for medicinal plants (QC 
Methods, WHO, 1998). 
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Pesticide residues 
The recommended maximum limit of aldrin and dieldrin is not more than 0.05 
mg/kg. For other pesticides, see the European pharmacopoeia and the WHO 
guidelines on quality control methods for medicinal plants and pesticide residues (QC 
Methods, WHO, 1998). 
 
2.7.1.5  Substitutes and adulterants (Henriette‟s herbal., 1999)  
The taste fenugreek seeds are often substituted with maple syrup and the leaf 
substituted with celery leaf. The Fenugreek seed power is mainly adulterated with 
starchy material and such adulteration can be detected by Iodine test because 
fenugreek powder does not contain starchy material  
 
2.7.1.6  Phyto chemistry (Hansel et al.1994, Bisset et al., 1994) 
It contains Alkaloides like  Trimethylamine, Neurin, Trigonelline (up to 
0.37%), Choline, Gentianine, Carpaine and Betain. Amino acids found are Isoleucine, 
4-Hydroxyisoleucine, Histidine, Leucine, lysine, L-tryptophan, Argenine. Major 
Saponins (0.6–1.7%) are  Graecunins, fenugrin B, fenugreekine, trigofoenosides A-G. 
It also contains Steroidal sapinogens like Yamogenin, diosgenin, smilagenin, 
sarsasapogenin, tigogenin, neotigogenin, gitogenin, neogitogenin, yuccagenin. Other 
chemical constituents like Coumarin, lipids, vitamins, minerals also reported (Figure 
2.12). 
The structure of trigonelline is presented below (Raghunathan et al., 1982). 
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Figure 2.12 Major Saponins from Trigonella foenum 
 
2.7.1.7  Traditional uses 
As an adjunct for the management of hypercholesterolaemia, and 
hyperglycaemia in cases of diabetes mellitus (Sharma et al., 1990). Prevention and 
treatment of mountain sickness (Bensky et al., 1993). Internally for loss of appetite, 
and externally as a poultice for local inflammations (Blumenthal et al., 2000). 
Treatment of pain, and weakness and oedema of the legs (Chinese Ph. 2000). As an 
aphrodisiac, carminative, diuretic, emmenagogue, emollient, galactagogue and tonic 
(Farnsworth et al., 2001). Treatment of abdominal colic, bronchitis, diarrhoea, 
eczema, gout, indigestion, dropsy, fever, impotence, chronic cough, liver disorders, 
wounds and the common cold. Fenugreek restores nitrogen in the soil as it comes 
from the pea family, hence used in Organic farming as a soil renovator. Fenugreek 
plants are also used as an oriental cattle fodder (Farnsworth et al., 2001).  
 
 Review of literature…  
 
 
 
 
    58 
 
2.7.1.8  Experimental and Clinical Pharmacology 
Owing to its effect on blood glucose levels in diabetic patients, Trigonella 
foenum should only be used in conjunction with oral antihyperglycaemic agents or 
insulin under the supervision of a health-care professional (Mahmoud et al., 1992). 
An aqueous and a chloroform/methanol extract of the seeds were not 
mutagenic in the Salmonella/microsome assay using S. typhimurium strains TA98 and 
TA100. The extracts were also not mutagenic in pig kidney cells or in trophoblastic 
placental cells (Mahmoud  et al., 1992). Dried seeds, extracts, fl uidextracts and 
tinctures. Store in a tightly sealed container away from heat and light (Bluementhal et 
al., 2000). 
Numerous clinical studies have assessed the effects of the seeds on serum 
cholesterol and glucose levels in patients with mild to moderate 
hypercholesterolaemia or diabetes (Al- Habbori et al., 1998). 
In a crossover trial, the effects of a powder of the seeds of Momordica charantia 
(MC) or Trigonella foenum-graecum (TF), or a combination of the two investigated in 
20 hypercholesterolaemic non-insulin dependent diabetes mellitus patients. Mean 
serum total cholesterol was significantly (P < 0.001) decreased after treatment (Awal 
et al., 1999). 
In a placebo-controlled clinical trial, the effect of ginger and Trigonella on 
blood lipids, blood sugar, platelet aggregation, and fibrinogen and fibrinolytic activity 
was investigated. (Bordia et al.,1997). 
A prescribed diet with or without the seeds was given to 60 patients with non-
insulin dependent diabetes for a 7-day preliminary period and then for a 24-week trial. 
The 24-hour urinary sugar excretion was significantly reduced (Sharma et al., 1996). 
The effect of the seeds on blood glucose and the serum lipid profile was assessed in 
patients with insulin-dependent (type I) diabetes patients. The high density- 
lipoprotein cholesterol concentrations remained unchanged (Raghuram et al., 1990). 
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In a long-term study, patients with diabetes ingested seeds per day for 24 
weeks. No changes in body weight or levels of liver enzymes, bilirubin or creatinine 
were observed, (Sharma et al., 1996). 
Antihypercholesterolaemic activity 
Intragastric administration of an ethanol extract of Trigonella daily for 4 
weeks to hypercholesterolaemic rats reduced plasma cholesterol levels by 18% and 
25%, respectively (Stark et al., 1993). 
Antihyperglycaemic activity 
Oral administration of 250.0 mg of an aqueous or methanol extract of seeds 
daily to normal and diabetic rats significantly reduced blood glucose levels after 
eating or the administration of glucose (P < 0.05) (Ali et al., 1995).  
Intragastric administration seeds to rats with or without alloxan-induced 
diabetes produced a significant decrease (P < 0.05) in blood glucose (Khosla et al., 
1995). Intragastric administration of a single dose of an ethanol extract of the seeds to 
mice with or without alloxan-induced diabetes reduced serum glucose levels. 
(Ajabnoor et al., 1988). 
Anti-implantation activity 
Extracts of the seeds (undefined) exhibited anti-implantation effects 
(approximately 30%) in rats when administered orally in a single dose of pregnancy. 
The average number of fetal implants was significantly decreased (P < 0.05) (Rastogi 
et al., 1993). 
Antioxidant activity 
Administration of 2 g/kg bw of the seeds in the diet of rats with 
alloxaninduced diabetes lowered lipid peroxidation, increased the glutathione and β-
carotene concentrations and reduced the α-tocopherol content in the blood 
(Ravikumar et al., 1999). 
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Gastrointestinal effects 
Administration of a steroid-enriched extract of the seeds per day in the diet to 
rats with or without streptozotocin-induced diabetes significantly (P < 0.01) increased 
food intake and the motivation to eat (Petit et al., 1995). 
Toxicology 
Intragastric administration of a debitterized powder of the seeds to mice and 
rats, did not produce any signs of acute toxicity or mortality. Pathological changes 
observed included fatty cytoplasmic vacuolation in the liver, necrosis of hepatocytes 
with lymphocytic infiltration, epithelial degeneration of the renal tubules, catarrhal 
enteritis, myositis and peritonitis (Dhawan et al., 1977). 
Intragastric administration of an aqueous or 95% ethanol extract of the seeds (dose 
not specified) stimulated uterine contractions in healthy and pregnant rats, mice and 
guinea-pigs. (Setty et al., 1976). 
 
2.7.2  Dioscorea alata 
2.7.2.1  Definition: It consist of a tuberous root of Dioscorea alata var. purpurea, 
known as purple yam belonging to family Dioscoreaceae. 
2.7.2.2  Vernacular Name: 
English         : Greateryam, Asiatic yam, Guyana arrowroot, water yam 
Hindi            : Khamalu, Chupri alu  
Gujarati  :Ratalu 
Marathi   : kondfal 
Tamil   : rasa valli kilangu 
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Bengali  : Bengo nari, Chupri alu, Kham alu 
Kannada  : Tuna genasu 
Telugu   : Dukka pendalam, Gunapendalamu, Niluvapendalamu 
Oriya   : Kambo alu 
Malayalam    : Kachil, Kavuttu 
2.7.2.3  Description: 
Normally grows for 8-10 months, then goes dormant for 3-4 months, with 
aerial stems dying back during dormancy. Fertile seeds rarely produced; spread by 
aerial tubers and fragments of underground tuber (Figure 2.13). 
Depending upon the yam variety, of which there are about 200, its flesh may 
be of varying colors including white, ivory, yellow or purple while its thick skin may 
either be white, pink or brownish-black. Their shape is long and cylindrical 
(oftentimes having offshoots referred to as "toes") while their exterior texture is rough 
and scaly. Yams have a very starchy and slippery texture and when cooked, will either 
be creamy or firm, depending upon the variety. Their taste is earthy and hardy, with 
most varieties having minimal, if any, sweetness. (George  et al., 2007) 
  
a) Macroscopic 
Vigorously twining herbaceous vine, from massive underground tuber (Figure 
2.14). Stems to 10 m (30 ft) or more in length, freely branching above; internodes 
square in cross section, with corners compressed into “wings,” these often red-purple 
tinged. Aerial tubers (bulbils) formed in leaf axils (not as freely as in D. bulbifera), 
elongate, to 10 cm (4 in) x 3 cm (1.2 in), with rough, bumpy surfaces. Leaves long 
petioled, opposite (often with only 1 leaf persistent); blades to 20 cm (8 in) or more 
long, narrowly heart shaped, with basal lobes often angular. Flowers small, 
occasional, male and female arising from leaf axils on separate plants (i.e., a 
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dioecious species), male flowers in panicles to 30cm (1 ft) long, female flowers in 
smaller spikes. Fruit a 3-parted capsule; seeds winged (Langeland et al., 2008) 
 
 
 
 
Figure 2.13 Dioscorea alata  plant 
 
Figure 2.14 Dioscorea alata  tuber root 
 
b) Microscopic 
The outer part of the yam tuber forms several layers of cork and the inner part 
is formed by a tissue of parenchyma cells, which are interwoven with vascular 
channels. Starch is contained within the tissue in thin walled parenchymatous cells 
and the non-carbohydrate components are mainly present in the cell wall. The thin 
cell wall imparts stability to individual cells while the cell walls of the major cells 
provide rigidity, strength and shape to the plant cell (Degras, 1986). It is assumed that 
starches with a range of granular structures behave uniquely. Starch granules were 
predominantly oval, round, elliptical or triangular with a few being irregular (Baah et 
al.,2009) 
 
2.7.2.4  Identity, Purity and Strength (Horng et al., 1999)  
Foreign matter  :  Not more than 2%  
Total Ash   :  Not more than 5%  
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Acid-insoluble ash  :  Not more than 0.05%  
Alcohol-soluble extractive :  Not less than 10%  
Water-soluble extractive : Not less than 10%  
 
2.7.2.5  Substitutes and adulterants (Zinash et al., 2008) 
Dioscorea alata- water yam, winged yam, purple yam 
Dioscorea opposita- Chinese yam (in China) 
Dioscorea bulbifera- air potato (found in both Africa and Asia) 
Dioscorea esculenta- lesser yam 
 
2.7.2.6  Phyto chemistry  
Diascorea alata contains alkaloids (58.73%), terpenoids (92.06%), flavonoids 
(90.48%), saponins (50.79) and tannins (31.74%) ( Maridass et al., 2010) . The most 
predominant phytochemical characteristic of yam is the presence of dioscorine 
alkaloid and diosgenin, Dioscin saponin (Figure 2.15). Although dioscorine and 
diosgenin are traditionally considered as toxic, such toxicity is removed by washing, 
boiling and cooking (Eka et al., 1998) 
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Figure 2.15 Major Saponins of Dioscorea alata 
 
2.7.2.7  Traditional uses 
Yams are a good source of vitamin B6. High intakes of vitamin B6 have also 
been shown to reduce the risk of heart disease. Yams are a good source of potassium, 
a mineral that helps to control blood pressure. Dioscorin, a storage protein contained 
in yam, may also be of benefit to certain individuals with hypertension. Preliminary 
research suggests that dioscorin can inhibit angiotensin converting enzyme, which 
would therefore lead to increased kidney blood flow and reduced blood pressure. 
Wild yam also has some history of traditional use in herbal medicine, 
especially Chinese herbal medicine, as a botanical that can affect organ system 
function. While the focus here has been on kidney function, wild yam (or Chinese 
yam) has also been used to support the female endocrine system. For example, there 
has been traditional use of this root in conjunction with lactation. We've only seen one 
high-quality, peer-reviewed research study in which women were actually given wild 
yam (in the form of a topical cream) to determine the impact of this plant on 
menopausal symptoms. Although this research showed some very limited benefits 
from the wild yam cream--and no side effects--none of the symptom changes were 
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statistically significant. In summary, we'd say that there's no research evidence to 
support the claim that yam has special benefits when it comes to menopause, but that 
more research is needed in this area because there is a clear connection between yam, 
diosgenin, and endocrine function that is not yet understood. (George  et al., 2007) 
 
2.7.2.8  Experimental and Clinical Pharmacology 
Antidiabetic activity 
In alloxan induced diabetic rats, the body wt. of the D alata ext. treated 
animals had shown a significant increase (P < 0.001) after 21 days treatment. The 
blood glucose level was reduced significantly by 47.48% and 52.09% after 21 days 
treatment at dose levels 100 and 200 mg/kg, respectively. Serum lipid levels, total 
protein, albumin, and creatinine were reversed toward near normal in treated rats as 
compared to diabetic control. The results indicate that ethanol ext. of DA tubers 
possesses significant antidiabetic activity (Maithili et al 2011) 
Antioxidant activity 
The radical scavenging activity of DAME was comparable with that of BHT 
(85%) at 100 mg/mL concn. DAME also showed higher reducing power than DAAE. 
A significant (p<0.01) correlation was observed between the phenolic content and the 
radical scavenging activity of the exts. indicating the contribution of phenolic 
compounds for the observed antioxidant effect. (Ahmed et al. 2009) 
Immunomodulatory Activity 
Lin et al., (2009) shown that Tainong yam dioscorins have a higher ability to 
stimulate the phagocytic activity of the lymphoid cells than Japanese yam dioscorins, 
whereas Japanese yam  dioscorins possess more abilities than Tainong yam dioscorins 
to enhance the proliferation of the lymphoid cells. 
Increased splenic cytotoxic activity following the administration of mucilages 
from MJ yam was observed, Furthermore, the production of specific antiovalbumin 
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(OVA) antibody and OVA-stimulated splenic cell proliferation were also enhanced by 
all mucilage groups. It is suggested that the tuber mucilage may function as an 
immunomodulatory substance (Shang et al., 2007). 
Anti-fenton reaction activity 
Wang et al. 2007, shown that a common, major ansialdehyde-sulfuric acid 
stained spot (possibly a polysaccharide mucilage) with an Rf of 0.09 may be the most 
likely contributor to the anti-Fenton reaction activities of the yam tuber exts. 
investigated. The present study identifies the mechanism of the health benefit of the 
Dioscorea family. The copper-chelating and absorbing capability of yam tuber pulp 
exts. may be useful in functional screening. 
Mucosal hydrolase activity 
The 25% yam diet was sufficient to modulate intestinal enzyme activities, but 
not the blood plasma and hepatic cholesterol levels. The blood plasma and liver 
cholesterol lowering effects of the 50% yam diet could be due to increased fecal fat 
and steroid excretion (chen et al., 2003) 
Angiotensin Converting Enzyme Inhibitory Activity 
Hsu et al (2002) found that the ACE inhibitory activity was increased from 
51.32% to about 75% during 32 h hydrolysis. The smaller peptides were increased 
with increasing pepsin hydrolytic times. Dioscorin and its hydrolyzates might be a 
potential for hypertension control when people consume yam tuber. 
Many other activites like a-Glucosidase inhibitory action (Mitsui et al., 2001), 
carbonic anhydrase and trypsin inhibitor activities (Hou e al., 2000),  Antifungal 
activity  (Aderiye et al., 1996),  Antiosteoporotic Activity (Peng et al., 2011) 
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2.7.3  Hemidesmus indicus 
2.7.3.1  Definition 
Hemidesmus indicus commonly known as Indian sarsaparilla, belonging to the 
family Asclepiadaceae, is a slender laticiferous, twing, sometimes prostate or semi 
erect shrub, occurring over the greater part of India. 
2.7.3.2  Vernacular Name: 
Sanskrit   :  Ananti, Gopasuti, Sirivi 
Bengali   :  Anantamul, Shvetashariva 
English   :  Indian Sarasa Parilla 
Gujrati   :  Upalsari, Kabri 
Hindi    :  Anantamul 
Kannada   :  Namada veru, Bili Namadaberu, Sogadeberu 
Malayalam   :  Nannari, Nannar, Naruneendi 
Marathi   :  Upalsari, Anantamula 
Telugu   :  Sugandhi Pala, Tella Sugandhi 
2.7.3.3  Description: 
Upper Gangetic plain, eastwards to Bengal and the Sundribans, and from the Central 
provinces to South India and Ceylon. It is a slender, laticiferous, twining, sometimes 
prostrate or semi-erect shrub as shown in figure 2.16. 
a) Macroscopic characters 
Roots occur in pieces, about 30 cm long and 3-8 mm in diameter, cylindrical, 
thick, hard, somewhat tortuous, sparcely branched, provided with few thick rootlets 
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and secondary roots, external appearance dark brown, sometimes with violet grey 
tinge, centre yellow, woody, surrounded by a mealy white cortical layer, bark 
brownish, corky, marked with transverse cracks and longitudinal fissures and easily 
detachable from the hard central core, odor, characteristic, taste, sweetish, slightly 
acrid and aromatic (Figure 2.17). 
  
Figure 2.16 Hemidesmus indicus Plant Figure 2.17 Hemidesmus indicus root 
b) Microscopic characters 
Transverse section of root shows periderm consisting of three layers of tissues, 
cork, cork cambium and secondary cortex, cork cells radially flattened and 
rectangular in appearance filled with dark brown contents giving reactions of tannins, 
cork cambium, 2 or 3 layered, compressed, and filled with deep brown contents, 
secondary cortex, 3-4 layers of cells, similar to cork cells, with very little or no dark 
brown contents, secondary phloem consists of sieve elements, parenchyma, phloem 
ray cells along with several laticiferous ducts, parenchyma cells filled with starch 
grains, diameter 7-10 µ, occasional prismatic crystals of calcium oxalate, laticiferous 
ducts scattered in parenchymatous tissue, cambium very narrow: xylem traversed by 
narrow medullary rays, vessels and tracheids characterized by the presence of pitted 
markings, pith absent and centra region occupied by woody tissues.  
2.7.3.4  Identity, Purity and Strength  
Foreign matter : Not more than 2 %. 
Total Ash   : Not more than 4.3 %. 
Acid insoluble ash  : Not more than 0.3 %. 
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Alcohol soluble extractive : Not more than 6.5 %. 
Water soluble extractive : Not more than 8.5 %. 
 
TLC Identity Test 
The TLC identity test for the drug has been reported using two solvent 
systems. 
I. Toluene : Ethyl acetate : Methanol ( 8 : 2 : 0.5 ) for Vanillin. 
II. Toluene : Ethyl acetate ( 9 : 1 ) for Lupeol.  
 The plate developed in I shows a band ( Rf 0.56 ) corresponding to vanillin in both 
reference and test solution tracks. Other bands appearing in the test sample have Rf 
values 0.27 and 0.48. The plate developed in II shows a band ( Rf  0.60 ) 
corresponding to lupeol in both reference and test solution tracks. 
2.7.3.5  Substitutes and Adulterants  
Ichnocarpus frutescens ( L.) R.Br.  
Decalepis  hamiltonii Wight & Arn.  
Cryptolepis buchanani Roem. & Schult.  
2.7.3.6  Phyto chemistry 
 It has some potential as raw material for the semi synthesis of medicinal 
steroids, being a source of sarsasapogenin and smilagenin. The root contain 1.8-2.4% 
steroidal saponin (Figure 2.18).  
Mukherjee et al., (1980) reported that roots of H. indicus contain steroids, 
terpenoids, flavanoids and saponins, but alkaloids is absent. Glycosides like indicine 
and hemidine were isolated from stem (Prakash et al., 1991). The flavanoid 
glycosides identified in the flowers of H. indicus were hyperoside, isoquercitin and 
rutin (Subramanian et al., 1968).      
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Figure 2.18 Major Saponins of Hemidesmus indicus 
 
2.7.3.7  Traditional uses 
Traditional Ayurveda medicine practitioners have used Sariva for hundreds 
and hundreds of years; it was used as a healing herb as well as a magical-spiritual 
dream herb. They used it to treat stomach problems, cure rashes, ease the mind, quell 
the symptoms of syphilis, to help induce trance states and deep meditation, and to 
clarify and prepare the mind for the dream world. Ayurveda tradition holds that the 
roots of the Hemidesmus indicus plant will transport the user to deeper states of sleep 
and through the four gates of dreaming, as written about by Carlos Castaneda, in The 
Art of Dreaming. It is used to help the experienced conscious dreamer achieve 
lucidity during the dream or REM phase of sleep.  
Ayurveda healers also prescribed it to men suffering from low libido and 
sexual impotence, it is believed that one of active compounds produced by roots 
improves male testosterone levels and therefore improves sexual desire, sperm count 
and overall sexual performance. In traditional Hindi folk wisdom, the healer or sages 
used the roots to cleanse the blood of toxins, soothe skin irritations and rashes, to 
reduce the burning sensations caused by urinary tract infections, to reduce fevers, as 
well as to heal moderate cases of acne. Women use Sugandi roots to promote a 
healthy pregnancy and to reduce the possibility of a miscarriage.     
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2.7.3.8  Experimental and Clinical Pharmacology: 
Antinociception 
Verma et al. (2005) revealed that alcoholic extract of H. indicus possesses a 
dose dependent antinociceptive effect. It blocked both the neurogenic and 
inflammatory pain and its activity is due to the presence of triterpenes, flavanoids and 
sterols. 
 
Anti-inflammatory 
Dutta et al. (1982) found that the ethyl acetate extract of roots of H. indicus 
exhibited significant anti inflammatory activity in both acute and subacute 
inflammation. 
Antiulcer 
Anoop et al., (2003) established the antiulcer activity of H. indicus var. indicus 
and var. pubescens. It acts through mucoprotective  action selectively inhibiting 
prostaglandin. 
Hepatotonic and hepatotoxic 
Prabakan et al. (2000) found out that oral administration of ethanolic (70%) 
extract of H. indicus significantly prevented Rifampicin and Isoniazid-induced 
hepatotoxicity in rats. Baheti et al. (2006) established the hepatoprotective effect of H. 
indicus by oral route. 
Diuretic 
Satoskar et al. (1962) found out that alcoholic and steam distilled extracts of 
roots of H. indicus had no significant diuretic activity, whereas aqueous extract 
caused a slight increase in urinary flow in rats, but not in dogs. 
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Antidiarrhoeal 
Das et al. (2003) proved that methanolic extract elicited antidiarrhoeal activity 
which was effective than the standard antidiarrhoeal drug, Lomotil and the activity 
was due to inhibition of intestinal motility and its bactericidal activity. 
 
Antivenom 
The methanolic extract of H. indicus significantly neutralized by viper-venom 
induced lethality and haemorrhagic activity in albino rat and mouse. It could 
significantly neutralize lethality, haemorrhage, defibrinogenation, edema, PLA(2) 
activity induced by D. russellii venom. Alam et al. (1998) found out that 2-hydroxy-
4-methoxy benzoic acid, isolated and purified from the methanolic extract possessed 
potent anti-inflammatory, antipyretic and antioxidant properties. 
Antileprotic 
Ethanolic (95%) extract was carried out for its delayed type cutaneous 
hypersensitivity stimulation effect by Atal et al. (1986). The aqueous extract of H. 
indicus was given orally at a concentration of 2% of diet in mice was active against 
Mycobacterium leprae (Gupta,1986).  The mice were infected with the test organism 
taken from the leprosy patients. It delayed the cutaneous hypersensitivity stimulation 
at a dose of 100 mg/kg. It also possessed immune-modulator as well as immune-
suppressant activities at 100 mg/kg. Phagocytosis was also decreased at 100 mg/kg. 
Anticancer 
Topical application of H. indicus resulted in significant protection against 
cutaneous tumourogenesis. The level of lipis peroxidation was significantly reduced. 
In addition, depleted levels of glutathione and reduced activities of antioxidant 
enzymes were restored, respectively which indicates its potent chemopreventive 
nature in skin carcinogenesis. 
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Chemopreventive 
Sultana et al.(2003a) found that H. indicus is an effective chemopreventive 
agent in skin and capable of ameliorating cumene hydroperoxide induced cutaneous 
oxidative stress and tumor promotion. Shetty et al. (2005) found that the 
radioprotective effect on lipid peroxidation in rat liver microsomes and plasmid DNA 
protected microsomal membranes by minimizing lipid peroxidation, which could 
protect DNA from radiation. 
Antioxidant and free radical scavenger 
Methanolic (50%) extract demonstrated antioxidant properties by several in 
vitro and ex vivo models (Ravishankara et al., 2002, Mary et al. 2003a) found out that 
methanolic extract of H. indicus roots inhibited lipid peroxidation and scavenges 
hydroxyl and superoxide radicals in vitro.  
2.7.4  Agave americana 
2.7.4.1  Definition 
Agave consists of the dried leaves of Agave americana var. marginata family 
Amaryllidaceae (Agavecea) (Figure 2.19) 
2.7.4.2 Vernacular Name 
Sanskrit : Kantala, Vanketaki 
English : Agave, Century Plant, maguey, American aloe 
Gujrati  : Ketaki 
Hindi   : Kamal cactus, Bharakhawar, Rakshpattah 
Kannada  : Kantala 
Malayalam  : Ageve, Anakaita 
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Marathi  : Ketaki, Ghaipaat 
Telugu : Kalabanda 
2.7.4.3  Description 
Century plant typically lives only 10 to 30 years. It has a spreading rosette 
(about 4 m/13 ft wide) of gray-green leaves up to 2 m (6.6 ft) long, each with a spiny 
margin and a heavy spike at the tip that can pierce to the bone. Large growing species. 
Which can be used as hedge plants. Agave leaves give good quality fibre. These 
plants flower only once in their life time. Century plant prefers full sun exposures and 
well drained soils, but is adaptable to a wide range of conditions, including coastal 
climates. It is cold hardy to 15° F. (perry et al., 1982) 
a) Macroscopic Characters 
Century plant has no stem. Its thick and massive gray-green leaves originate 
from a basal rosette. The leaves get up to 6' long and 10" wide, and have sharp spines 
on the margins and tips. Solitary or slowly clumping succulent rosette that grows to a 
height of 90-120 cm. The arching leaves are characteristically variegated and have a 
broad creamy white band down the centre of each leaf, with grey-blue sharp-spine 
edges. The margin spines are recurved like fishhooks and the tip spines can be more 
than an inch long (Figure 2.20). The flower stalk is branched, 20-40' tall, and bears 
large (3-4") yellow-green flowers. Popular cultivars are 'Marginata' with yellow 
margins on the leaves,. (Floridata, Plant Encyclopedia). Fruits are flat disk seed 
enclosed in capsule 
b) Microscopic Characters 
Microcopy of plant leaf shoos that ultimate fibers are held together by sticky 
and waxy substances to finally form a technical fiber with section forms which are 
difficult to define. The ultimate fibers show oval and irregular sections with a large 
lumen Compared to other fibers from the same family, the Agave americana L. fibers 
are light. the Agave americana L. fibers are more hydrophilic than cotton, flax, and 
other vegetable fibers.  (Slah et al. 2006)  
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Figure 2.19 Plant of Agave americana Figure 2.20 Leaves of Agave 
americana 
The fibers are yellow white to white and consist of fiber cell, large spiral 
vessels, and parenchyma cells containing single oxalate crystals up to 0.5 mm long. 
The cells of parenchyma are mostly destroyed and glittering crystals or pieces of 
crystals are left deposited on longitudinal rows on the fiber. The sclerenchymatious 
fibers cells are very uniform in structure, iodine and sulphuric acid gives yellowish 
brown color with wall. (Andrew et al., 1907) 
2.7.4.4  Identity, purity and strength
 
Foreign matter  :  Not more than 3%  
Total Ash   :  Not more than 5%  
Acid-insoluble ash  :  Not more than 2%  
Alcohol-soluble extractive :  Not less than 5%  
Water-soluble extractive : Not less than 35% 
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Figure 2.21  Major Saponins from Agave americana  
 
2.7.4.5  Substitutes and adulterants  
Agave americana var. expansa  
Agave americana var. latifolia  
Agave americana var. oaxacensis  
Agave americana ssp. Protamericana 
2.7.4.6  Phytochemistry  
Several pregnane glycosides were discovered from Agavaceae plants. The 
species of the genus Agave constitute an important source of steroidal sapogenins 
(Bedour et al., 1979; Gupta, 1995). In the pharmaceutical industry, these natural 
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compounds are used for the semisynthesis of medicinal steroids as corticosteroids, 
sexual hormones and steroid diuretics (Tyler et al., 1988). 
Previously isolated constituents are steroidal sapogenins and saponins (Blunden et al.,  
1978), chromones, alcohols, and esters (Parmar et al., 1992). Agave americana 
contains principle saponins hecogenin, cantalasaponin-1,  Ticogenin and barbourgenin 
as shown in figure 2.21. (Wang et al., 2006) 
2.7.4.7  Traditional uses 
Century plants are often used for fencing in Mexico and Central America. A 
dense hedge of these spiny succulents is impermeable to cattle and people. As an 
ornamental, century plant usually is grown in rock gardens, in cactus and succulent 
gardens, in Mediterranean-style landscapes, in borders, or as a specimen. It tends to 
dominate the landscape wherever it is grown. Century plant also is grown in 
containers where it stays much smaller than its outdoor brethren. Keep it in a cool, 
frost-free area in winter and put it out on the balcony or patio in summer. Water 
century plant only in the summer. The sap of century plant is used as a diuretic and a 
laxative. The juice of the leaves is applied to bruises and taken internally for 
indigestion, flatulence, constipation, jaundice and dysentery. If the flower stem is cut 
without flowering, a sweet liquid called agua miel ("honey water") gathers in the heart 
of the plant. This may be fermented to produce a beer-like drink called pulque, which 
may then be distilled to produce mezcal.   
2.7.4.8  Experimental and Clinical Pharmacology 
Concerning toxic effects, in a preliminary toxicological evaluation of Aga6e 
sp. „Amole‟, doses of 1 g:kg administered to rats during 10 days did not manifest any 
lethal action (Segura, 1991), although adverse reactions such as gastritis and diarrhea 
were produced with doses higher than the therapeutic dose (Gupta et al., 1995). 
Anticancer activity 
The ethanol extract of A. americana has a potential cytotoxic and antitumor 
activity. Antitumor activity of ethanolic extract of A. americana leaves demonstrated 
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by using PA-1 human cell line of ovarian teratocarcinoma. Brine shrimp lethality 
bioassay (LC50= 923.10 µg/ml), Allium cepa root meristem model and MTT assay 
(IC50 =0.01 μg/ml) showed potent cytotoxic and anticancer activity of ethanolic 
extract of A. americana leaves. The ethanolic extract of A. americana leaves has a 
cytotoxic and antitumor activity. (Ketan et al., 2011) 
Antifungal activity  
Leaf ext. of Agave americana was evaluated for antifungal activity against 
Alternaria brassicae, the causal agent of Alternaria blight of Indian mustard [Brassica 
juncea (L.) Czern. & Coss]. Methanolic leaf ext. (crude ext.) of A. americana showed 
antifungal activity against A. brassicae. (Guleria et al ., 2009) 
Anti-inflammatory activity 
Doses of genins (total steroidal sapogenins, hecogenin and tigogenin) equiv. to 
the amt. in the lyophilized exts. produced an antiedeniatous effect which was much 
stronger and more efficacious than that obtained with an i.p. administration of 5 mg 
/kg of indomethacin or dexamethasone 21-phosphate at a dose equiv. to the molar 
content of hecogenin administered. At the doses used to evaluate the anti-
inflammatory activity, the genins did not have any harmful effect on the gastric 
mucous membranes. (Peana et al., 1997) 
Three biogenetically related compounds have been isolated from Agave 
americana, namely 5-hydroxy-7-methoxy-2-tritriacontyl-4H-1- benzopyran-4-one, 
tetratriacontyl hexadecanoate and tetratriacontanol. The first two compounds 
exhibited significant antibacterial activity.  (Parmar et al., 1992) 
Antiallergics and antihistaminics 
An ethanolic  ext. of A. americana showed dose-dependent inhibition on 
compound 48/80-induced histamine release from rat peritoneal mast cells. Emulsions, 
packs, shampoos, hair tonics, bath preparations, etc. containing extract were also 
formulated and their efficacies for skin troubles were examined. (Kawai et al., 2000) 
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Other Activities 
Agave american . has shown antibacterial and anti-inflammatory activities 
(Feng et al., 1964; Peana et al., 1997). Antimicotic, antiviral and antituberculosis are 
different effects described for species of this genus (Gupta et al., 1995).  
 
2.7.5  Solanum xanthocarpum 
2.7.5.1  Definition 
Kantakari consists of mature, dried whole plant of Solanum surattense Burm. 
f.,Syn. Solanum xanthocarpum Schrad. & Wendl, (Fam. Solanaceae), perennial 
(Figure 2.22), very prickly diffused herb of waste land, found throughout India. 
(Indian Herbal Ph. 1998) 
2.7.5.2  Vernacular Name (Indian Herbal Ph. 1998)
 
Sanskrit : Vyaghri, Nidigdhika, Ksudra, Kantakarika 
Bengali : Kantakari 
English : Febrifuge plant 
Gujrati  : Bharingani 
Hindi   : Katai, Katali, Ringani, Bhatakataiya, Chhotikateri 
Kannada  : Nelagulla, Kiragulla 
Malayalam  : Kantakari chunda 
Marathi  : Bhauringani, Kataringani 
Tamil   : Kandangatri, Kandankatri, Kandanghathiri 
Telugu  : Nelamulaka, Pinnamulaka, Mulaka, Chinnamulaka, Vakudu 
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2.7.5.3  Description
 
a) Macroscopic characters 
Fruit -Berry globular, measuring 0.8-1 cm in diameter, surrounded by 
persistent calyx at base unripe fruits variegated with green and white strips, ripe fruit 
shows different yellow and white shades (Figure 2.23). Root -10-45 cm long, few mm 
to two cm in diameter, almost cylindrical and tapering, transversely smoothened 
surface shows a thin bark and wide compact cylinder of wood, fracture, short, taste, 
bitter. 
  
Figure 2.22 Solanum xanthocarpum 
Herb  
Figure 2.23  Solanum xanthocarpum 
Fruits 
Stem-herbaceous, prickly with prominent nodes and internodes, green when fresh, 
young branches, covered with numerous hairs, Leaves-petiolate, exstipulate, ovate--
oblong or elliptic, sinuate or sub-pinnatifid, subacute hairy, Flower- bracteate, 
pedicellate, bisexual, pentamerous, regular, complete, bright blue or bluish purple. 
Seeds-circular, flat, numerous, embedded in a fleshy mesocarp about 0. 2 cm in 
diameter, glabrous taste, bitter and acrid. (Indian Herbal Ph. 1998) 
b) Microscopic characters 
Transverse section of mature fruit shows single layered epidermis, covered 
externally by a thin cuticle, 1-2 layers of collanchyma present below epidermis, 
narrow endosperm with embryo, some cells of endosperm contain oil globules. 
Petiole-transverse section of petiole shows circular to wavy outlines, epidermis single 
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layered, covered externally by a thick cuticle, hypodermis consists of 3-4 layers of 
collenchymatous, cells, , epidermis shows mostly stellate and rarely urn to tricellular 
hairs. Midrib-transverse section of midrib shows a biconvex structure, , some stellate 
hair present on epidermis. Lamina-transverse section shows dorsiventral structure, 
epidermis on either side, palisade ratio 1.7-4 (mean 2 .85). (Indian Herbal Ph. 1998) 
2.7.5.4  Identity, Purity and Strength (Indian Herbal Ph. 1998)  
Foreign matter  :  Not more than 2 % 
Total Ash   :  Not more than 9 % 
Acid-insoluble ash  :  Not more than 3 % 
Alcohol-soluble extractive :  Not less than 6 % 
Water-soluble extractive :  Not less than 16 % 
2.7.5..5  Substitutes and adulterants 
The commercial drug of S. xanthocarpum is often found adulterated with the 
allied species S. indicum. (Indian Herbal Ph. 1998)
 
 
2.7.5..6  Phytochemistry  
Steroidal alkaloid solasodine is the principal alkaloid. Alcoholic extracts of the 
plant contain fatty and resinous substances. Solasonine is present in fruits (Figure 
2.24). The glycoalkaloid content of fruits collected from plants growing in Jammu & 
Kashmir is reported to be 3.5 per cent (total alkaloids: 1.1%). The plant samples 
collected from Calcutta contained solasodine of 0.0287%. The presence of diosgenin 
in the plant has been reported (Pendse et al., 1932). Seeds yield 19.3 % of a greenish 
yellow, semi-drying oil with a characteristic odour. The unsaponifiable matter of 
fruits contains two sterols, one of which is carpesterol (Gupta et al., 1936). The dried 
plants give 10.8% ash and 7.6% soluble ash consisting mainly of potassium nitrate, 
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carbonate and sulphate. It contains 1.6% total sugar with 0.3 % glucose as reducing 
sugar.
 
(Saiyed et al., 1936) It contains alkaloids, tannin, sugar, starch, fat and oil. 
Protein, mucilage, lignin, cutin and calcium oxalate which react positively with 
different concentrations of acids, alkalis, salts and dyes. (Johansen et al.,1940)  
 
 
Figure 2.24  Major Saponins and Glycoalkaloids of Solanum Xanthocarpum 
 
Plant shown presence of Solasodine in fruits; the glycoalkaloid content of fruits 
collected from plants growing in Jammu and Kashmir is reported to be 3.5 %. The 
presence of diosgenin in the plant has been reported. (Sato et al.,1953). It showen that 
the minor constituents are solamargine, solasonine (Kusano et al., 1975). Its reported 
that cycloartenol, norcarpesterol, cholesterol and their derivatives. The yield of pure 
solasodine, a steroidal alkaloid is reported to be 5 gm/ kg. Which was double in 
quantity as compared to other previously described methods. Banik  et al., (1990) 
reported 0.028 % solasodine contents in S. xanthocarpum. Modified acid-dye method 
for detection of solasodine was found suitable. 
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2.7.5.7  Traditional uses 
The roots, fruits and the whole plant are used for medicinal purpose. Roots are 
one of the constituents of Dasamulasava. The fumigation of kantakari is helpful in 
piles. The paste applied on swollen and painful joints in arthritis, reduces the pain and 
swelling effectively. Internally, kantakari is useful in vast range of diseases. In 
respiratory ailments like colds, asthma, sore throat, hoarseness of voice etc, it is 
valuable drug. The decoction of the roots works well in cough, when given with 
honey. The fruit is useful as an aphrodisiac in males and the seeds, in women for 
irregular menstruation and dysmenorrheal. The white flowered variety of kantakari 
(Laksmana) helps to promote conception in females. As the herb is stimulant to the 
heart and is a blood purifier, it is extremely beneficial in the treatment of cardiac 
diseases associated with edema.
 
 
2.7.5.8  Experimental and Clinical Pharmacology 
Adaptogenic effects 
Gupta et al., (2009) demonstrated the adaptogenic effects of Solanum 
xanthocarpum and Solanum nigrum in forced swimming test and cold restraint stress 
models in swiss albino mice. They concluded that adaptogenic effects of steroidal 
saponins were found to be better than those of the total extracts. 
Anthelmintic Activity 
Priya et al., (2010) showed antimicrobial, antioxidant and anthelmintic 
potential of extracts of Solanum xanthocarpum whole herb.
 
Gunaslevi G et al., (2010) 
demonstrated methanolic and aqueous extracts of Solanum xanthocarpum fruits have 
amazing anthelmintic activity of parasite. 
Antiandrogenic potency  
Dixit et al., (1989) administered Solasodine obtained from the Solanum 
xanthocarpum berries to rhesus monkeys to evaluate their effect on testicular cell and 
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found antiandrogenic nature of the compound.
 
Gupta RS et al., (2002) showed that 
oral administration of Solasodine suggest antiandorgenic potency of Solasodine. 
Anti asthmatic and respiratory activity 
Govindan et al., (1999) shown, Solanum xanthocarpum and Solanum 
trilobatum herbs significantly improved the various parameters of pulmonary function 
in asthmatic subjects. Govindan S et al., (2004) proved clinical efficacy of Solanum 
xanthocarpum in the ventilator function of asthmatic individuals.           
Mast cell stabilizing activity 
Parmar  et al., (2008) revealed antihistaminic and mast cell stabilizing activity 
of ethanolic extract of Solanum xanthocarpum in experimental animal. Anti-
infalmmatory activity was also revealed using acute (carrageenan-induced paw 
edema) and chronic (cotton pellet granuloma) models of inflammation. 
Antiasthamatic effect also reported by Navin et al. (2010).  
Anti-urolithiactic and natriuretic activity 
Patel et al., (2010) evaluated the isolated compounds, solasonine and 
Solasodine, from methanolic extracts of Solanum xanthocarpum berries for 
antiurolithiatic activity on rodent and concluded that solasonine showed good 
natriuretic activity as compared to Solasodine.  
Wound healing activity 
Kumar  et al., (2010) verified the effects of fruits of Solanum xanthocarpum 
on experimentally induced excision and incision wound models in Sprague dowlay 
rats and suggested that methanolic extract of fruits possess significant wound healing 
potential.
 
Hypoglycaemic activity 
Kar et al., (2006) showed that aqueous extract of fruits of Solanum 
xanthocarpum found to possess significant hypoglycaemic activity compared to 
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standard glibenclamide in rats and mice. The in vitro study on glucose utilization by 
isolated rat hemidiaphragm suggested that the aqueous extract may have direct insulin 
like activity which enhances the peripheral utilization of glucose and have extra 
pancreatic effect.  
Other pharmacological activities like Antibacterial activity (Saini V et al., 2006), 
Antifungal activities (Singh et al., 2007), Antimicrobial activity (Thenmozi et al., 
2008) Antinociceptive activity (Salar et al., 2009) 
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3. Aim and Objectives 
A steroid is a type of organic compound that contains a characteristic arrangement of 
four cycloalkane rings that are joined to each other. Examples of steroids include the 
dietary fat cholesterol, the sex hormones estradiol and testosterone, and the anti-
inflammatory drug dexamethasone.  
Steroids can be organ saving and even life saving when the autoimmune disease is 
very active. It can also help control the inflammation in rheumatoid arthritis and 
especially the acute flares of arthritis. 
Steroids are considered as harmful drugs by many scientist and it may cause weight 
gain, raised blood pressure, worsening of diabetes, water retention, stomach irritation, 
acidity, cataract, osteoporosis, muscle weakness, increased susceptibility to infections 
etc. 
Till today, more than four thousand plant species have been investigated which has 
resulted in the identification of some thirty naturally occurring steroids which could 
provide valuable source materials for steroids compounds (Atal et al., 1982). 
Many well established medicines originate from plants. For example, the painkiller 
morphine comes from poppies, aspirin comes from the bark of willow trees and 
digoxin (a drug used to treat heart failure) derives from foxglove. Many 
pharmacologic activities of steroid containing plants like Wildyam, kanthkari, Agave 
spices, Indian Sarsaparilla and Fenugreek  have been reported. This may be a clue for 
investigating use of herbal steroids as therapeutic agents. Hence, in order to find a 
safer alternate steroid treatment for management of various ailments, we have 
resolved to investigate therapeutic potential of herbal steroids. 
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The objective of the present investigation was  
1. To carry out phytochemical investigation of major steroid containing medicinal 
plants. 
2. To screen various herbal steroids for corticoid potential by using in-vivo tests. 
3. To screen selected herbal steroids for their steroidal activities and prepare a 
comparative index of their glucocorticoid activities by using in-vivo tests. 
4. To investigate effect of selected herbal steroids on hepatic and hematological 
parameter. 
5. To screen various selected herbal steroids for their steroidal activities and prepare 
a comparative index of their mineralocorticoid activities by using  in-vivo tests. 
6. To investigate quantitative effect of selected herbal steroids on urine content. 
7. To design quality control parameter for steroidal herbal formulation. 
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4. Materials and Methods 
 
4.1 Plant procurement, identification and authentification 
Plant selected as major source of herbal steroid were Fenugreek (Trigonella 
foenum graecum) seed, Wild Yam (Dioscorea alata) underground tuber, Indian 
Sarsaparilla (Hemidesmus indicus) root, Agave americana leaf and Kantakari 
(Solanum xanthocarpum) fruits. Agave americana and Kantakari (Solanum 
xanthocarpum) collected from Saurashtra university campus while Fenugreek 
(Trigonella foenum graecum) seed and Indian Sarsaparilla (Hemidesmus indicus) 
purchased from local market, Rajkot. The wildyam was procured from modasa, 
district sabarkantha, Gujarat.  
The study protocol was approved by Institutional animal ethics committee and 
the protocol no. is SU/DPS/IAEC/1001 date 11/02/2010 as attached in annexure. 
The plant materials herbariums (No. SU/DPS/407-411, dated 14/10/2011) were 
prepared as per the guideline given by centre for advanced studies in plant 
biotechnology and genetic engineering, Saurashtra University, Rajkot and sent for the 
identification and authentification. The voucher specimens of the collected plant 
sample were deposited at department of pharmaceutical sciences, Saurashtra 
University, Rajkot (Figure 4.1-4.5) 
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4.2 Material and Reagents (AR Grade) 
 Cyclohexane 
 Acetone 
 Chloroform 
 Ethylacetate 
 Methanol 
 Water (Distilled)  
 Toluene 
 Propanol 
 Formic acid 
 Sulphuric acid 
 Glacial acetic acid 
 Antimony (III) Chloride 
 Liebermann- Burchard reagent 
 Anthrone  
 Periodic acid-Schiff reagent 
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Figure 4.1  The authenticated herbarium specimen of Trigonella foenum graecum 
(Fenufreek) 
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Figure 4.2  The authenticated herbarium specimen of Dioscorea alata (Wild Yam) 
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Figure 4.3  The authenticated herbarium specimen of  Hemidesmus indicus (Indian 
Sarsaparilla) 
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Figure 4.4  The authenticated herbarium specimen of  Agave americana (Century 
Plant) 
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Figure 4.5 The authenticated herbarium specimen of  Solanum xanthocarpum 
(Kantakari) 
 Materials and Methods…  
 
 
 
 
 95 
 
4.3 Macroscopic observations 
The plant material was subjected to macroscopic studies which comprise of characters 
like shape, size, surface characteristics, texture, fracture, appearance of cut surface, 
color, odor, taste, smell etc. These characters were examined for primary 
identification and purity of material. 
4.4 Plant extraction 
All the chemicals used for experimental purpose were of analytical grade. The plant 
materials were washed with distilled water to remove dirt and shade dried. Routine 
pharmacognostic studies including organoleptic examination, macroscopic 
examination and microscopic examination were carried out to confirm the identity of 
material. The collected samples were subjected to grinding and passed through 
moderately coarse sieve and packed in wide mouth air tight jar.  
 
Figure  4.6  soxhlet apparatus for Extraction 
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The powdered plant materials (100 gm) were soaked with 20 ml distilled water for 12 
hrs before extraction with ethanol. The drug was defatted with petroleum ether (60-
80°C) and extracted with ethanol (95%) using soxhlet apparatus continuously for 48 
hrs (Fig. 4.6). 
All ethanolic extracts were individually filtered, through Whatmann filter paper # 42 
and evaporated to dryness at 50oC in oven. The ratio of powder to solvent was 1:5.  
The extracts were weighed for and yield were calculated and stored in desiccators till 
further use (Kotadia K, M.Pharm Thesis, 2005) 
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4.5 Phytochemical Evaluation (Hostettamann et al. 1995) 
4.5.1 Chemical test 
Selected chemical test were performed for presence of saponins and steroidal content 
in plant. Following chemical test were performed 
4.5.1.1. Foam test: To 1 gm of drug add 5 ml of water; shake for few minutes, 
formation frothing which persists for 60-120 seconds in presence of saponins. 
4.5.1.2. Haemolysis test: A drop blood on slide was mixed with few drops of aq. 
Saponin solution, RBCs becomes ruptured in presence of saponins. 
4.5.1.3. Libermann Bruchard test: Plant extract of drug was extracted with CHCl3, 
add few drops of acetic anhydride followed by conc. H2SO4 from side wall of test 
tube to the CHCl3 extract. Formation of violet to blue colored ring at the junction of 
two liquid, indicate the presence of steroid moiety. 
4.5.1.4. Antimony trichloride test: Plant extract of drug was extracted with CHCl3, 
add saturated solution of SbCl3 (Antimony trichloride) in CHCl3 containing 20% 
acetic anhydride. Formation of pink color on heating indicates presence of steroids 
and triterpenoids. 
 
4.5.2 Thin Layer Chromatography 
4.5.2.1 Preparation of Test Solution 
Accurately weighed 1 gram quantity of all five alcoholic extract were transferred to 
10 ml volumetric flask and dissolved separately in 10 ml methanol. All five test 
sample were sonicated for 15 minutes in sonicator.  
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4.5.2.1Chromatographic conditions 
 Stationary phase :  Methanol pre-washed TLC  Aluminum sheets of 
silica gel 60 F254, layer thickness 0.2 mm 10x10 
cm  
 Mobile phase : Toluene: Ethyl acetate: Methanol (6:1:0.8      
v/v/v) 
 Chamber saturation Time :  45 min 
 Distance run :  80 mm 
 Scanning wavelength :  254 nm, 366 nm 
 Temperature :  25 2o C 
Thin Layer Chromatography was performed to ensure presence of saponins / Steroids 
in plant extracts. The prepared TLC plates were used to separate saponins/steroids 
from mixture and it’s confirmed by spraying reagents. Twin trough chambers (10X10 
cm) were used to provide saturate environment and   developed TLC plates. All 
samples were applied with glass capillary.  
 
4.5.2.2. Preparation of Lieberman Burchard reagent 
Concentrated sulphuric acid (1 ml) is mixed with acetic anhydride (20 ml) and 
chloroform (50 ml). Heating at 80-90 OC gives required coloration. 
 
4.5.2.3 Preparation of 20% H2SO4 reagent 
Prepare 20% H2SO4 solution in water and spray on TLC plate. Heating at 80-90 
OC 
gives required coloration. 
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4.6 Animals 
Male albino wistar rats weighing 150–210 gm were used in this study. Animals were 
housed in groups of six rats on 12-hour light and 12-hour dark cycle; and were 
maintained in an air-conditioned animal quarter at a temperature of 22±2 °C and a 
relative humidity of 60±10 %. They were offered water and food ad libitum. The 
animals were acclimatized to the facilities for 5 days. Experiments reported in this 
study were carried out in accordance with current guidelines for the care of laboratory 
animals and the ethical guidelines for investigation of experimental pain in conscious 
animals. The Institutional Animal Ethical committee (IAEC) has approved the 
protocol of the study. All efforts were made to minimize the number of animals used 
and their suffering. 
 
4.7 Adjuvant arthritis in rats 
Albino Wistar Male rats with an initial body weight of 150 to 200 g was used.  On 
day 1, they were injected with ketamine (40mg/kg) intraperitoneally (Fahim et al. 
1973) and anesthetized. Each animal injected into the sub plantar region of the left 
hind paw with 0.1 ml of heat-killed Mycobacterium tuberculosis (H37Ra) suspended 
in incomplete freund’s adjuvant (4mg/ml). Vehicle administered orally and treated as 
control group, All animal were grouped (n=6) according to following, 
Group-I    Control Group  
Group-II  Standard Drug- Hydrocortisone  
Group-III Ethanolic extract of Trigonella foenum graecum (ETF)  
Group-IV Ethanolic extract of Dioscorea alata (EDA) 
Group-V Ethanolic extract of Hemidesmus indicus (EHI) 
Group-VI Ethanolic extract of Agave americana (EAA) 
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Group-VII Ethanolic extract of Solanum xanthocarpum (ESX) 
All test drugs ETF (Asmena et al. 2009), EDA (Dhanabal et al. 2008), EHI (Anoop et 
al. 2008), EAA (Dana et al. 2006), ESX (Rahman et al.2003) 300mg/kg per rat and 
the standard (Hydrocortisone-Primacort200) 10 mg per rat administered orally for 12 
days. Purposely, from day 13 to 21, the animals received neither test compound nor 
the standard.  Paw volumes of both sides and body weight were recorded on the day 
of injection, day 5, day 12, day 17 and day 21 whereby paw volume is measured 
plethysmographically (Vogel et al. 2002). The severity of the secondary lesions on 
day 12 is evaluated visually and graded according the following scheme  
 
Table No. 4.1 Grading for Evaluation of Secondary lesions 
Body Part Effect Score 
Ears 
Absence of nodules and redness 0 
Presence of nodules and redness 1 
Nose 
No swelling of connective tissue 0 
Intensive swelling of connective tissue 1 
Tail 
Absence of nodules 0 
Presence of nodules 1 
Forepaws 
Absence of inflammation 0 
Inflammation of at least 1 joint 1 
Hind paws 
Absence of inflammation 0 
Slight inflammation 1 
Moderate inflammation 2 
Marked inflammation 3 
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4.8 Liver glycogen deposition test in rats  
4.8.1 Adrenalectomy 
Albino Wistar male rats weighing 150–210 g are used. The dorsal fur is shaved; the 
rat is anesthetized with ether and placed on a block (8 × 3 × 2 cm) in order to elevate 
the viscera. A transverse incision about 5 mm long is made in the midline at the 
costovertebral angle. To remove the left adrenal gland, the skin is retracted to the 
ventral side and the lumbar muscles incised just superior and anterior to the splenic 
shadow. In this way, the adrenal gland appears directly beneath the incision and no 
exteriorization of the kidney is necessary (Figure 4.7).  
The periadrenal tissue is grasped between the kidney and the adrenal by small curved 
forceps and the intact gland together with the periadrenal fat and the mesenteric 
attachments is removed in toto. The adrenal gland and its capsule are not touched and 
any remnants of the capsule to which cortical tissue may adhere are removed (Vogel 
et al. 2002). The bleeding is negligible in young animals so that no vessels need be 
tied off (Figure 4.8). 
After ablation of the left adrenal, the animal is turned around and the right gland is 
removed through the original skin incision. A small incision through the lumbar 
muscles is made just above and anterior to the prominent lumbocostal artery which is 
seen near the costal margin. The curved forceps are inserted over the kidney and by 
elevating the liver, which covers the adrenal on this side; the gland is brought into 
view and grasped by the forceps removing again the intact gland with the periadrenal 
fat and the mesenteric attachments. 
The incisions made in the lumbar muscles need not exceed 3 mm in length and may 
be made by spreading the blades of a pair of scissors, hemostasis or closure by sutures 
is not necessary. The incision is closed by a skin clip. The entire procedure is done in 
a time sufficiently short to avoid long-acting anesthetics. The animals appear normal 
in every aspect within a few min following the operation. 
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Figure 4.7  The  kidney and adrenal gland beneath the incision  
 
 
Figure 4.8  Post operative condition after adrenalectomy  
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4.8.2 Animal Experiment 
Albino Wistar (Chen et al. 1952) Male rats (n=6) weighing 150–210 g are 
adrenalectomized. They are fed stock laboratory diet and 1% sodium chloride solution. 
On the morning of the fourth postoperative day, food is withdrawn. On the morning of 
the fifth day, the drinking fluid is withdrawn and the rats are grouped in following 
manner. 
Group-I    Control Group  
Group-II  Standard Drug- Hydrocortisone  
Group-III Ethanolic extract of Hemidesmus indicus (EHI) 
Group-IV Ethanolic extract of Agave americana (EAA) 
Group-V Ethanolic extract of Solanum xanthocarpum (ESX) 
Control group received only 1% w/v tween-80 solution in distilled water. 
Hydrocortisone- (Primacort-200), 10 mg/rat orally in 1% tween 80, given to group-II.  
Test drug Ethanolic extract of Hemidesmus indicus (EHI), Ethanolic extract of Agave 
americana (EAA) and Ethanolic extract of Solanum xanthocarpum (ESX) by 300 
mg/kg per rat, oral dose given to group III, IV and V respectively. Seven hours later, 
the rats are sacrificed (Vogel et al. 2002). 
The livers are removed and blotted on filter paper to remove blood, weighed, dropped 
into flasks containing 10 ml hot 30% potassium hydroxide and digested on a hot plate. 
The digest is diluted to 100 ml and appropriate dilution used for colorimetric 
estimation. 
4.8.3 Estimation of Liver Glycogen 
Ten ml 0.2% anthrone in 95% sulfuric acid is slowly added to 5 ml of liver digest 
dilution with cooling. The mixture is heated in a boiling water bath for 10 min and 
then placed into cold water. Optical density (Absorbance) is measured in a 
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spectrophotometer UV 1800 SHIMADZU at 620 nm using the anthrone-reagent as 
blank. Quantization of Liver glycogen carried out from Glucose calibration curves in 
range 20µg-100µg (Vogel et al. 2002).  
4.8.4 Preparation of calibration glucose curve 
Weigh accurately 30 mg of Dextrose and transfer to 100 ml volumetric flask and 
dissolve in distilled water (300 µg/ml). Transfer 1 ml, 2 ml, 3 ml, 4 ml, and 5 ml of 
above solution to 5 ml volumetric flask separately and dilute up to the mark with 30% 
KOH (stock solution). The final concentration of 5ml volumetric flask was 60 µg/ml, 
120 µg/ml, 180 µg/ml, 240 µg/ml and 300 µg/ml. Ten ml 0.2% anthrone in 95% 
sulfuric acid is slowly added to 5 ml of glucose stock solution with cooling separately. 
The resultant solution will have concentration 20 µg/ml, 40 µg/ml, 60 µg/ml, 80 
µg/ml and 100 µg/ml. The mixture is heated in a boiling water bath for 10 min and 
then placed into cold water. Optical density (Absorbance) is measured in a 
spectrophotometer UV 1800 SHIMADZU at 620 nm using the anthrone-reagent as 
blank. Calibration curves are established using glucose as standard in range 20 µg-100 
µg. 
4.8.5 Hematological Evaluation 
Blood collected from rat through retro orbital plexus and transfer 3 ml to EDTA 
coated blood collecting disposable tube and 2 ml to non-EDTA coated blood 
collecting disposable tube. Hematological evaluation carried out for quantitative 
estimation White blood cell, Red blood Corpuscle, Platelets, of 3 ml for all animals 
carried out for heamatological parameter, Serum glutamic pyruvic transaminase 
(SGPT), Serum glutamic oxaloacetic transaminase (SGOT), Serum Calcium and 
Serum potassium. All samples were analysed at Dr. Bhatt Pathology Laboratory, 
Rajkot.  
4.8.5.1 Determination of Blood cells 
The determination WBC, RBC and Platelets for all sample were performed on 
Automated 3 part blood cell counter BC 3000 plus with two counting modes, whole 
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blood and prediluted. Instrument works on the principle of electrical impedance 
method. Coulter's electrical impedance principle in which cells pulled through an 
aperture break an electric circuit, indicating both the presence of a cell and the size of 
the cell. Increased resistance between electrodes results in an electrical pulse while 
RBCs and Platelets counted together, separated by pulse heights. Sample size for 
whole blood and prediluted were 13 µl and 20 µl respectively. Automatic diluting, 
lyzing, mixing, rinsing and unclogging performed by BC 3000 plus.  
4.8.5.1 Determination of SGPT and SGOT 
The liver function test, SGPT and SGOT were performed on MISPA NANO fully 
automatic biochemistry analyzer by UV method without pyridoxal phosphate. Alanine 
aminotransferase (ALT) reagent and aspartate aminotransferase (AST) reagents were 
used for quantitative determination of SGPT and SGOT respectively. Enzyme reagent 
and subtract reagents were used for formation of color complex and absorbance was 
determine at 340nm. At 340nm, with the one-reagent procedure and the two reagent 
procedure, Activity (U/L) =ΔOD/min. x 1746 (Henderson et al. 2001). 
Principle for SGPT 
 
 
Principle for SGOT 
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4.8.5.1 Determination of Serum Calcium and Serum potassium 
Estimation of serum potassium and serum calcium was performed on Roche 9180 
electrolyte analyzer by ion selective electrode measurement.  Roche 9180 electrolyte 
analyzer can perform electrolytic analysis from whole blood as well as plasma. 
Electrolyte results can be obtained from just 95 μl of whole blood, serum, plasma, 
acetate or bicarbonate dialysate, or pre-diluted urine. Linearity in serum was 
established with the analysis of two specimen set in non clinical test; commercially 
prepared serum linearity standard for potassium and calcium and group of random 
patient serum sample. 
 
4.8.6 Histopathology of Liver 
Clean liver with distilled water and accurately weigh one of liver. Transfer the liver 
lobe to 10% formaline solution in wide mouth disposable plastic sample jar.  
Histopathology of liver performed at B.T. Savani Kidney Hospital, Rajkot. Wax 
blocks were made and section was made by microtome, stained by Periodic acid-
Schiff (PAS) and photographed (Ulusoy  et al. 2006). 
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4.9 Mineralocorticoid activity in rat 
4.9.1 Animal Experiment 
Albino Wistar (Pierre et al. 1980) Male rats weighing 150–210 gm are 
adrenalectomized as per 4.8.1. They are maintained on 1% NaCl solution as drinking 
fluid. On the morning of the fourth postoperative day, food and drinking fluid are 
withdrawn. 
On the following day, each rat is given 5 ml water by stomach tube; one hour later 5 
ml 0.9% NaCl orally and the rats are grouped (n=6) in following manner. 
 
Group-I    Control Group  
Group-II  Standard Drug- Hydrocortisone  
Group-III Ethanolic extract of Hemidesmus indicus (EHI) 
Group-IV Ethanolic extract of Agave americana (EAA) 
Group-V Ethanolic extract of Solanum xanthocarpum (ESX) 
Control group received only 1% w/v tween-80 solution in distilled water. Test drug, 
Ethanolic extract of Hemidesmus indicus (EHI), Ethanolic extract of Agave 
americana (EAA) and Ethanolic extract of Solanum xanthocarpum (ESX) by 300 
mg/kg per rat, oral dose given to group III, IV and V respectively. Hydrocortisone-
(Primacort-200) 10 mg/rat given orally in 1% w/v tween-80 solution. The rats were 
lightly anesthetized with ether to induce emptying of the bladder and placed in 
metabolic cages for 4 h, again anesthetized with ether and removed from the cages. 
Urine volume is recorded and cages rinsed over the collection cylinders with a 
distilled water spray. Collections are diluted to 100 ml and appropriate dilutions 
analyzed for sodium ion (Vogel et al. 2002).  
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4.9.2 Urine Analysis 
Sodium is expressed as percent of excretion of control animals. Collected urine 
sample stored in disposable urine collection bottle. Urine analysis performed for 
quantitative evaluation of Sodium, Potassium, Creatinine, and Chloride. All urine 
samples were analyzed at Dr. Bhatt Pathology Laboratory, Rajkot. 
Determination of Sodium, Potassium, Chloride and Creatinine were performed on 
Dade Behring Dimension RxL automated clinical chemistry analyzer using respective 
reagents. 
 
4.10 Statistical Analysis 
The data are presented as mean±SEM. Statistical significance was tested between 
more than two groups using one-way ANOVA followed by the Dunnett’s control 
comparisons test using a computer-based fitting program (Prism, Graphpad 5). 
Dunnett's Test is used as a post hoc test. In statistical significance testing, the p-value 
is the probability of obtaining a test statistic at least as extreme as the one that was 
actually observed, assuming that the null hypothesis is true.  P value expressed as 
"Michelin Guide" scale, *: P < 0.05 (significant), **: P < 0.01 (highly significant) and 
***: P < 0.001 (extremely significant). 
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4.11 Quality control of selected steroidal herbs 
4.11.1 Instrument 
(A) winCATS planner chromatography system manager  
(B) Camag linomat 5 semi automatic spot / band applicator 
(C) Twin trough chromatogram development glass chambers 
(D) Photo recording UV cabinet 
(E) Camag scanner 3 winCATS with quantitative evaluation 
(F) Linomat syringe, 100 micro liters for TLC visualiser 
(G)  0.45 micron syringe filters 
(H) Sonicator 
4.11.2 Preparation of Sample solution 
Weigh accurately 30 mg finely powdered EHI, EAA and ESX, transfer to 100 ml 
volumetric flask and dilute up to 100 ml with methanol (AR Grade). Sonicate all three 
solutions for 15 minutes in sonicator and ensure all drugs remain in dissolved form. 
Transfer the solution with Whatman filter paper and store solution in 100 ml 
volumetric flask covered with aluminum foil (Stock solution).   
The common extract solution prepared by adding equal volume (10 ml) of all thee 
plant extract stock solution and mixed for 15 minutes. Label the solution and use for 
HPTLC fingerprinting. 
 
4.11.3 Prewashing and activation of precoated TLC plate 
TLC Aluminum sheets of silica gel 60 F254 (Precoated) 10.0 x 10.0 cm sheet was 
placed in twin trough glass chamber containing methanol as mobile phase. Methanol 
was allowed to travel up to upper edge of plate (ascending method). Plate was 
removed, allowed to dry at 50
0
 C for 10 min. 
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4.11.4 Mobile Phase Optimization 
Different mobile phase were prepared and checked for resolution of  methanolic 
solution of Ethanolic extract of Trigonella foenum graecum (ETF), Ethanolic extract 
of Dioscorea alata (EDA), Ethanolic extract of Hemidesmus indicus (EHI), Ethanolic 
extract of Agave americana (EAA) and Ethanolic extract of Solanum xanthocarpum 
(ESX). Out of all, primarily four different mobile phases were selected for HPTLC 
fingerprinting.  
(1) Cyclohexane / Ethyl acetate / Chloroform  1 : 1 : 1 v/v/v 
(2) Chloroform / Methanol                          7.5 : 2.5 v/v 
(3) Toluene / Ethyl acetate / Formic acid  5 : 5 : 1 v/v/v 
(4) Toluene / Ethyl acetate / Methanol   6 : 1 : 0.8 v/v/v 
Drug sample were applied 9000ng/spot and developed in different four mobile phase 
and evaluated for resolution. 
 
4.11.3 HPTLC fingerprinting  
4.11.4.1 Chromatographic conditions 
 Stationary phase :  Methanol pre-washed TLC  Aluminum 
sheets of silica gel 60 F254, layer thickness 
0.2 mm 10x10 cm  
 Mobile phase :   Toluene: Ethyl acetate: Methanol   (6:1:0.8      
v/v/v) 
 Chamber saturation Time :    45 min 
 Distance run :    80 mm 
 Scanning wavelength :    254 nm, 366 nm 
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 Temperature :   25 2o C 
 Band length :   6 mm 
 Syringe size :  100 µl 
 Distance between tracks :  20 mm 
 Slit dimention :  4.0 X 0.45 mm Micro 
 Scanning speed :  20 mm / second 
 
4.11.4.2 Procedure for fingerprinting 
Methanolic solution of Ethanolic extract of Hemidesmus indicus (EHI), Ethanolic 
extract of Agave americana (EAA) and Ethanolic extract of Solanum xanthocarpum 
(ESX) applied. On pre-washed, pre-coated TLC Aluminum sheets of silica gel 60 F254 
30μl (9000 ng per spot) of three drug solution and mixture were spotted with the help 
of spotting device using 100μl syringe. The plate was dried for 5 min at 500 C and 
developed in previously saturated twin trough chamber at constant temperature 25±2
0
 
C using Toluene / Ethyl acetate / Methanol  6 : 1 : 0.8 v/v/v,  as mobile phase. After 
development the plate was dried at 50
0
 C for 10 min. Densitometric scanning was 
performed in the absorbance/reflectance as per prescribed chromatographic parameter. 
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5. Results 
5.1 Plant extraction 
The ethanolic extracts (95%) of  Fenugreek (Trigonella foenum graecum) seed 
and Wild Yam (Dioscorea alata) underground tuber were dark brown sticky mass and 
remaining plant material extract were in solid  after evaporation of solvent. The yield 
of plant ethanolic extract in % W/W for given procedure laid down in table 5.1.   
 
Table 5.1  Ethanolic (95% v/v) plant extracts and their respective yields 
Sr. No Extract Color and Consistency Yield (%W/W) 
1 ETF Sticky, Dark brown mass 16.2 
2 EDA Sticky, Dark brown mass 8.0 
3 EHI Solid, Dark yellowish brown 7.5 
4 EAA Solid, Dark greenish 7.8 
5 ESX Solid, Dark yellowish 6.8 
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5.2 Phytochemical Evaluation 
5.2.1 Chemical test 
Steroidal saponins are chemical compounds abundant in different types of 
plant species. Their structure is composed of one or more hydrophilic glycoside 
moieties held by a lipophilic triterpene derivative. 
Foam Test, Haemolysis test, Libermann Bruchard test and Antimony 
trichloride chemical test were performed and their observations were as per table 5.2.   
In Foam test, ethanolic plant extract of all plant material shows characteristic 
foaming when mixed and shake with water.  The comparative evaluation of all five 
extracts shown in figure 5.1. 
Saponin containing plants are among the secondary metabolites and produce 
soap-like foam when they are shaken in water solutions. Soap like compound 
produces heamolysis in RBC.  The aqueous solution of all plant extracts shows clear 
RBC rupture under microscope.  
Libermann Bruchard test commonly used to check presence of steroidal 
moiety in plant material. All plant extracts clearly showed violet to blue colored ring 
at the junction between two liquids which supported presence of steroids. 
The reaction of steroidal moiety with antimony trichloride also used to 
evaluate presence of steroids. All plant material extracts produced formation of pink 
color on heating which indicate presence of steroids and triterpenoids 
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Figure 5.1  Foam test of all ethanolic plant extracts 
 
A- Ethanolic extract of Trigonella foenum graecum 
B- Ethanolic extract of Dioscorea alata 
C- Ethanolic extract of Hemidesmus indicus 
D- Ethanolic extract of Agave americana 
E- Ethanolic extract of Solanum xanthocarpum 
 
 
Table 5.2  Chemical test for all extracts  
Chemical Test ETF EDA EHI EAA ESX 
Foam test ++ + ++ + ++ 
Haemolysis test ++ + ++ + + 
Libermann Bruchard test ++ ++ + ++ ++ 
Antimony trichloride test + + + + + 
[- Absence, + Present, ++ Abundance] 
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5.2.2 Thin Layer Chromatography 
Ethanolic solution of all plant extracts were used to performe HPTLC analysis 
using TLC aluminum sheets of silica gel 60 F254. Development of TLC plates 
performed on previously developed and optimized mobile phase, Toluene: Ethyl 
acetate: Methanol (6:1:0.8      v/v/v). 
The TLC plate were sprayed with Libermann Bruchard reagent showed clear 
indication for presence of steroidal molecule (table 5.3) in all plant extracts. After 
development TLC, plates were visualized in white light (figure 5.2). In TLC profile of 
ETF spot, major steroidal spot were visualized at Rf 0.23 (dark purple), 0.34 (dark 
purple), 0.58 (dark purple) and 0.86(pink). In TLC profile of EDA spot, major 
steroidal spot were found at Rf 0.20 (light purple), 0.28 (light purple), 0.58 (light 
purple), 0.69 (light purple), 0.79 (light purple) and 0.98 (dark purple). EHI spot 
showed presence of steroidal spot at 0.19 (dark purple), 0.70 (dark pink), 0.79(dark 
pink) and 0.95(dark pink). In EAA spot, major steroidal compounds were separated at 
0.21 (dark purple), 0.28(dark purple), 0.34(green), 0.74 (dark green) and 0.84 (dark 
green). ESX spot showed major steroidal band at Rf   0.23 (dark purple), 0.34 (light 
purple) and 0.38(light purple). 
Another TLC plate was developed in 20% H2SO4 solution which gives red to 
pink color for triterpenoids and saponins (figure 5.3). All observation for TLC 
derivatized with 20% H2SO4 solution shown in table 5.4. 
TLC developed with spraying reagent Libermann Bruchard and observed in 
UV366 (figure 5.4) and UV254 (figure 5.6) as well as TLC developed with spraying 
reagent 20% H2SO4 solution and observed in UV366 (figure 5.5) and UV254 (figure 5.7) 
serve additional basis for qualitative evalution by TLC method.  
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Figure 5.2    TLC developed with spraying reagent Libermann Bruchard and 
observed in white light 
 
 
Figure 5.3  TLC developed with spraying reagent-  20% H2SO4 and observed in 
white light 
 
Mobile Phase -   Toluene: Ethyl acetate: Methanol (6:1:0.8      v/v/v) 
ETF -                   Band of ethanolic extract of Trigonella foenum graecum 
EDA-                   Band of ethanolic extract of Dioscorea alata 
EHA-                   Band of ethanolic extract of Hemidesmus indicus 
EAA-                   Band of ethanolic extract of Agave americana 
ESX-                   Band of ethanolic extract of Solanum xanthocarpum 
       -                    Indicate Solvent front 
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Figure 5.4  TLC developed with spraying reagent Libermann Bruchard and observed 
in UV366 
 
 
 
Figure 5.5  TLC developed with spraying reagent-  20% H2SO4 and observed in 
UV366 
 
Mobile Phase -   Toluene: Ethyl acetate: Methanol (6:1:0.8      v/v/v) 
ETF -                   Band of ethanolic extract of Trigonella foenum graecum 
EDA-                   Band of ethanolic extract of Dioscorea alata 
EHA-                   Band of ethanolic extract of Hemidesmus indicus 
EAA-                   Band of ethanolic extract of Agave americana 
ESX-                   Band of ethanolic extract of Solanum xanthocarpum 
       -                    Indicate Solvent front 
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Figure 5.6  TLC developed with spraying reagent Libermann Bruchard and observed 
in UV254 
 
Figure 5.7  TLC developed with spraying reagent-  20% H2SO4 and observed in 
UV254 
 
 
Mobile Phase -   Toluene: Ethyl acetate: Methanol (6:1:0.8      v/v/v) 
ETF -                   Band of ethanolic extract of Trigonella foenum graecum 
EDA-                   Band of ethanolic extract of Dioscorea alata 
EHA-                   Band of ethanolic extract of Hemidesmus indicus 
EAA-                   Band of ethanolic extract of Agave americana 
ESX-                   Band of ethanolic extract of Solanum xanthocarpum 
       -                    Indicate Solvent front 
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Table 5.3  TLC profile of all plant extracts derivatized with Libermann Bruchard 
reagent 
 
TLC 
Band 
Test 
Observation  in 
White Light 
Observation  in UV366 
Light 
Observation  in 
UV254 Light 
Rf 
Value 
Color of 
Band 
Rf 
Value 
Color of Band Rf 
Value 
Color of 
Band 
ETF 
0.23 Dark purple 0.23 Brownish purple 0.20 Dark black 
0.28 Light brown 0.28 Dark brown 0.25 Dark black 
0.34 Dark purple 0.35 Dark brown 0.35 Dark black 
0.39 Light brown 0.41 Light green 0.44 Dark black 
0.58 Dark purple 0.44 Green 0.60 Dark black 
0.63 Light brown 0.64 Light blue 0.63 Dark black 
0.86 Pink 0.69 Light blue   
EDA 
0.20 Light purple 0.21 Light blue 0.15 Dark black 
0.28 Light purple 0.23 Blue 0.29 Dark black 
0.58 Light purple 0.58 Bluish green 0.59 Dark black 
0.69 Light purple 0.69 Light green 0.69 Dark black 
0.79 Light purple 0.78 Light green 0.98 Dark black 
0.98 Dark purple 0.98 Light green   
EHI 
0.19 Dark purple 0.31 Light blue 0.31 Dark black 
0.29 Dark purple 0.35 Light blue 0.35 Dark black 
0.54 Dark purple 0.58 Light blue 0.58 Dark black 
0.64 Dark pink 0.68 Brownish green 0.68 Dark black 
0.70 Dark pink 0.81 Light blue 0.81 Dark black 
0.79 Dark pink 0.93 Brownish green 0.93 Dark black 
0.95 Dark pink     
EAA 
0.21 Dark purple 0.19 Bluish green 0.19 Dark black 
0.28 Dark purple 0.31 Reddish purple 0.31 Dark black 
0.34 Green 0.36 Red 0.36 Dark black 
0.59 Light brown 0.65 Reddish purple 0.65 Dark black 
0.74 Dark green 0.75 Red 0.75 Dark black 
0.84 Dark green 0.86 Red 0.86 Dark black 
ESX 
0.23 Dark purple 0.23 Greenish blue 0.23 Dark black 
0.34 Light purple 0.34 Greenish blue 0.34 Dark black 
0.38 Light purple 0.60 Greenish blue 0.60 Dark black 
0.61 Light brown 0.66 Greenish blue 0.66 Dark black 
0.69 Light brown 0.71 Light blue 0.71 Dark black 
0.75 Light brown 0.78 Greenish blue 0.78 Dark black 
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Table 5.4  TLC profile of all plant extracts derivatized with 20 % H2SO4 
 
TLC 
Band 
Test 
Observation  in White 
Light 
Observation  in UV366 
Light 
Observation  in UV254 
Light 
 Rf 
Value 
Color of Band Rf 
Value 
Color of Band Rf 
Value 
Color of Band 
ETF 
0.25 Dark purple 0.28 Dark purple 0.28 Dark purple 
0.30 Light brown 0.30 Brownish blue 0.30 Brownish blue 
0.38 Dark purple 0.44 Light green 0.44 Light green 
0.40 Light brown 0.56 Light green 0.56 Light green 
0.48 Light purple 0.65 Dark purple 0.65 Dark purple 
0.63 Dark purple     
0.70 Light orange     
EDA 
0.24 Dark purple 0.20 Light blue 0.31 Light blue 
0.31 Dark purple 0.25 Light blue 0.44 Light blue 
0.63 Light purple 0.44 Light blue   
0.73 Light purple     
0.78 Light purple     
EHI 
0.20 Dark purple 0.35 Bright blue 0.35 Bright blue 
0.31 Dark purple 0.45 Bright blue 0.45 Bright blue 
0.48 Light orange 0.68 Bright blue 0.68 Bright blue 
0.61 Dark purple   0.88 Bright blue 
0.69 Dark pink     
0.81 Pinkish orange     
EAA 
0.24 Dark purple 0.25 Dark purple 0.25 Dark purple 
0.31 Dark purple 0.31 Dark purple 0.31 Dark purple 
0.45 Dark green 0.39 Dark orange 0.39 Dark orange 
0.65 Light  green 0.48 Bright red 0.48 Bright red 
0.75 Light  green 0.78 Bright red 0.78 Bright red 
0.78 Dark green 0.88 Bright red 0.88 Bright red 
0.85 Light  green     
0.88 Dark green     
ESX 
0.25 Dark purple 0.24 Greenish blue 0.24 Greenish blue 
0.40 Light orange 0.38 Greenish blue 0.38 Greenish blue 
0.48 Light purple 0.44 Light blue 0.44 Light blue 
0.61 Bluish purple 0.74 Bright blue 0.74 Bright blue 
0.69 Dark purple 0.78 Dark blue 0.78 Dark blue 
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5.3 Effect of treatment of plant extract on adjuvant arthritis in rats 
In present protocol albino Wistar rat were treated with complete Freund’s 
adjuvant to evaluate steroidal potential of ETF, EDA, EHI, EAA and ESX. The result 
of this study gives important direction for preparation of glucocorticoid and 
mineralocorticoid comparative index of selected herbs.  
All animal were grouped (n=6) as control, hydrocortisone treated, ETF treated, 
EDA treated, EHI treated, EAA treated and ESX treated. Hydrocortisone 10 mg per 
rat administered orally and 300 mg/kg per rat dose kept common for all other 
treatment group for comparative evaluation of relative potencies.  
Paw volumes of both sides (figure 5.8 (A) and figure 5.8 (B)) and body weight 
were recorded on the day of injection, day 5, day 12, day 17 and day 21 whereby paw 
volume is measured plethysmographically. The severity of the secondary lesions on 
day 12 is evaluated visually and graded according scheme given in materials and 
methods. 
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Figure 5.8 (A) Effect of complete Freund’s adjuvant Injected left paw and Non-
injected right paw of rat 
 
 
Figure 5.8 (B) Comparision of paw volume for  both fore paw and both hind paw 
after  complete Freund’s adjuvant Injection 
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Decrease of weight of normally observed with catabolic steroids in rat. After 
the completion of study, on day 21 the weight were measure and change in weight 
compare with initial weight (day 1, before injection of CFA).  The result for change in 
weight shown in table 5.5 while its graphical representation for day 5, day 12, day 17 
and day 21 given in figure 5.9 (A) and Figure 5.10 (B) 
On day 21, the increase in body weight in gram for control, HC, ETF, EDA, EHI, 
EAA and ESX were 36.33±1.358, 2.0 ±0.894***, 31.0 ±2.955, 28.83±2.428, 
25.83±3.270*, 23.67±3.721* and 22.17±2.868** when compared with weight on day 
1 (*p<0.05, **p<0.01 and ***p<0.001) 
 
Table 5.5 Effect of HC, ETF, EDA, EHI, EAA and ESX on body weight during 
Adjuvant arthritis study 
Group 
Increase in Body Weight (gram) 
At Day 5 At day 12 At day 17 At day 21 
Control 12.00± 0.516 22.50±0.991 28.17±1.424 36.33±1.358 
HC 8.50  ±0.341* 16.67±0.666* 9.66 ±0.802*** 2.0 ±0.894*** 
ETF 9.83 ±0.601 18.17±1.249 22.83±2.040 31.0 ±2.955 
EDA 10.50±0.763 18.33±1.542 23.00±2.324 28.83±2.428 
EHI 10.00 ±0.816 18.50±1.522 22.33±2.431 25.83±3.270* 
EAA 10.00 ±0.632 17.33±1.820 20.50±3.233 23.67±3.721* 
ESX 11.17 ±1.641 17.00±1.983 19.33±2.171* 22.17±2.868** 
 
Six rats were used in each group. The increase in body weight in gram was calculated 
by subtracting weight at day 1 from that after FCA injection. The value expressed 
mean±S.E.M. *p<0.05, **p<0.01 and ***p<0.001 vs control group. 
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Figure 5.9 (A) Effect of HC, ETF, EDA, EHI, EAA and ESX on body weight on day 
21 during adjuvant arthritis study. Each column represents the mean±S.E.M. of six 
rats.  *p<0.05, **p<0.01 and ***p<0.001 vs. control group. 
 
 Figure 5.9 (B) Effect of HC, ETF, EDA, EHI, EAA and ESX on body weight during 
Adjuvant arthritis study. Each line represents the mean±S.E.M. of six rats.  *p<0.05, 
**p<0.01 and ***p<0.001 vs. control group. 
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  The injection of CFA into left hind paw of rat provoked inflammatory reaction 
marked by edema in left paw (Figure 5.8 (A)) edema in right paw as secondary 
infection (figure 5.8 (B)).  
  The change in paw volume in ml measure for both paw and compare with 
control. Change in paw volume expressed as change in ml and % inhibition by 
treatment group.  
 
Where, 
VControl = Difference in Volume of paw of control  (ml) compare to day 1 
V Test       = Difference in Volume of paw of test group (ml) compare to day 1 
 
The change in left (injected) paw volume compare to day 1 given in table 5.6 
while percentage inhibition of paw volume (figure 5.26) compare to control group 
given in table 5.8. The change in right (non-injected) paw volume compare to day 1 
given in table 5.7 while percentage inhibition of paw volume (figure 5.27) compare to 
control group given in table 5.9. 
 Paw volume measured on day 5 for left and right paw in ml. On day 5, the 
change in left (injected) paw volume (ml) for control, HC, ETF, EDA, EHI, EAA and 
ESX were 0.54±0.041, 0.35±0.042, 0.46±0.075, 0.44±0.038, 0.48±0.079, 0.42±0.073 
and 0.44±0.085  ml respectively (figure 5.10). The percentage inhibition (left paw) on 
day 5 for HC, ETF, EDA, EHI, EAA and ESX were 14.51±5.166, 9.07±5.254, 
1.41±5.855, 5.72±7.874, and 7.96±7.041 and 9.39±6.193 respectively (figure 5.11). 
 On day 5, the change in right (non-injected) paw volume (ml) for control, HC, 
ETF, EDA, EHI, EAA and ESX were 0.19±0.017, 0.09±0.0211, 0.13±0.046, 
0.08±0.033, 0.09±0.042, 0.09±0.025 and 0.08±0.026  ml respectively (figure 5.12). 
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The percentage inhibition (right paw) on day 5 for HC, ETF, EDA, EHI, EAA and 
ESX were 16.31±4.380, 6.86±6.619, 5.67±8.293, 11.58±4.882, 12.06±3.513 and 
13.24±6.934 respectively (figure 5.13). 
 On day 12, the change in left (injected) paw volume (ml) for control, HC, ETF, 
EDA, EHI, EAA and ESX were 0.76±0.031, 0.35±0.025***, 0.55±0.059, 0.55±0.049, 
0.62±0.062, 0.53±0.081* and 0.58±0.067  ml respectively (figure 5.14). The 
percentage inhibition (left paw) on day 12 for HC, ETF, EDA, EHI, EAA and ESX 
were 29.25±2.960, 17.99±3.455, 10.31±4.767, 11.37±4.895, 14.41±6.348 and 
14.02±4.071 respectively (figure 5.15) (***p<0.001). The reduction in edema for HC 
found extremely significant and EAA significant (*p<0.05, **p<0.01 and 
***p<0.001). 
 The change in right (non-injected) paw volume (ml) on day 12 for control, HC, 
ETF, EDA, EHI, EAA and ESX were 0.26±0.025, 0.06±0.021***, 0.19±0.054, 
0.09±0.019**, 0.11±0.036*, 0.12±0.032* and 0.11±0.025** ml respectively (figure 
5.16). The percentage inhibition (right paw) on day 12 for HC, ETF, EDA, EHI, EAA 
and ESX were 29.18±4.354, 6.92±6.815, 13.70±5.452, 19.00±3.937, 17.51±3.649 and 
19.85±5.793 respectively (figure 5.17) (*p<0.05, **p<0.01 and ***p<0.001).  The 
reduction in edema for HC found extremely significant, EDA and ESX highly 
significantly reduced paw edema while EHI and EAA highly significantly reduced 
paw edema  (*p<0.05, **p<0.01 and ***p<0.001). 
 Edema (Paw volume) measured on day 17 for left and right paw in ml. On day 
17, the change in left (injected) paw volume (ml) for control, HC, ETF, EDA, EHI, 
EAA and ESX were 0.94±0.046,  0.12±0.042***, 0.63±0.062**, 0.66±0.054*, 
0.65±0.060**, 0.57±0.076*** and 0.63±0.074**  ml respectively (figure 5.18). The 
percentage inhibition (left paw) on day 17 for HC, ETF, EDA, EHI, EAA and ESX 
were 14.51±5.166, 9.07±5.254, 1.41±5.855, 5.72±7.874, and 7.96±7.041 and 
9.39±6.193 respectively (figure 5.19). The reduction of edema for HC and EAA were 
extremely significant while ETF, EHI and ESX showed highly significant decrease in 
paw volume. EDA showed significant decline in paw volume (*p<0.05, **p<0.01 and 
***p<0.001).  
                                                                                                            Results … 
 
 
 127 
 
 On day 17, the change in right (non-injected) paw volume (ml) for control, HC, 
ETF, EDA, EHI, EAA and ESX were 0.29±0.034, 0.09±0.038**, 0.22±0.054, 
0.16±0.037, 0.18±0.038, 0.22±0.031 and 0.16±0.044 ml respectively (figure 5.20). 
The percentage inhibition (right paw) on day 17 for HC, ETF, EDA, EHI, EAA and 
ESX were 29.70±6.117, 8.89±6.340, 9.9±3.880, 14.34±4.835, 8.889±4.883 and 
16.16±5.833respectively (figure 5.21). The reduction of edema for only HC found 
highly significant (**p<0.01). 
 Paw volume measured on day 21 for left and right paw in ml. On day 21, the 
change in left (injected) paw volume (ml) for control, HC, ETF, EDA, EHI, EAA and 
ESX were 1.13±0.065, 0.03±0.032***, 0.92±0.078, 0.79±0.067**, 0.66±0.054***, 
0.61±0.077*** and 0.72±0.077***  ml respectively (figure 5.22). The percentage 
inhibition (left paw) on day 21 for HC, ETF, EDA, EHI, EAA and ESX were 
65.54±2.482, 13.91±4.187, 15.34±1.997, 28.53±3.663, 29.14±4.300 and 25.26±3.939 
respectively (figure 5.23). The reduction of edema for HC EAA, EHI and ESX were 
extremely significant and the reduction of edema for EDA was highly significant 
(**p<0.01 and ***p<0.001).  
 The change in right (non-injected) paw volume (ml) on day 21 for control, HC, 
ETF, EDA, EHI, EAA and ESX were 0.42±0.062, 0.05±0.023***, 0.15±0.031***, 
0.12±0.046***, 0.15±0.049***, 0.21±0.043** and 0.13±0.041*** ml respectively 
(figure 5.24). The percentage inhibition (right paw) on day 21 for HC, ETF, EDA, 
EHI, EAA and ESX were 42.68±3.720, 27.34±4.022, 25.40±3.683, 28.22±5.343, 
22.22±4.863 and 30.86±4.003 respectively (figure 5.25).  The reduction in paw 
volume for HC, ETF, EDA, EHI and ESX found extremely significant while EAA 
highly significantly reduced paw edema (**p<0.01 and ***p<0.001). 
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Figure 5.10 Effect of HC, ETF, EDA, EHI, EAA and ESX on left (injected) paw 
volume after 5 days during adjuvant arthritis study. Each column represents the 
mean±S.E.M. of six rats.  *p<0.05 vs. control group. 
 
Figure 5.11 Percentage inhibition of left (injected) paw volume after 5 days  during 
adjuvant arthritis study by HC, ETF, EDA, EHI, EAA and ESX. Each column 
represents the mean±S.E.M. of six rats.  
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Figure 5.12 Effect of HC, ETF, EDA, EHI, EAA and ESX on right ( non-injected) 
paw volume after 5 days  during adjuvant arthritis study. Each column represents the 
mean±S.E.M. of six rats.  *p<0.05 vs. control group. 
 
Figure 5.13 Percentage inhibition of  right (non-injected) paw volume after 5 days  
during adjuvant arthritis study by HC, ETF, EDA, EHI, EAA and ESX. Each column 
represents the mean±S.E.M. of six rats. 
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Figure 5.14 Effect of HC, ETF, EDA, EHI, EAA and ESX on left (injected) paw 
volume after 12 days during adjuvant arthritis study. Each column represents the 
mean±S.E.M. of six rats.  *p<0.05 and ***p<0.001vs. control group. 
 
Figure 5.15 Percentage inhibition of left (injected) paw volume after 12 days  during 
adjuvant arthritis study by HC, ETF, EDA, EHI, EAA and ESX. Each column 
represents the mean±S.E.M. of six rats. 
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Figure 5.16 Effect of HC, ETF, EDA, EHI, EAA and ESX on right (non-injected) 
paw volume after 12 days during adjuvant arthritis study. Each column represents the 
mean±S.E.M. of six rats.  *p<0.05, **p<0.01 and ***p<0.001 vs. control group. 
 
Figure 5.17 Percentage inhibition of  right (non-injected) paw volume after 12 days  
during adjuvant arthritis study by HC, ETF, EDA, EHI, EAA and ESX. Each column 
represents the mean±S.E.M. of six rats. 
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Figure 5.18 Effect of HC, ETF, EDA, EHI, EAA and ESX on left (injected) paw 
volume after 17 days during adjuvant arthritis study. Each column represents the 
mean±S.E.M. of six rats.  *p<0.05, **p<0.01 and ***p<0.001 vs. control group. 
 
Figure 5.19 Percentage inhibition of  left (injected) paw volume after 17 days  during 
adjuvant arthritis study by HC, ETF, EDA, EHI, EAA and ESX. Each column 
represents the mean±S.E.M. of six rats. 
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Figure 5.20 Effect of HC, ETF, EDA, EHI, EAA and ESX on right (non-injected) 
paw volume after 17 days during adjuvant arthritis study. Each column represents the 
mean±S.E.M. of six rats.  **p<0.01 vs. control group. 
 
Figure 5.21 Percentage inhibition of  right (non-injected) paw volume after 17 days  
during adjuvant arthritis study by HC, ETF, EDA, EHI, EAA and ESX. Each column 
represents the mean±S.E.M. of six rats. 
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Figure 5.22 Effect of HC, ETF, EDA, EHI, EAA and ESX on left (injected) paw 
volume after 21 days during adjuvant arthritis study. Each column represents the 
mean±S.E.M. of six rats.  **p<0.01 and ***p<0.001 vs. control group. 
 
 
Figure 5.23 Percentage inhibition of left (injected) paw volume after 21 days during 
adjuvant arthritis study by HC, ETF, EDA, EHI, EAA and ESX. Each column 
represents the mean±S.E.M. of six rats. 
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Figure 5.24 Effect of HC, ETF, EDA, EHI, EAA and ESX on right (non-injected) 
paw volume after 21 days during adjuvant arthritis study. Each column represents the 
mean±S.E.M. of six rats.  **p<0.01 and ***p<0.001vs. control group. 
 
 
Figure 5.25 Percentage inhibition of  right (non-injected) paw volume after 21 days  
during adjuvant arthritis study by HC, ETF, EDA, EHI, EAA and ESX. Each column 
represents the mean±S.E.M. of six rats. 
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Figure 5.26 Percentage inhibition of left (injected) paw volume during adjuvant 
arthritis study by HC, ETF, EDA, EHI, EAA and ESX. Each value represents the 
mean±S.E.M. of six rats. 
 
 
Figure 5.27 Percentage inhibition of  right (non-injected) paw volume during 
adjuvant arthritis study by HC, ETF, EDA, EHI, EAA and ESX. Each value 
represents the mean±S.E.M. of six rats. 
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Table 5.6  Effect of HC, ETF, EDA, EHI, EAA and ESX on left (injected) paw 
volume during adjuvant arthritis study 
Group 
Change in Injected (Left) paw volume in ml. 
At Day 5 At day 12 At day 17 At day 21 
Control 0.54±0.041 0.76±0.031 0.94±0.046 1.13±0.065 
HC 0.35±0.042 0.35±0.025*** 0.12±0.042*** 0.03±0.032*** 
ETF 0.46±0.075 0.55±0.059 0.63±0.062** 0.92±0.078 
EDA 0.44±0.038 0.55±0.049 0.66±0.054* 0.79±0.067** 
EHI 0.48±0.079 0.62±0.062 0.65±0.060** 0.66±0.054*** 
EAA 0.42±0.073 0.53±0.081* 0.57±0.076*** 0.61±0.077*** 
ESX 0.44±0.085 0.58±0.067 0.63±0.074** 0.72±0.077*** 
 
Six rats were used in each group. The change in left paw volume in ml was calculated 
by subtracting weight at day 1 from that after FCA injection. The value expressed 
mean±S.E.M. *p<0.05, **p<0.01 and ***p<0.001 vs control group. 
 
Table 5.7 Effect of HC, ETF, EDA, EHI, EAA and ESX on right (non-injected) paw 
volume during adjuvant arthritis study 
Group 
Change in Injected (Right) paw volume in ml. 
At Day 5 At day 12 At day 17 At day 21 
Control 0.19±0.017 0.26±0.025 0.29±0.034 0.42±0.062 
HC 0.09±0.0211 0.06±0.021*** 0.09±0.038** 0.05±0.023*** 
ETF 0.13±0.046 0.19±0.054 0.22±0.054 0.15±0.031*** 
EDA 0.08±0.033 0.09±0.019** 0.16±0.037 0.12±0.046*** 
EHI 0.09±0.042 0.11±0.036* 0.18±0.038 0.15±0.049*** 
EAA 0.09±0.025 0.12±0.032* 0.22±0.031 0.21±0.043** 
ESX 0.08±0.026 0.11±0.025** 0.16±0.044 0.13±0.041*** 
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Table 5.8 Percentage inhibition of  left (injected) paw volume during adjuvant 
arthritis study by HC, ETF, EDA, EHI, EAA and ESX 
Group 
% inhibition of paw volume of the injected left paw 
At Day 5 At day 12 At day 17 At day 21 
HC 14.51±5.166 29.25±2.960 54.81±2.484 65.54±2.482 
ETF 9.07±5.254 17.99±3.455 22.45±2.934 13.91±4.187 
EDA 1.41±5.855 10.31±4.767 13.55±3.246 15.34±1.997 
EHI 5.72±7.874 11.37±4.895 20.37±4.135 28.53±3.663 
EAA 7.96±7.041 14.41±6.348 21.98±4.952 29.14±4.300 
ESX 9.39±6.193 14.02±4.071 21.98±4.274 25.26±3.939 
 
Six rats were used in each group. The change in right paw volume in ml was 
calculated by subtracting weight at day 1 from that after FCA injection. The value 
expressed mean±S.E.M. *p<0.05, **p<0.01 and ***p<0.001 vs control group. 
 
Table 5.9  Percentage inhibition of  right (non-injected) paw volume during adjuvant 
arthritis study by HC, ETF, EDA, EHI, EAA and ESX 
Group 
% inhibition of paw volume of the non-injected right paw 
At Day 5 At day 12 At day 17 At day 21 
HC 16.31±4.380 29.18±4.354 29.70±6.117 42.68±3.720 
ETF 6.86±6.619 6.92±6.815 8.89±6.340 27.34±4.022 
EDA 5.67±8.293 13.70±5.452 9.9±3.880 25.40±3.683 
EHI 11.58±4.882 19.00±3.937 14.34±4.835 28.22±5.343 
EAA 12.06±3.513 17.51±3.649 8.889±4.883 22.22±4.863 
ESX 13.24±6.934 19.85±5.793 16.16±5.833 30.86±4.003 
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 The immunosuppressive activity can also express by inhibition of lesion 
compare to control on day 21 (table 5.10). The arthritic lesion on day 21 for control, 
HC, ETF, EDA, EHI, EAA and ESX were 6.167±0.402, 1.167±0.167***, 
4.667±0.422*, 3.167±0.477**, 2.333±0.333***, 2.167±0.307*** and 
2.000±0.258*** respectively (figure 5.28 (A)). The percentage inhibition of arthritic 
lesion (figure 5.28 (B)) on day 21 for HC, ETF, EDA, EHI, EAA and ESX were 
81.08±2.703, 29.72±3.419, 48.65±4.983, 62.16±5.405, 64.86±4.983 and 67.56±4.187 
respectively. The suppression of arthritic lesion on day 21 for HC, EHI, EAA and 
ESX found extremely significant. ETF and EDA showed significant and highly 
significant inhibition of arthritic lesion (*p<0.05, **p<0.01 and ***p<0.001).   
 The total percentage change (table 5.11) calculated by addition of percentage 
inhibition of left paw on day 5, percentage inhibition of right paw on day 12 and 
percentage inhibition of arthritic score on day 21 (figure 5.30). The total percentage 
change for HC, ETF, EDA, EHI, EAA and ESX were 124.77, 45.71, 63.76, 86.88, 
90.33 and 96.8 respectively. 
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Figure 5.28 (A) Arthritic lesion on day 21 during adjuvant arthritis study by HC, 
ETF, EDA, EHI, EAA and ESX. Each column represents the mean±S.E.M. of six 
rats.  *p<0.05, **p<0.01 and ***p<0.001 vs. control group. 
 
Figure 5.28 (B) Percentage inhibition of arthritic lesion during adjuvant arthritis 
study by HC, ETF, EDA, EHI, EAA and ESX. Each column represents the 
mean±S.E.M. of six rats. 
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Table 5.10  Percentage inhibition of  arthritic index during adjuvant arthritis 
study by HC, ETF, EDA, EHI, EAA and ESX 
Group Arthritic index on day 21 % inhibition of arthritic 
lesion  
Control 6.167±0.402 ------ 
HC 1.167±0.167*** 81.08±2.703 
ETF 4.667±0.422* 29.72±3.419 
EDA 3.167±0.477** 48.65±4.983 
EHI 2.333±0.333*** 62.16±5.405 
EAA 2.167±0.307*** 64.86±4.983 
ESX 2.000±0.258*** 67.56±4.187 
 
Six rats were used in each group. The arthritic index was graded on the scale of 
0-4. The value were expressed mean±S.E.M. *p<0.05, **p<0.01 and 
***p<0.001 vs. control group 
 
Table 5.11 Total percentage change during adjuvant arthritis study by 
HC, ETF, EDA, EHI, EAA and ESX 
Group Total percentage change 
HC 124.77 
ETF 45.71 
EDA 63.76 
EHI 86.88 
EAA 90.33 
ESX 96.8 
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Figure 5.29 Arthritic index during adjuvant arthritis study by HC, ETF, EDA, EHI, 
EAA and ESX. Each value represents the mean±S.E.M. of six rats. 
 
Figure 5.30 Total percentage change during adjuvant arthritis study by HC, ETF, 
EDA, EHI, EAA and ESX. Each column represents the mean±S.E.M. of six rats. 
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5.4 Effect of treatment of plant extract on liver glycogen deposition 
test in rats  
The choice of the animal strain has been found to be very important for the 
performance of this test. Wistar rats have been proven to be very suitable in contrast 
to other sub strains. In present study albino Wistar rat were used as test animal and 
references (Nobuhiko et al.1975) available for liver glycogen deposition animal 
model (figure 5.31). 
The Calibration curve (figure 5.32) of glucose for estimation of liver glycogen 
was prepared same as procedure explained in materials and methods. Linearity range 
of standard glucose calibration curve (n=3) was found in range of 20-100 µg/ml with 
co-relation coefficient (r
2
) of 0.986 and the linearity equation was found to be Y = 
0.006X + 0.103 (figure 5.33). 
 
  
Image of Rat liver Rat liver after removal of blood 
 
Figure 5.31 Rat liver during surgery and after removal of blood 
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Figure 5.32   UV spectrum of glucose after interaction with anthrone reagent 
 
 
 
Figure 5.33 Calibration curve of glucose for estimation of liver glycogen 
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The glycogen deposition in liver was expressed as liver glycogen in mg per 
gm of liver (figure 5.34). The liver glycogen deposition was found for control, HC, 
EHI, EAA and ESX groups were 17.67 ± 1.279, 46.22 ± 2.279 ***, 27.90 ± 1.955 **, 
27.17 ± 1.791** and 25.57 ± 1.731* respectively as shown in table 5.12. . The gain in 
liver glycogen for EHI and EAA was found highly significant while ESX was found 
significant when compared with control. The glycogen deposition in liver increase 
with extreme significance. (*p<0.05, **p<0.01 and ***p<0.001). 
 
 
Figure 5.34 Effect of HC, EHI, EAA and ESX on liver glycogen during liver 
glycogen deposition study. Each column represents the mean±S.E.M. of six rats.  
*p<0.05, **p<0.01 and ***p<0.001 vs. control group. 
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Table 5.12 Effect of HC, EHI, EAA and ESX on liver glycogen deposition 
Group Liver Glycogen (mg/gm of liver) 
Control 17.67 ± 1.279 
HC 46.22 ± 2.279 *** 
EHI 27.90 ± 1.955 ** 
EAA 27.17 ± 1.791** 
ESX 25.57 ± 1.731* 
 
Six rats were used in each group. The liver glycogen deposition was 
calculated in mg per gram of liver. The value were expressed mean±S.E.M. 
*p<0.05, **p<0.01 and ***p<0.001 vs. control group   
 
The hematological evaluation for blood cells, SGPT, SGOT, serum calcium 
and serum potassium was performed for control group and treatment groups. The 
results for hematological evaluation expressed in table 5.13.  
The red blood corpuscle (RBC) count (10
6
/cumm) for control, HC, EHI, EAA and 
ESX were found to be 7.39±0.519, 10.6±0.950**, 7.4 ± 0.705, 6.2 ± 0.568 and 7.4 ± 
0.464 respectively (figure 5.35). The increase in RBC for HC was found to be highly 
significant as compare to control (**p<0.01).  
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Figure 5.35 Effect of HC, EHI, EAA and ESX on red blood corpuscles during liver 
glycogen deposition study. Each column represents the mean±S.E.M. of six rats.   
**p<0.01 vs. control group. 
 
Figure 5.36 Effect of HC, EHI, EAA and ESX on white blood cell during liver 
glycogen deposition study. Each column represents the mean±S.E.M. of six rats.  
*p<0.05 and **p<0.01 vs. control group. 
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Figure 5.37 Effect of HC, EHI, EAA and ESX on platelets during liver glycogen 
deposition study. Each column represents the mean±S.E.M. of six rats.  *p<0.05 vs. 
control group. 
 
 The white blood cells (WBC) count per cu mm for control, HC, EHI, EAA 
and ESX were found to be 7509 ± 721.7, 5469 ± 420.9 *, 8133 ± 323.0, 6819 ± 448.2 
and 10239 ± 575.9 ** respectively (figure 5.36). The increase in WBC for HC was 
found to be significant as compare to control while ESX showed highly significant 
gain in WBC as compare to control (*p<0.05 and **p<0.01). 
The platelets count per (10
3
/cumm) for control, HC, EHI, EAA and ESX were 
found to be 851.0 ± 48.06, 940.0 ± 33.59, 803.7 ± 31.56, 664.0 ± 40.28 * and 
823.3±43.47 (figure 5.37) only EAA showed significant decrease in platelet counts as 
compare to control (*p<0.05). 
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The serum calcium level (mg/dl) for control, HC, EHI, EAA and ESX were 
found to be 8.233 ± 0.567, 14.00 ± 1.378 **, 5.673 ± 0.943, 12.52 ± 0.953 * and 
8.967±0.605 (figure 5.38). The HC shown highly significant increase in serum 
calcium level as compare to control while EAA shown significant gain in serum 
calcium level as compare (*p<0.05 and **p<0.01). 
The serum potassium level (mMol/liter) for control, HC, EHI, EAA and ESX 
were found to be 5.100 ± 0.193, 2.667 ± 0.191***, 4.147 ± 0.353, 4.073 ± 0.582 and 
4.300 ± 0.238 (figure 5.39). The HC showed extremely significant increase in serum 
potassium level as compare to control (***p<0.001).  
Serum glutamate pyruvate transaminase, or SGPT (ALT) level (IU/L) for 
control, HC, EHI, EAA and ESX were found 62.30±4.594, 105.3±9.207**, 
50.43±4.646, 56.73±10.67 and 48.30±4.838 (figure 5.40). The HC showed highly 
significant increase in SGPT as compare to control (**p<0.01).   
SGOT or Serum glutamic-oxaloacetic transaminase (AST) level (IU/L) for 
control, HC, EHI, EAA and ESX were found 178.7 ± 11.98, 233.0 ± 8.71*, 174.0 ± 
14.01, 193.3 ± 10.33 and 157.7 ± 10.09 (figure 5. 5.41). The HC showed significant 
increase in SGOT level as compare to control (*p<0.05). 
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Figure 5.38 Effect of HC, EHI, EAA and ESX on serum calcium level during liver 
glycogen deposition study. Each column represents the mean±S.E.M. of six rats.  
*p<0.05 and **p<0.01 vs. control group. 
 
Figure 5.39 Effect of HC, EHI, EAA and ESX on serum potassium level during liver 
glycogen deposition study. Each column represents the mean±S.E.M. of six rats.  
***p<0.001 vs. control group. 
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Figure 5.40 Effect of HC, EHI, EAA and ESX on SGPT (ALT) level during liver 
glycogen deposition study. Each column represents the mean±S.E.M. of six rats.  
**p<0.01 vs. control group. 
 
Figure 5.41 Effect of HC, EHI, EAA and ESX on SGOT (AST) level during liver 
glycogen deposition study. Each column represents the mean±S.E.M. of six rats.  
*p<0.05 vs. control group. 
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Table 5.13  Effect of HC,  EHI, EAA and ESX on Hematological parameter during liver glycogen deposition study 
Group 
RBC 
10
6
/cumm 
WBC per cumm 
Pletlet 
10
3
/cumm 
Serum Ca
++
 
Mg/dl 
Serum K
+
 
mMol/L 
SGPT 
(ALT) 
IU/L 
SGOT 
(AST) 
IU/L 
Control 7.39 ± 0.519 7509 ± 721.7 851.0 ± 48.06 8.233 ± 0.567 5.100 ± 0.193 62.30 ± 4.594 178.7 ± 11.98 
HC 10.6 ± 0.950 ** 5469 ± 420.9 * 940.0 ± 33.59 14.00 ± 1.378 ** 2.667 ± 0.191*** 105.3 ± 9.207 ** 233.0 ± 8.71 * 
EHI 7.4 ± 0.705 8133 ± 323.0 803.7 ± 31.56 5.673 ± 0.943 4.147 ± 0.353 50.43 ± 4.646 174.0 ± 14.01 
EAA 6.2 ± 0.568 6819 ± 448.2 664.0 ± 40.28 * 12.52 ± 0.953 * 4.073 ± 0.582 56.73 ± 10.67 193.3 ± 10.33 
ESX 7.4 ± 0.464 10239 ± 575.9 ** 823.3 ± 43.47 8.967 ± 0.605 4.300 ± 0.238 48.30 ± 4.838 157.7 ± 10.09 
 
Six rats were used in each group. The hematological parameters were calculated in blood. The value were expressed mean±S.E.M. *p<0.05, 
**p<0.01 and ***p<0.001 vs. control group   
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Histopathology of Liver 
Liver glycogen was determined under standard conditions on intact and 
adrenalectomized rats. The liver uses glucose as a fuel and also has the ability to store 
it as glycogen and synthesize it from noncarbohydrate precursors (gluconeogenesis). 
Periodic acid-Schiff (PAS) is a staining method used to detect glycogen and other 
polysaccharides in tissues. The reaction of periodic acid oxidizes the diol functional 
groups in glucose and other sugars, creating aldehydes that react with the Schiff 
reagent to give a purple-magenta color. A suitable basic stain is often used as a 
counterstain. Wax blocks were made and section was made by microtome, stained by 
Periodic acid-Schiff (PAS) and photographed. 
The effect of HC, EHI, EAA and ESX on histopathology of liver during liver 
glycogen deposition study shown in figure 5.42. The Histopathology of liver treated 
with HC clearly showed more deposition of glycogen in hepatocytes. The Glycogen 
deposition was comparatively observed more in HC, EHI and EAA while ESX 
showed least signs for glycogen deposition. 
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Figure 5.42 Effect of HC,  EHI, EAA and ESX on histopathology of liver  during liver 
glycogen deposition study 
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5.5  Effect of treatment of plant extract on sodium excretion in rat 
The mineralocorticoid activity by measurement of sodium excretion carried 
out only for Hydrocortisone, Ethanolic extract of Hemidesmus indicus (EHI), 
Ethanolic extract of Agave americana (EAA) and Ethanolic extract of Solanum 
xanthocarpum (ESX). Along with sodium excretion, urine alalysis also performed for 
urine chlorides, urine potassium and urine Creatinine as shown in table 5.14. 
 The urine chloride (Cl
-
) level (mMol/L) for control, HC, EHI, EAA and ESX 
were found to be 102.3 ± 5.453, 44.20 ± 6.583 ***, 104.3 ± 4.902, 91.33 ± 10.85 and 
107.3 ± 9.404 (figure 5.43). HC showed extremely significant decrease in urine 
chloride level as compare to control (***p<0.001). 
The urine Creatinine level (mg/dl) for control, HC, EHI, EAA and ESX were 
found to be 0.546 ± 0.049, 1.005 ± 0.129 **, 0.646 ± 0.069, 0.566 ± 0.083 and 0.600 ± 
0.074 (figure 5.44). The HC showed highly significant gain in urine Creatinine level as 
compare to control (**p<0.01). 
The urine sodium level (mMol/L) for control, HC, EHI, EAA and ESX were 
found to be 76.40 ± 3.530, 30.20 ± 3.878 ***, 59.78 ± 5.207, 48.80 ± 8.496* and 74.60 
± 7.871 (figure 5.45). The HC showed extremely significant fall in urine sodium level 
as compare to control while EAA showed significant reduction in urine sodium level as 
compare to control (*p<0.05 and ***p<0.001). 
The urine potassium level (mMol/L) for control, HC, EHI, EAA and ESX 
were found to be 11.52 ± 0.8133, 19.06 ± 1.364 **, 12.62 ± 2.209, 13.34 ± 1.515 and 
12.84 ± 1.547 (figure 5.46). HC showed highly significant increase in potassium 
excretion level as compare to control (**p<0.01).  
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Figure 5.43 Effect of HC, EHI, EAA and ESX on urine chlorides (Cl
-
) during 
evaluation of mineralocorticoid activity. Each column represents the mean±S.E.M. of 
six rats.  ***p<0.001 vs. control group. 
 
Figure 5.44 Effect of HC, EHI, EAA and ESX on urine Creatinine level during 
evaluation of mineralocorticoid activity. Each column represents the mean±S.E.M. of 
six rats.  **p<0.01 vs. control group. 
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Figure 5.45 Effect of HC, EHI, EAA and ESX on Sodium (Na
+
) excretion during 
evaluation of mineralocorticoid activity. Each column represents the mean±S.E.M. of 
six rats.  *p<0.05 and ***p<0.001 vs. control group. 
 
Figure 5.46 Effect of HC, EHI, EAA and ESX on Potassium (K
+
) excretion during 
evaluation of mineralocorticoid activity. Each column represents the mean±S.E.M. of 
six rats.  **p<0.01 vs. control group. 
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Figure 5.47 Effect of HC, EHI, EAA and ESX on Sodium /Potassium (Na
+
 / K
+
)
 
Ratio during evaluation of mineralocorticoid activity. Each column represents the 
mean±S.E.M. of six rats.  **p<0.01 vs. control group. 
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Table 5.14  Effect of HC,  EHI, EAA and ESX on urine parameter during evaluation of  Mineralocorticoid activity 
Group 
Chloride 
mMol / L 
Creatinine 
Mg / dl 
 
Sodium 
mMol / L 
Potassium 
mMol / L 
Na
+
 / K
+
 Ratio 
Control 102.3 ± 5.453 0.546 ± 0.049 76.40 ± 3.530 11.52 ± 0.8133 6.81 ± 0.748 
HC 44.20 ± 6.583 *** 1.005 ± 0.129 ** 30.20 ± 3.878 *** 19.06 ± 1.364 ** 1.66 ± 0.320 ** 
EHI 104.3 ± 4.902 0.646 ± 0.069 59.78 ± 5.207 12.62 ± 2.209 5.52 ± 1.148 
EAA 91.33 ± 10.85 0.566 ± 0.083 48.80 ± 8.496 * 13.34 ± 1.515 3.75 ± 0.636 
ESX 107.3 ± 9.404 0.600 ± 0.074 74.60 ± 7.871 12.84 ± 1.547 6.28 ± 1.229 
 
Six rats were used in each group. The urine parameters were calculated and the value were expressed mean±S.E.M. *p<0.05, 
**p<0.01 and ***p<0.001 vs. control group   
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Table 5.15 Relative Potencies of Hydrocortisone, EHI, EAA and ESX 
 
Sr. No. Steroidal 
Compound 
Glucocorticoid activity 
(Liver glycogen 
deposition) 
Mineralocorticoid 
Activity 
(Na
+
 excretion) 
1 Hydrocortisone 1 1 
2 EHI 0.61 0.57 
3 EAA 0.58 0.73 
4 ESX 0.55 0.36 
 
The Na
+
/K
+ 
ratio for control, HC, EHI, EAA and ESX were found to be 
6.81±0.748, 1.66 ± 0.320 **, 5.52 ± 1.148, 3.75 ± 0.636 and 6.28 ± 1.229 (figure 
5.47). The HC showed highly significant fall in Na
+
/K
+ 
ratio as compare to control 
(**p<0.01) 
Relative Potencies of Hydrocortisone, EHI, EAA and ESX were described in 
table 5.15. Glucocorticoid potential of (Liver glycogen deposition) HC, EHI, EAA 
and ESX were found to be 1, 0.61, 0.58 and 0.55 while Mineralocorticoid potential 
(Na+ excretion) of HC, EHI, EAA and ESX were found to be 1, 0.57, 0.73 and 0.36. 
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5.10 Statistical Analysis 
In statistics, one-way analysis of variance (abbreviated one-way ANOVA) is a 
technique used to compare means of two or more samples (using the F distribution). 
This technique can be used only for numerical data. The ANOVA tests the null 
hypothesis that samples in two or more groups are drawn from the same population. 
When ANOVA shows a significant difference between groups, if one of the groups is 
a control (reference) group, Dunnett's Test is used as a post hoc test. In statistical 
significance testing, the p-value is the probability of obtaining a test statistic at least 
as extreme as the one that was actually observed, assuming that the null hypothesis is 
true.  P value expressed as "Michelin Guide" scale, *: P < 0.05 (significant), **: P < 
0.01 (highly significant) and ***: P < 0.001 (extremely significant). This multiple 
comparison test can be used to determine the significant differences between a single 
control group mean and the remaining treatment group means in an analysis of 
variance setting. It is one of the least conservative post hoc tests (Anscombe  et al., 
1948). 
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5.11 Quality control of selected steroidal herbs 
Various parameter like mobile phase, HPTLC band, saturation time, activation 
time and operational parameters were developed based on trial and error method. The 
mobile phase for optimization carried out with more than 10 different combination of 
mobile phase and selected 4 mobile phases which were again evaluated with 
optimized parameter. The development of four screened mobile phase showed in 
figure below. The figure 5.48 indicates visualization of HPTLC plate in UV254  using 
four mobile phase while figure 5.49 indicates visualization of HPTLC plate in UV366  
using four mobile phase. 
Ethanolic extract of Trigonella foenum graecum (ETF), Ethanolic extract of 
Dioscorea alata (EDA), Ethanolic extract of Hemidesmus indicus (EHI), Ethanolic 
extract of Agave americana (EAA) and Ethanolic extract of Solanum xanthocarpum 
(ESX) evaluated for presence of steroids by TLC while HPTLC performed only for 
EHI, EAA and ESX, those herbs which showed significant activity as steroids in 
adjuvant arthritis activity. 
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A B 
  
C D 
Figure 5.48 Thin layer chromatography for selected herbal steroids developed and 
visualized in UV254 
 
1-EDA, 2-EAA, 3-ESX, 4-EHI, 5-ETF 
 
Mobile Phase 
A. Cyclohexane/Ethyl acetate/ Chloroform  1:1:1 v/v/v 
B. Chloroform/Methanol 75:25 v/v 
C. Toluene/Ethyl acetate/Formic acid 5:5:1 v/v/v 
D. Toluene/Ethyl acetate/Methanol 6:1:0.8  v/v/v 
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A B 
  
C D 
Figure 5.49 Thin layer chromatography for selected herbal steroids developed and 
visualized in UV366 
 
1-EDA, 2-EAA, 3-ESX, 4-EHI, 5-ETF 
 
Mobile Phase 
E. Cyclohexane/Ethyl acetate/ Chloroform  1:1:1 v/v/v 
F. Chloroform/Methanol 75:25 v/v 
G. Toluene/Ethyl acetate/Formic acid 5:5:1 v/v/v 
H. Toluene/Ethyl acetate/Methanol 6:1:0.8  v/v/v 
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HPTLC fingerprinting for EAA, ESX, EHI and mixture of all three extract 
developed, dried and visualized. Figure 5.50 (A) showed visualization in UV366 and 
figure 5.50 (B) showed visualization in UV254 
 
 
  
A B 
Figure 5.50 HPTLC fingerprinting for EAA, ESX, EHI and mixture of all three 
extract visualized in (A) UV366 and (B) UV254 
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Figure 5.51 Chromatogram and HPTLC fingerprinting details of EAA 
 
The Developed and scanned band of EAA showed good resolution of 7 bands 
when scanned ay UV366. As showed in figure 5.51, the chromatogram of EAA 
produced major peak at R
f
  0.07, 0.32 and 0.85. Figure 5.50 (A) clearly produced red 
colored peak in developed HPTLC plate. 
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Figure 5.52 Chromatogram and HPTLC fingerprinting details of ESX 
 
 
The Developed and scanned band of ESX showed good resolution of 6 bands 
when scanned ay UV366. As showed in figure 5.52, the chromatogram of ESX 
produced major peak at R
f
  0.04, 0.09 and 0.88. Figure 5.50 (A) clearly produced light 
blue colored peak in developed HPTLC plate. 
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Figure Chromatogram of EHI 
 
Figure 5.53 Chromatogram and HPTLC fingerprinting details of EHI 
 
The Developed and scanned band of EHI showed good resolution of 13 bands 
when scanned ay UV366. As showed in figure 5.53, the chromatogram of EHI 
produced major peak at R
f
  0.12, 0.40, 0.48 and 0.90. Figure 5.50 (A) clearly 
produced blue colored peak in developed HPTLC plate. 
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Figure Chromatogram of mixture of EAA, ESX and EHI 
 
Figure 5.54 Chromatogram details of mixture  
The Developed and scanned band of mixture showed good resolution of 12 
bands when scanned ay UV366. As showed in figure 5.54, the chromatogram of 
mixture fingerprinting for all three herbs. Figure 5.50 (A) and (B) produced well 
resolved peak in developed HPTLC plate. 
Figure 5.55 showed Overlain Chromatogram of EAA, ESX, EHI and Mixture 
while figure 5.56 explain 3D image for Chromatogram of EAA, ESX, EHI and 
Mixture 
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Figure 5.55 Overlain Chromatogram of EAA, ESX, EHI and Mixture 
 
 
 
Figure 5.56  3DChromatogram of EAA, ESX, EHI and Mixture 
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6. Discussion 
Steroids are most helpful drug candidates in treatment of anti-inflammatory 
diseases. In present study, selection of plants containing steroidal moiety done based 
on availability of plant material and its reported uses. Many herbal plant steroids are 
investigated for their benefits but no systematic study was reported for evaluation of 
steroidal contents as corticoids.  
Plant and its part selected as major source of herbal steroid were Fenugreek 
(Trigonella foenum graecum) seed, Wild Yam (Dioscorea alata) underground tuber, 
Indian Sarsaparilla (Hemidesmus indicus) root, Agave americana leaf and Kantakari 
(Solanum xanthocarpum) fruits.  The plant materials herbariums (No. SU/DPS/407-
411, dated 14/10/2011) were identified and authentifed by centre for advanced studies 
in plant biotechnology and genetic engineering, Saurashtra University, Rajkot. The 
report for the identification and authentification attached in Annexure. 
Fenugreek (Trigonella foenum graecum) seed, Wild Yam (Dioscorea alata) 
underground tuber, Indian Sarsaparilla (Hemidesmus indicus) root, Agave americana 
leaf and Kantakari (Solanum xanthocarpum) fruits were procured from authentic 
source and evaluated for macroscopic characters as per references given in previous 
section. All selected plant material were packed and stored properly. 
The steroid hormone such as the adrenocorticoids is present in the body only 
in very low concentrations (e.g., 0.1-1.0 nM). Yet, these hormones exert potent 
physiologic effects on sensitive tissues at those low concentrations. Over the past 
several decades, the general mechanism of steroid hormone action has been 
extensively studied (David  et al., 2002). 
The corticoid steroids may be classified as those having important effects on 
intermediary metabolism (glucocorticoids) and those having principally salt-retaining 
activity (mineralocorticoids) (Katzung  et al., 2007). 
Glucocorticoids dramatically reduce the manifestations of inflammation. This 
is due to their profound effects on the concentration, distribution, and function of 
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peripheral leukocytes and to their suppressive effects on the inflammatory cytokines 
and chemokines and on other lipid and glucolipid mediators of inflammation. The 
benefits obtained from use of the glucocorticoids vary considerably. Use of these 
drugs must be carefully weighed in each patient against their widespread effects on 
every part of the organism (Mehdi et al., 2007). 
The major undesirable effects of the glucocorticoids are the result of their 
hormonal actions, which lead to the clinical picture of iatrogenic Cushing's syndrome 
and many other side effects. The study protocol was approved by Institutional animal 
ethics committee and the protocol no. is SU/DPS/IAEC/1001 date 11/02/2010 as 
attached in annexure. 
The aim of present study was to investigate effect of steroidal saponins and 
indexed them as glucocorticoid and mineralocorticoid. The selection of solvent 
performed based on solubility of steroidal content of plant. The plant materials were 
pre-socked for 12 hrs with water to enhance its extraction through soxhlet hot 
extraction. The common solvent and common procedure for all extract applied to 
performed comparative evaluation of all plant materials. Literature survey reveals that 
the steroidal saponins are best extracted with ethanol. 
Evaluation of steroidal content of selected plant material is important and it 
was important task to check presence of steroidal content in present ethanolic extracts. 
The plant extract were evaluated for qualitative estimation of steroidal by chemical 
test and thin layer chromatography.   
Many chemical tests in literature reported for saponins and plant steroids 
(Hostettamann et al., 1995). In present study four representative chemical tests were 
selected and performed to check presence of steroidal content.  Saponin containing 
plants produce foam when they are shaken in water solutions. saponin like compound 
produces heamolysis in RBC showed clear RBC rupture under microscope. 
Libermann Bruchard test commonly used to check presence of steroidal 
moiety in plant material. Unsaturated and hydroxylated triterpenes and steroids give a 
red, blue or green coloration with acetic anhydride and sulphuric acid (Abisch et al. 
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1960). Since terpenoid saponins tend to produce a pink or purple shade and steroidal 
saponins a blue-green coloration. In another chemical test with antimony trichloride, 
all plant material extracts produced formation of pink which indicate presence of 
steroids (Hostettamann et al., 1995). 
The qualitative analysis of saponins by TLC is of great importance for all 
aspects of saponin investigations. TLC plates (usually silica gel) can handle both pure 
saponins and crude extracts, are inexpensive, rapid to use and require no specialized 
equipment. A number of visulization reagents are available for spraying onto the 
plates. Here in present study two TLC visualization reagents, Lieberman Burchard 
reagent and 20% H2SO4 solution were used (Hostettamann et al., 1995). 
The Libermann Bruchard reagent showed clear indication for presence of 
steroidal molecule in all plant extracts when pre coated TLC plates observed under 
white light. In ETF spot, major steroidal spot were visualized with dark purple and 
pink color. In EDA spot, major steroidal spot were found light purple and dark purple 
coloration. EHI spot gave presence of steroidal spot with dark purple and dark pink 
tint. In EAA spot, major steroidal spot showed dark purple, green and dark green 
coloration. ESX spot gave major steroidal band of dark purple and light purple tint. 
Another TLC plate was developed in 20% H2SO4 solution which gives red to pink 
color for triterpenoids and saponins ( Abisch  et al., 1960).  
TLC observed in UV366 UV254 serve additional basis for qualitative evaluation 
by TLC method. The TLC developed with spraying reagent 20% H2SO4 solution and 
observed in UV254 shown blue appearance because of destruction of illuminating 
substance of HPTLC plate by H2SO4. 
The ANOVA tests the null hypothesis that samples in two or more groups are 
drawn from the same population. When ANOVA shows a significant difference 
between groups, if one of the groups is a control (reference) group, Dunnett's Test is 
used as a post hoc test. This multiple comparison test can be used to determine the 
significant differences between a single control group mean and the remaining 
treatment group means in an analysis of variance setting. It is one of the least 
conservative post hoc tests (Anscombe  et al., 1948). 
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Adjuvant arthritis in rats 
Utilizing the footpad for immunization of rat may be necessary in particular 
studies where the isolation of a draining lymph node, as a primary action site, is 
required. The well being of subject animals should be addressed such as limiting the 
quantity of adjuvant-antigen solution injected into the footpad, the use of only one 
foot per experimental animal, and housing on soft bedding rather than screens. In 
instances where there is no evidence indicating a specific requirement for footpad 
inoculation, this technique should not be used for routine immunization of rat. If 
scientific justification is provided, the recommended maximum footpad injection 
volumes are 0.01-0.05 in mice and 0.10 ml for rats (Jackson et. al. 1995). 
Adjuvant arthritis (AA) is an induced form of (sub) chronic arthritis. Strains of 
rats have a varying genetic susceptibility to AA, whereas mice generally are not 
susceptible. Adjuvant arthritis (AA) was initially observed by accident when complete 
Freund’s adjuvant (CFA) was used for immunization (Pearson et al., 1956). An 
injection of complete Freund’s adjuvant into the rat paw induces inflammation as 
primary lesion with a maximum after 3 to 5 days. In this protocol, adjuvant arthritis 
(AA) is induced in albino Wistar rats in the classical manner using ground, heat-killed 
Mycobacterium tuberculosis H37Ra suspended in incomplete freund’s adjuvant in left 
paw of rat. 
The choice of the animal strain has been found to be very important for the 
performance of this test. Wistar rats have been proven to be very suitable in contrast 
to other sub strains. In present study albino Wistar rat were used as test animal and 
reference (Rekha et. al. 2010, Mingxing et. al. 2005, and David et. al. 1980) available 
for adjuvant arthritis animal model. 
Secondary lesions occur after a delay of approximately 12 days which are 
characterized by inflammation of non-injected sites (hind leg, forepaws, ears, nose 
and tail), a decrease of weight and immune responses. The procedure has been 
modified by several authors in order to differentiate between anti-inflammatory and 
immunosuppressive activity (Perper et al. 1971). Anti-inflammatory compounds do 
not inhibit secondary lesions, which are prevented or diminished by 
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immunosuppressive agents. The result of this study gives important direction for 
preparation of glucocorticoid and mineralocorticoid comparative index of selected 
herbs.  
All animal were grouped (n=6) as control, HC, ETF, EDA, EHI, EAA and 
ESX. Dose 300 mg/kg per rat kept common for all other treatment group for 
comparative evaluation of relative potencies.  Paw volumes of both sides and body 
weight were recorded on the day of injection, day 5, day 12, day 17 and day 21 
whereby paw volume is measured plethysmographically. 
Decrease of weight of normally observed with catabolic steroids in rat. After 
the completion of study, on day 21 the weight were measure and change in weight 
compare with initial weight (day 1, before injection of CFA).   
The injection of catabolic steroid, hydrocortisone provoked steroid like action 
marked by decrease in body weight. The decrease in body weight by hydrocortisone 
on day 5 and day 12 found significant (p<0.05) when compared to control. The 
significant weight loss of any plant extracts observed after day 17. The weight 
reduction by hydrocortisone and ESX on day 17 found extremely significant 
(p<0.001) and significant (p<0.05) when compared to control. 
 On day 21 all treatment groups except ETF and EDA showed significant 
weight loss as compare to control group. The reduction in weight loss by HC and ESX 
were extremely significant (p<0.001) and highly significant (p<0.01) while EHI and 
EAA showed significant (p<0.05) weight loss when compared to control. 
Catabolic steroids have some noted side effects including weight gain. The 
hydrocortisone treated group showed weight loss which is because of more calcium 
per unit length of bone and decrease in the skeletal structure (Yasumura et. al. 1976).  
Corticoids produce anti-inflammatory and Immunosuppressant activity and 
both activity can be differentiate in adjuvant arthritis in rat (Vogel et al., 2002). The 
inhibition of paw volume at injected site after 5 days is because of its anti-
inflammatory potential while inhibition of paw volume at non-injected site after 12 
 Discussion…  
 
 
 177 
 
days and inhibition of arthritic lesion are because of its potential to modulate immune 
response. 
Paw volume measured on day 5 for left (injected) and right (non injected) paw 
in ml for control, HC, ETF, EDA, EHI, EAA and ESX. No group showed significant 
change in paw volume as compare to control (P<0.05). The result after day 5 suggests 
mild anti inflammatory activity by all treatment groups.  
 On day 12, the change in left (injected) paw volume (ml) for control, HC, ETF, 
EDA, EHI, EAA and ESX were calculated. The reduction in edema for HC found 
highly significant and EAA significant (p<0.05). The change in right (non-injected) 
paw volume (ml) on day 12 for control, HC, ETF, EDA, EHI, EAA and ESX were 
calculated and The reduction in edema for HC found highly significant while EDA, 
EHI, EAA and ESX significantly reduced paw edema (p<0.05). 
Edema (Paw volume) measured on day 17 for left and right paw in ml. On day 
17, the change in left (injected) paw volume (ml) for control, HC, ETF, EDA, EHI, 
EAA and ESX were calculated and The reduction of edema for HC and EAA were 
highly significant while ETF, EDA, EHI and ESX showed significant decrease in paw 
volume (p<0.05). On day 17, the change in right (non-injected) paw volume (ml) for 
control, HC, ETF, EDA, EHI, EAA and ESX were calculated. The reduction of 
edema for only HC found significant (p<0.05). 
Paw volume measured on day 21 for left and right paw in ml. On day 21, the 
change in left (injected) paw volume (ml) for control, HC, ETF, EDA, EHI, EAA and 
ESX were expressed. The reduction of edema for HC EAA, EHI and ESX were 
highly significant and the reduction of edema for EDA was significant (p<0.05). The 
change in right (non-injected) paw volume (ml) on day 21 for control, HC, ETF, EDA, 
EHI, EAA and ESX were calculated and The reduction in paw volume for HC, ETF, 
EDA, EHI and ESX found highly significant while EAA significantly reduced paw 
edema (p<0.05). 
The immunosuppressive activity can also express by inhibition of lesion 
compare to control on day 21. The arthritic lesion on day 21 for control, HC, ETF, 
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EDA, EHI, EAA and ESX were calculated as per the scheme given in materials and 
method. The suppression of arthritic lesion on day 21 for HC, EHI, EAA and ESX 
found highly significant while ETF and EDA showed significantly inhibition of 
arthritic lesion (p<0.05). 
 Primary lesions expressed by change in paw volume by injected left paw on 
day 5. All treatment groups showed mild anti inflammatory action on day 5 when we 
recorded change in left (injected) paw volume as compare to day 1.  
 Secondary lesions (immune response) expressed by change in paw volume by 
non injected right paw on day 12. All treatment groups except ETF showed significant 
immunosuppressive action on day 12 when we recorded change in right (non-
injected) paw volume as compare to day 1. 
 The immunosuppressive action also expressed by inhibition of arthritic lesion 
on day 21 and all treatment group showed significant reduction in lesion (p<0.05). 
The total percentage change calculated by addition of percentage inhibition of 
left paw on day 5, percentage inhibition of right paw on day 12 and percentage 
inhibition of arthritic score on day 21. The total percentage change for HC, ETF, EDA, 
EHI, EAA and ESX were calculated which shows overall potential of plant extract as 
herbal steroids.  
Liver glycogen deposition  
The liver glycogen deposition test, as described by Stafford et al. (1955) is a 
simple and specific test for Glucocorticoid activity.  
A well-established action of adrenal-cortical steroids in the intact animal is to 
stimulate hepatic glycogen deposition, as may be inferred from the decline in liver 
glycogen after Adrenalectomy (Vogel et al. 2002). This effect of glucocorticoid is due 
to activation of glycogen synthetase to produce the form, as shown by measurements 
of pathway intermediates and of enzyme activities. Conversely, in starved 
adrenalectomized animals, activation of synthetase to the form is impaired, and the 
capacity for glycogen deposition is diminished. This lesion in the synthetase system 
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may be corrected by glucocorticoid and also by administration of glucose or insulin to 
intact animals, and is impaired in insulin deficient animals, suggesting that the 
impairment in glycogen synthesis may reflect insulin insufficiency (Patricia et. al. 
1976). 
The classical evaluation of hormone functions is the surgical ablation of the 
hormone producing endocrine gland and the substitution with exogenously 
administered substances. Most studies on the physiological role of adrenocortical 
hormones and the pharmacological effects of corticosteroids were performed in 
adrenalectomized rats. This procedure involved complete removal of both, adrenal 
gland cortex and medulla. As a results the glucose, glycogen and mineral metabolism 
of rat altered and their ability to store minerals, glucose, glycogen etc. impaired. 
Therefore this animals model is useful for the wide range of metabolic studies 
including hormone metabolism, obesity, drug metabolism etc. This model frequently 
used in studies related to endocrinology and neurology (Stafford et al., 1955). 
Carbohydrate exists as free sugars and polysaccharides. The basic units of 
carbohydrates are the monosaccharide which cannot be split by hydrolysis into 
simpler sugars. The carbohydrate content can be measured by hydrolysing the 
polysaccharides into simple sugars by acid hydrolysis and estimating the resultant 
monosaccharide. Carbohydrates are first hydrolyzed into simple sugars using dilute 
hydrochloric acid. In hot acidic medium glucose is dehydrated to hydroxymethyl 
furfural. This compound forms with anthrone a green colored product with an 
absorption maximum at 620 nm (Vogel et al. 2002). 
The Calibration curve of glucose for estimation of liver glycogen was 
prepared and linearity range, co-relation coefficient (r
2
) and linearity equation were 
20-100 µg/ml, 0.986 and Y = 0.006X + 0.103. 
The care should be taken while mixing 30% KOH solution with anthrone 
reagent in sulphuric acid (95%) which laid to effervescence of fumes. The liver 
glycogen deposition was measure on day 5 after seven hrs post treatment from 
calibration curve of glucose. The glycogen deposition in liver was expressed as liver 
glycogen in mg per gm of liver. The increase in liver glycogen for HC was found 
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highly significant. The gain in liver glycogen for EHI and EAA was found moderately 
significant while ESX was found significant when compared with control (P<0.05). 
Glucocorticoids exert minor effects on hemoglobin and erythrocyte content of 
blood, as evidenced by the frequent occurrence of polycythemia in Cushing's 
syndrome and of normochromic, normocytic anemia in adrenal insufficiency 
(Wardlaw et al., 2001). More profound effects are seen in the setting of autoimmune 
hemolytic anemia, in which the immunosuppressive effects of glucocorticoids can 
diminish the self-destruction of erythrocytes. The administration of glucocorticoids 
leads to a decreased number of circulating lymphocytes, eosinophils, monocytes, and 
basophils. The hematological evaluation for blood cells, SGPT, SGOT, serum calcium 
and serum potassium was performed for control group and treatment groups. 
The red blood corpuscle (RBC) count (10
6
/cumm) for control, HC, EHI, EAA 
and ESX were calculated and The increase in RBC for HC was found to be significant 
as compare to control (P<0.05). The white blood cells (WBC) count per cu mm for 
control, HC, EHI, EAA and ESX were measured and the gain in WBC for ESX was 
found to be moderately significant as compare to control which support its 
immunomodulatory activity. The increase in WBC for HC was found to be significant 
as compare to control (P<0.05). The platelets count per (10
3
/cumm) for control, HC, 
EHI, EAA and ESX were calculated and only EAA showed significant decrease in 
platelet counts as compare to control (P<0.05). 
Aldosterone is by far the most potent endogenous corticosteroid with respect 
to fluid and electrolyte balance. Mineralocorticoid act on the distal tubules and 
collecting ducts of the kidney to enhance reabsorption of Na
+
 from the tubular fluid, 
they also increase the urinary excretion of K
+
 and H
+
. Conceptually, it is useful to 
think of aldosterone as stimulating a renal exchange between Na+ and K
+ 
or H
+ 
(Bernard et al., 2008). 
In addition to their effects on monovalent cations and water, glucocorticoids 
also exert multiple effects on Ca
2+
 metabolism. Steroids interfere with Ca
2+
 uptake in 
the gut and increase Ca
2+
 excretion by the kidney. These effects collectively lead to 
decreased total body Ca
2+
 stores (Bernard et al., 2008).  
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The serum calcium level (mg/dl) for control, HC, EHI, EAA and ESX were 
calculated. The HC shown moderately significant increase in serum calcium level as 
compare to control while EAA shown significant gain in serum calcium level as 
compare (P<0.05). The serum potassium level (mMol/liter) for control, HC, EHI, 
EAA and ESX were calculated. The HC shown highly significant increase in serum 
potassium level as compare to control (P<0.05). 
Liver has to perform different kinds of biochemical, synthetic and excretory 
functions, so no single biochemical test can detect the global functions of liver. 
Enzymes that are often measured in LFTs include gamma-glutamyl transferase 
(GGT); alanine aminotransferase (ALT or SGPT); aspartate aminotransferase (AST or 
SGOT); and alkaline phosphatase (ALP). LFTs also may include prothrombin time 
(PT), a measure of how long it takes for the blood to clot (Henderson et al. 2001).  
Alanine aminotransferase (ALT), formerly called serum glutamate pyruvate 
transaminase, or SGPT, is an enzyme necessary for energy production. It is present in 
a number of tissues, including the liver, heart, and skeletal muscles, but is found in the 
highest concentration in the liver. Aspartate aminotransferase (AST), formerly called 
serum glutamic-oxaloacetic transaminase, or SGOT, is another enzyme necessary for 
energy production. It, too, may be elevated in liver and heart disease. In liver disease, 
the AST increase is usually less than the ALT increase. However, in liver disease 
caused by alcohol use, the AST increase may be two or three times greater than the 
ALT increase (Henderson et al. 2001). 
Serum glutamate pyruvate transaminase, or SGPT (ALT) level (IU/L) for 
control, HC, EHI, EAA and ESX were calculated and The HC shown moderately 
significant increase in SGPT as compare to control (P<0.05). SGOT or Serum 
glutamic-oxaloacetic transaminase (AST) level (IU/L) for control, HC, EHI, EAA and 
ESX were calculated the HC shown significant increase in SGOT level as compare to 
control (P<0.05). 
Liver glycogen was determined under standard conditions on intact and 
adrenalectomized rats. The liver uses glucose as a fuel and also has the ability to store 
it as glycogen and synthesize it from noncarbohydrate precursors (gluconeogenesis). 
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Periodic acid-Schiff (PAS) is a staining method used to detect glycogen and other 
polysaccharides in tissues. The reaction of periodic acid oxidizes the diol functional 
groups in glucose and other sugars, creating aldehydes that react with the Schiff 
reagent to give a purple-magenta color. A suitable basic stain is often used as a 
counterstain. Wax blocks were made and section was made by microtome, stained by 
Periodic acid-Schiff (PAS) and photographed (Ulusoy  et al.,  2006). 
The effect of HC, EHI, EAA and ESX on histopathology of liver during liver 
glycogen deposition study carried out and the Histopathology of liver treated with HC 
clearly showed more deposition of glycogen in hepatocytes. The Glycogen deposition 
was comparatively observed more in HC, EHI and EAA while ESX showed least 
signs for glycogen deposition. 
Mineralocorticoid activity in rat 
Corticoid hormones exert their physiological action by binding to receptors 
that belong to a transcription factor superfamily, which also includes some of the 
proteins regulating steroid synthesis. Steroids stimulate sodium absorption by the 
activation and/or de novo synthesis of the ion-gated, amiloride-sensitive sodium 
channel in the apical membrane and that of the Na/K -ATPase in the basolateral 
membrane. Receptors, channels, and pumps apparently are linked to the cytoskeleton 
and are further regulated variously by methylation, phosphorylation, ubiquination, and 
glycosylation, suggesting a complex system of control at multiple checkpoints. 
Mutations in genes for many of these different proteins have been described and are 
known to cause clinical disease. Mineralocorticosteroids enhance sodium retention 
and potassium excretion. The sodium excretion in adrenalectomized rats is dose-
dependently decreased. This parameter can be used for mineralocorticoid activity of 
test compounds  (Chrousos et al., 1995). 
Wistar rats have been proven to be very suitable in contrast to other sub strains 
(Vogel et al., 2002). In present study albino Wistar rat were used as test animal and 
many references available for determination of electrolyte excretion in 
mineralocorticoid activity model. The mineralocorticoid activity by measurement of 
sodium excretion carried out only for all herb extracts and standard drug. Along with 
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sodium excretion, urine analysis also performed for urine chlorides, urine potassium 
and urine Creatinine (Vogel et al. 2002).  
The urine chloride (Cl
-
) level (mMol/L) for control, HC, EHI, EAA and ESX 
were calculated and HC shown moderately significant decrease in urine chloride level 
as compare to control (P<0.05). The urine Creatinine level (mg/dl) for control, HC, 
EHI, EAA and ESX were calculated and The HC showed moderately significant gain 
in urine creatinine level as compare to control (P<0.05). 
The urine sodium level (mMol/L) for control, HC, EHI, EAA and ESX were 
calculated and The HC showed highly significant fall in urine sodium level as 
compare to control while EAA showed significant reduction in urine sodium level as 
compare to control (P<0.05). The urine potassium level (mMol/L) for control, HC, 
EHI, EAA and ESX were calculated and HC showed moderately significant increase 
in potassium excretion level as compare to control (P<0.05). 
The Na
+
/K
+ 
ratio for control, HC, EHI, EAA and ESX were expressed and The 
HC showed moderately significant fall in Na
+
/K
+ 
ratio as compare to control (P<0.05) 
which clearly suggest reduction in sodium excretion and increase in potassium 
excretion. 
Relative Potencies of Hydrocortisone, EHI, EAA and ESX were calculated 
and Glucocorticoid potential of (Liver glycogen deposition) HC, EHI, EAA and ESX 
were found to be 1.0, 0.61, 0.58 and 0.55 while Mineralocorticoid potential (Na+ 
excretion) of HC, EHI, EAA and ESX were found to be 1.0, 0.57, 0.73 and 0.36 
All plant extracts exert insignificant action on vital hematological parameter except 
reduction in platelets count and increase serum calcium by EAA. Except EAA, both 
EHI and ESX have not shown any significant sigh on urine electrolyte in evaluation 
as mineralocorticoid.  Final conclusion drawn from study is that combined extract of 
EHI and ESX can be used as alternative for synthetic steroids in steroid therapy while 
EAA can be used in condition like Addison’s disease.  
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Quality control 
In general, the methods for quality control of herbal medicines involve sensory 
inspection (macroscopic and microscopic examinations) and analytical inspection 
using instrumental techniques such as thin layer chromatography and High 
performance thin layer chromatography. TLC is still frequently used for the analysis 
of herbal medicines since various pharmacopoeias such as American Herbal 
Pharmacopoeia, Chinese Drug Monographs and Analysis; Pharmacopoeia of the 
People’s Republic of China etc. still use TLC to provide first characteristic 
fingerprints of herbs. Rather, TLC is used as an easier method of initial screening with 
a semi quantitative evaluation together with other chromatographic techniques 
(Kotadia  et al., 2005). 
High performance thin layer chromatography (HPTLC) is an enhanced form 
of thin layer chromatography (TLC). A number of enhancements can be made to the 
basic method of thin layer chromatography to automate the different steps, to increase 
the resolution achieved and to allow more accurate quantitative measurements. 
Automation is useful to overcome the uncertainty in droplet size and position when 
the sample is applied to the TLC plate by hand. One recent approach to automation 
has been the use of piezoelectric devices and inkjet printers for applying the sample 
(Hostettamann et al., 1995).  
High performance thin layer chromatography (HPTLC) is an invaluable 
quality assessment tool for the evaluation of botanical materials. It allows for the 
analysis of a broad number of compounds both efficiently and cost effectively. 
Additionally, numerous samples can be run in a single analysis thereby dramatically 
reducing analytical time. With HPTLC, the same analysis can be viewed using 
different wavelengths of light thereby providing a more complete profile of the plant 
than is typically observed with more specific types of analyses. HPTLC finger 
printing provides important information to evaluate composition of any herbal extract 
as single or in mixture (Kotadia  et al., 2005).  
In present study we developed a HPTLC method for fingerprinting of EHI, 
EAA and ESX. The mixture also prepared in same proportion for EHI, EAA and ESX 
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and the HPTLC fingerprinting developed for mixture. Based on result obtained after 
mobile phase optimization, it clearly showed that mobile phase Toluene/Ethyl 
acetate/Methanol, 6:1:0.8 v/v/v resolved more number of peaks for ETF, EDA, EHI, 
EAA and ESX. 
HPTLC performed only for EHI, EAA and ESX, those herbs which showed 
significant activity as steroids in adjuvant arthritis activity. Selected mobile phase, 
Toluene/Ethyl acetate/Methanol, 6:1:0.8 v/v/v used for further investigation of plant 
extracts. In instrumental component winCATS planner chromatography system 
manager used along with Camag linomat 5 semi automatic applicator and Camag 
scanner 3 with quantitative evaluation. TLC Aluminum sheets of silica gel 60 F254 pre 
washed with methanol before HPTLC analysis and the saturation time optimized to 45 
min. 
The Developed and scanned band of EAA showed good resolution of 7 bands,  
ESX showed good resolution of 6 bands and EHI showed good resolution of 13 bands 
when scanned ay UV366. Overlain Chromatogram of EAA, ESX, EHI and Mixture 
while figure 5.56 explain 3D image for Chromatogram of EAA, ESX, EHI and 
Mixture for HPTLC fingerprinting. 
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7. Summary and Conclusion 
The adrenocorticoids are mainly used because of its glucocorticoid and 
mineralocorticoid action.  The use of sterids is almost unavoidable in many clinical 
situations like chronic inflammation, arthritis, Addison’s disease etc. which lead to 
toxic manifestation. Selection of corticoids depends on its potential as glucocorticoid 
and mineralocorticoid.  The use of adrenocorticoids can be replaced with herbal 
steroids. To generate clinical evidence for herbal steroids we need to established 
herbal steroids as glucocorticoid and mineralocorticoid.   
Pharmacologic activities of steroid containing plants like Wildyam, Kantakari, agave 
spices, Indian Sarsaparilla and fenugreek have been reported and this may be a hint 
for investigating use of herbal steroids as therapeutic agents. Hence, in order to find a 
safer alternate steroid management for various ailments. 
Literature survey revealed that no systematic study has been reported to classify 
herbal steroids as glucocorticoid and mineralocorticoid. The indexing of herbal 
steroids based on its corticoid potential, it can be used to replace allopathic steroids 
and adverse manifestation can be overcome. 
Identified and authentified plant herbal steroid were Trigonella foenum graecum seed, 
Dioscorea alata underground tuber, Hemidesmus indicus root, Agave americana leaf 
and Solanum xanthocarpum fruits. The common solvent and common procedure for 
all extract applied to performed comparative evaluation of all plant materials. 
Literature survey reveals that the steroidal saponins are best extracted with ethanol.  
The presence of steroids in plant extract were ensure by test like foam test, 
haemolysis test, libermann bruchard test and antimony trichloride test. The all plant 
extracts were also by checked for its steroidal content by TLC and visualized in 
Libermann Bruchard reagent and 20% H2SO4 solution. 
Adjuvent arthritis in rat (n=6) used as animal model to evaluate steroidal potential of 
selected herbs. The total percentage change was calculated for all extracts and top 
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three results against control group were 96.8, 90.33 and 86.88 for ESX, EAA and EHI 
respectively. 
The proved extracts of EHI, EAA and ESX further investigated for glucocorticoid 
potential by liver glycogen deposition in rat (n=6) and mineralocorticoid potential by 
measuring sodium excretion in urine. 
All herbal extracts showed significant glycogen deposition in rat with clear indication 
in histopathology. All plant extracts exert insignificant action on vital hematological 
parameter except reduction in platelets count and increase serum calcium by EAA. 
Except EAA, both EHI and ESX have not shown any significant sigh on urine 
electrolyte in evaluation as mineralocorticoid.  Final conclusion drawn from study is 
that combined extract of EHI and ESX can be used as alternative for synthetic steroids 
in steroid therapy while EAA can be used in condition like Addison’s disease.  
The said work can be extend in following direction 
 More herbal extracts should be screened for its glucocorticoid and 
mineralocorticoid potential. 
 Polyherbal formulation of glucocorticoid herbal steroids should be 
evaluated for synergistic action and clinical trials in chronic inflammation 
like rheumatoid arthritis. 
 Polyherbal formulation of mineralocorticoid herbal steroids should be 
evaluated for synergistic action and clinical trials in condition like 
Addison’s disease. 
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